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ABSTRACT 
In recent years, the environmen!al occurrence, lltte and effects of phannaceuticals or phannaceutically active compounds 
(PhACs) and their metabolites have received increased attention. PhACs have been detected in wastewater, river water, 
marine waters and even sewage sludge and soil. Since PhACs are developed with the intention of stimulating or inhibiting 
physiological responses, these findings have prompted concern over their environmental fate and potential adverse effects 
on nontarget ecological•species. 
The major source of discharge of PhACs to the environment is through sewage treatment works (STWs) effluents and 
sludges. Although used in quantities similar to many agrochemicals and other organic micropollutants, PhACs are' not 
required by legislation to undergo the same level of testing for possible environmental effects. Therefore, PhACs and their 
metabolites have been subject to many years of unrestricted emission to the environment. Typically, concentrations 
measured in municipal sewage treatment plant effluents are mg L· 0, whilst those in the surface waters range from ng L"0 to 
Ill! L"0• 
The fate of PhACs in the aquatic environment is determined by both abiotic and biotic processes. Abiotic transformations in 
surface waters may occur via hydrolysis-and photolysis, with photolysis thought to be a significant factor in determining 
their environmental fate. In the present study, the ·anti-anxiety drug, diazepam (Valium~ along with its known human 
metabolites, nordiazepam, temazepam and oxazepam were selected for photodegradation studies. 
The photodegradability of each drug in distilled llnd natuml waters was evaluated using a Suntest CPS Xenon arc lamp, 
selected to reproduce the spectral distribution of solar irmdiation, with emphasis on the determination of degradation mte 
constants anci half-lives under realistic environmental conditions. Solid phase extraction (SPE) methods were developed for 
extraction of these compounds from natuml waier samples and analysis was performed using high performance liquid 
chromatogmphy (HPLC) separation with electrospmy ionisation multistage mass spectrometry (ESI-MS") detection. 
Results demonstmted that whilst the compounds were hydrolytically stable in aqueous solutions, photolysis significantly 
reduced the concentration of diazepam Wld its metabolites in aqueous solutions. The measured half-lives (1 012) of diazepam, 
nortliazepam, temazepam and oxazepam in distilled water were 100, 193, 36 Wld 32 hours respectively. Novel 
photoproducts including 5-chloro-2-methylaminoben7.ophenone (m/z 246, [M+H]') and 2-amino-5-chlorobenzophenone 
(mlz 232, [M+Hj} were detected and characterised by electrospmy ionisation multistagc mass spectrometry (ESI-MS") and 
comparison with-reference compounds. The identities of a range of further photoproducts observed,in-aqueous solutions of 
photodegraded PhACs were proposed based on ESI-MS" data analysis. 
The presence of natural organic matter (NOM), specifically humic acids at environmental levels (I mg L" 0) were-found to 
approximately double the mte of photodegmdation for di87.epam and nortliazepam (Ion 28 and 48 hours respectively). In 
contrast, results for the metabolites temazepam and oxazepam suggest•that the presence of humic acids led to a reduction in 
the mte ofphotodegmdation (ton 72 and 66 hours respectively). 
The direct and indirect photodegrodation kinetics determined in the present study for diazepam and its human metabolites 
were applied to UK river catchment models using a computer ll!odel, GREAT-ER. Maximum predicted environmental 
concentrations (PECs) were .determined for each compound and the impact of phototransformation on the removal of each 
compound was evaluated in two river catchments representing an urban/industrial catchment (river Aire) and a ruml 
catchment (river Exe) respectively, under low now (summer) and mean now (winter) river conditions. The modelling 
predictions suggest that phototransformation may be an important process for removing di87.epam and excreted human 
mctabolites of diazepam froin natural rivCrine and lacustrine environments. The overall results demonstrated that with 
photolysis half-lives ranging from .193-32 hours, diazepam and its human metabolites'are unlikely to be persistent in natural 
waters. 
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CHAPTER ONE 
Introduction 
This thesis describes an investigation of the photodegradation of selected pharmaceuticals 
(diazepam, nordiazepam, temazepam and oxazepam) in water in an attempt to better 
understand their envirorunental fate. In particular the study focuses on the determination of 
mte constants and half-lives under realistic envirorunental conditions and the formation of 
photoproducts and elucidation of the photochemical pathways responsible for photoproduct 
formation. The thesis begins with a review of current knowledge of the fate of 
pharmaceuticals in the envirorunent, together with an overview of the selection procedures 
used to identify suitable candidate pharmaceuticals for study. 
1.1 Introduction 
Over the last three decades, research on the impact of chemical pollution has focussed 
almost exclusively on the conventional ''priority" pollutants [i.e. persistent organic 
pollutants (POPs)], especially those considered to be toxic or carcinogenic such as 
polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), 
polychlorinated dibenzo-p-dioxins and furans (PCDD/Fs) and many organochlorine 
pesticides including DDT and its metabolites (e.g. Anderson et al., 1988; Borrell, 1993; 
Fromberg et al., 1999; Jones et al., 1999). The majority of developed countries have 
adopted legal measures for eliminating many of the dominant pollution sources of such 
compounds (Jones et al., 2005). More recently, scientific focus has shifted to compounds 
present at lower concentrations but which might nevertheless represent an environmental 
threat. One diverse group of bioactive chemicals which is receiving increasing attention is 
the pharmaceuticals or pharmaceutically active compounds (PhACs) and their metabolites 
(Halling-Sorensen et al., 1998; Daughton, 200 I). 
Many of the more commonly used pharmaceuticals (e.g. antibiotics), are used in quantities 
similar to those of many agrochernicals and other organic micropollutants but they are not 
required by legislation to undergo the same level of testing for possible environmental 
effects (Jones et al., 2002). PhACs and their metabolites have therefore been subject to 
many years of unrestricted emission to the aquatic environment as complex mixtures 
through a number of pathways, primarily from sewage treatment works (STWs) effluents 
and sludges (Temes, 2000). Studies in Austria, Brazil, Canada, Croatia, Gennany, Italy, 
Spain, Switzerland, Netherlands, UK and the US have detected more than 80 PhACs in 
surface waters (Heberer, 2002; Boyd et al., 2003), including analgesics, antibiotics, 
antiepileptics, 13-blockers and lipid regulators (Daughton and Temes, 1999). 
2 
PhACs are developed with the intention of stimulating or inhibiting physiological 
responses in humans and domestic animals. However, there is potential for unforeseen 
adverse effects on nontarget ecological species. For example, many phannaceuticals are 
designed to affect human endocrine systems and have obvious potential as endocrine 
disruptors (Ayscough et al., 2000). PhACs often have physico-chemical properties similar 
to those of other hannful xenobiotics such as DDT and PCBs and most drugs are designed 
to be persistent, retaining their chemical integrity long enough to perform their therapeutic 
action. Coupled with their continuous inputs via waste streams this may enable them to 
remain in the environment for significant time periods and thus be considered persistent 
pollutants. 
PhACs are produced in very large volumes and their use and diversity is increasing every 
year. Although exact data are rarely available, estimates based on the number of 
prescriptions issued by doctors suggests that, for example, around l 00 tons of individual 
drugs were prescribed in Germany in 1995 (Ternes et al., 1998). In the UK, where there 
are currently almost 3000 active substances licensed for use (Ayscough et al., 2000), usage 
in the year 2000 exceeded 10 tonnes per year for each of the top 25 compounds and the 
figure for the top three compounds (paracetamol, metaformin hydrochloride and ibuprofen) 
was greater than I 00 tonnes per year (Jones et al., 2002). This amount underestimates the 
total usage of all drugs, many of which can be purchased without a phannacy prescription 
and others which are procured illegally. An escalating introduction to the marketplace of 
new phannaceuticals is adding to this already large array of chemical classes, each with 
distinct modes of biochemical action. 
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Table 1.1 The 25 most used pharmaceuticals by weight in England in 2000 
Compound Name Therapeutic use 
Paracetamol Analgesic 
Metafonnin hydrochloride Antihyperglycaemic 
lbuprofen Analgesic 
Amoxycillin Antibiotic 
Sodium valproate Anti-epileptic 
Sulphasalazine Antiheumatic 
Mesalazine (systemic) Treabnent of ulcerative 
colitis 
Carbamazepine Anti-epileptic 
Ferrous sulphate Iron supplement 
Ranitidine hydrochloride Anti-ulcer drug 
Cirnetidine H2 receptor antagonist 
Naproxen Anti-inflammatory 
Atenolol b-blocker 
Oxytetracycline Antibiotic 
Erythromycin Antibiotic 
Diclofenac Anti-inflammatory and 
analgesic 
Flucloxacillin Antibiotic 
Phenoxymethylpenicillin Antibiotic 
Allopurinol Antigout drug 
Diltiazem hydrochloride Calcium antagonist 
Gliclazide Antihyperglycaemic 
Aspirin Analgesic 
Quinine sulphate Muscle relaxant 
Mebeverine hydrochloride Antispasmodic 
Mefanamic acid Anti-inflammatory 
(Data compiled by Jones et al., 2002) 
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Total 
prescription 
items 
dispensed 
(x103) 
10,636 
3,596 
6,683 
12,849 
1,495 
622 
622 
2,256 
2,639 
3,770 
1,496 
1,381 
11,554 
1,195 
2,936 
7,639 
2,552 
2,716 
2,038 
2,844 
3,060 
16,769 
1,633 
1,323 
544 
Amount used per 
year (kg) 
390,95426 
205,795.00 
162,209.06 
71,466.83 
47,479.65 
46,430.43 
40,421.72 
40,348.75 
37,538.52 
36,319.24 
35,654.20 
35,065.98 
28,976.55 
27,195.11 
26,483.78 
26,120.53 
23,381.47 
22,227.59 
22,095.64 
21,791.50 
18,783.11 
18,105.89 
16,731.26 
15,497.35 
14,522.77 
1.2 Pharmaceutical Sources, Exposure routes and Toxicity 
Phannaceuticals are released into the environment after usage and to a lesser extent during 
manufacturing and disposal of out of date medications. Figure 1.1 illustrates some of these 
exposure routes. 
The most significant entry route for phannaceuticals into the aquatic environment is 
believed to be from the frequent use of over-the-counter medications. Once administered, 
the majority of phannaceuticals are well absorbed, after which some are subsequently 
excreted essentially unaltered in their free form, whilst many are metabolised to various 
extents before elimination from the body in urine and faeces. In vertebrate species the 
metabolism of these xenobiotics is largely governed by what are referred to as Phase I and 
Phase 11 reactions (Gibson and Skett, 2001). Common Phase I reactions include oxidation, 
reduction or hydrolysis and typically result in the addition of reactive functional groups to 
the molecule. The subsequent products can be more reactive and sometimes more toxic, 
than the ingested parent drug. Phase 11 metabolism serves to create metabolites, which are 
successively more polar than the parent compound, by means of conjugation (e.g. addition 
of glucuronic acid, sulphate, acetic acid or amino acid), thereby enhancing excretion. 
Although uncommon, there is evidence that conjugates (e.g. gluconorides and sulphates) 
entering sewage treatment works (STWs) can be hydrolysed to the parent drug or 
metabolite through bacteria hydrolases (Hirsch et al., 1999; Temes et al., 1999; Belfroid et 
al., 1999; Panter et al., 1999). In dilute aerobic experiments, 1713-estradiol-17 -glucuronide 
and 1713-estradiol-3-glucuronide were cleaved to yield the parent compound 1713-estradiol 
(Temes et al., 1999). 
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Figure 1.1 Established exposure routes for PhACs into the environment 
(Adapted from Heberer, 2002). 
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Elimination rates for drugs vary depending on the individual recipient, the drug and the 
dosage, although it is estimated that 50-90% may be in biologically active forms (Ternes, 
1998; Hirsch et al., 1999). Figure 1.2 gives two examples of Phase I and Phase IT 
metabolism. Clofibric acid, which is the principal and active metabolite of the three lipid 
regulators clofibrate, theofibrate and etofibrate, is conjugated to clofibric-O-J3-
acylglucuronide (Temes, 2001). More than 90% of the clo:fibric acid, administered in the 
form of the parent compounds, is excreted as glucuronide. Another example illustrated is 
ibuprofen, which is first hydroxylated and then conjugated to ibuprofen-0-13-
hydroxyglucuronide. Approximately 9% of ibuprofen is excreted as hydroxy-ibuprofen, 
17% as the glucuronide of hydroxy-ibuprofen, and the remaining percentage is allocated to 
further metabolites and the non-metabolized ibuprofen (Temes, 2001). 
~I 
HOyx:O~ Phase IT 
0 
Clofibric acid Clofibric-0-~-acylglucuronide (> 90%) 
fj ~ - lj ~ - HOOC Phase I xO-< Phase IT xa-<~ 
- COOH HO - COOH H~O  - COOH 
OH 
Ibuprofen Hydroxy-lbuprofen (9%) lbuprofen-0-P-hydroxyglucuronide (17%) 
Figure 1.2 Metabolites of clofibric acid and ibuprofen excreted by humans 
(Ternes, 2001). 
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Further examples include the J3-blocker nadolol, which is not metabolised at all by the body 
and the antibiotic amoxicillin, of which 80-90% is excreted unchanged. Conversely, only 
3% of the antiepileptic carbamazepine and little or none of the anti-inflammatory 
diclofenac is released in its parent form (Daughton and Temes, 1999). 
1.2.1 Detection and Monitoring 
For human pharmaceuticals, the excreted substances generally enter sewage treatment 
works (STWs) where treated effluents are released to surface waters. Although a wide 
range of waste treatment practices are employed worldwide, increasing numbers of 
investigations have revealed clear evidence that PhACs are often not removed during waste 
water treatment (Temes, 1998; Lagana et al., 2000; Heberer et al., 2001; Heberer, 2002; 
Jelicic and Ahel, 2003; Thomas and Foster, 2004; Temes et al., 2005; Roberts and Thomas, 
2006). One of the earliest and most complete investigations to date of STW removal 
efficiencies for pharmaceuticals was reported by Temes (1998). The study surveyed 
German STW effluents and rivers for 32 drugs and selected metabolites belonging to 
different medicinal classes, including antiphlogistics, lipid regulators, psychiatric drugs, 
antiepileptic drugs, 13-blockers and 132-sympathomimetics. Over 80% of the selected drugs 
were detectable in at least one municipal STW effluent with concentrations of up to 6.3 JJ.g 
L'1 (carbamazepine); thus resulting in the contamination of the receiving waters. It was 
concluded that the conventional treatment technologies employed in STWs are ineffective 
in completely removing many PhACs and their metabolites from influents. 
Increased improvements in analytical capabilities in the past decade, along with growing 
alarm surrounding the inability of conventional treatment technologies to remove PhACs 
from influents has led to the routine detection of PhACs in surface and groundwaters at 
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concentrations ranging from ng L" 1 to J.Lg L-1 (Heberer et al., 1997; Belfroid et al., 1999; 
Ternes, 2000; Snyder et al., 2001; Kolpin et al., 2002; Bruchet et al., 2002; Calamari et al., 
2003; Sanderson et al., 2004; Zuccato et al., 2005). To put this in perspective, Richardson 
and Bowron (1985) state that 1000 kg of a chemical distributed evenly among rivers in 
England and Wales wou1d yield a concentration of approximately 0.1 J.Lg L-1• Calcu1ations 
based on the number of prescriptions issued by doctors confirm that many pharmaceuticals 
are used in quantities far exceeding 1000 kg. For example, Richardson and Bowron (1985) 
report 170 pharmaceuticals used annually in excess of this amount. Further investigations 
have reported the detection of PhACs in marine waters (Buser et al., 1998a; Weigel et al., 
2002; Weigel et al., 2004), sewage sludge and soil (Golet et al., 2002; Golet et al., 2003) 
and even drinking water (Heberer et al., 1998; Jones et al., 2005; Webb et al., 2003). Few 
pharmaceuticals have been identified in domestic drinking water, but this may be partly 
due to the difficulties of analysis of pollutants at very low, parts per trillion (ng L"1) 
concentrations. In Germany, however, clofibric acid concentrations up to 270 ng L-1 have 
been measured in tap water (Heberer et al., 1998; Stan et al., 1994), though the source was 
determined to be from recharged groundwaters that had been contaminated by sewage. 
Ternes et al. (1999) found that diclofenac, benzafibrate, phenazone and carbamazepine 
were occasionally present in German drinking water in the lower ng L"1 range, with a 
maximum of 70 ng L"1 for clofibric acid. However, in the majority of investigations 
completed, no PhACs have been observed in drinking water, indicating that contamination 
of drinking water is unlikely. 
Most of the monitoring data available to date originates from continental Europe, the 
United Kingdom and the United States. The available literature on detection of PhACs in 
environmental matrices is now extensive, with many reviews (e.g. Ayscough, 2002; Boreen 
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et al., 2003; Daughton and Ternes, 1999; Halling-Sorensen et al., 1998; Heberer, 2002), 
and even a book, 'Pharmaceuticals and Personal Care Products in the Environment: 
Scientific and Regulatory Issues' (Daughton C and Jones-Lepp, 2001) having been 
published recently. The content of these excellent reviews is therefore not repeated here. 
However, the data available on concentrations of PhACs in environmental matrices are 
summarised in Appendix A 1. 
1.2.2 Toxicity 
The continual release of numerous PhACs raises concerns over their potential toxicological 
effects towards aquatic species due to continuous exposure (Breton and Boxall, 2003). 
Whilst pharmaceuticals receive considerable pharmacological and clinical testing, 
information on the ecotoxicity of these biologically active substances is generally limited. 
Current regulatory guidance only requires pharmaceuticals to undergo standard acute 
toxicity tests (often for algae, Daphnia and fish) unless there is good reason to believe the 
compound may bioaccumulate. Halling-Sorensen et al. (1998) suggested that the use of 
conventional acute ecotoxicity tests may be inappropriate when assessing the 
environmental risks of pharmaceuticals. Despite this, most published aquatic toxicity data 
for pharmaceuticals are based on short-term acute studies. A common strategy for the 
selection of PhACs for acute toxicity testing seems to adopt the most prescribed drugs or 
pharmaceuticals. Nine frequently used pharmaceutical compounds (clofibric acid, 
carbamazepine, ibuprofen, diclofenac, naproxen, captopril, metaformin, propranolol and 
metaprolol) were investigated for acute toxicity in the crustacean D. magna and the green 
alga Desmodesmus subspictus (Cieuvers, 2003). EC5o-values (effective concentration to 
effect or kill 50% of the population) were generally between 10 and lOO mg L" 1• Lower 
EC5o-values (5-8 mg L"1) were observed only for diclofenac, propranolol and metaprolol. 
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Other reports have focused on specific classes of pharmaceuticals. Brain et al., (2004) 
assessed the phytotoxicity of 25 pharmaceutical compounds to the aquatic higher plant 
Lemna gibba and reported EC50-values in the 1-5 mg L"1 range. Biaccumulation of some 
selective serotonin reuptake inhibitors (SSRJs) was recently demonstrated in fish living in 
rivers receiving municipal effluents (Brooks et al., 2005) and the toxicity of SSRJs to 
several aquatic organisms has been investigated (Brooks et al., 2003). 
Jones et al. (2002) compiled data for the acute ecotoxicity of seven large pharmaceutical 
classes on different organisms. Unsurprisingly, antibiotics were extremely toxic to 
microorganisms (EC50 <0.1 mg L"1) but were also very toxic to algae (EC50 0.1-1 mg L"1). 
Antidepressants and cardiovascular pharmaceuticals were very toxic to crustaceans. 
Cytostatics were very toxic to microorganisms and harmful to crustaceans (EC50 10-100 
mg L"1) and fish. Analgesics were toxic (EC50 1-10 mg L"1) or harmful to crustaceans and 
harmful to fish. Anti epileptics were toxic to cnidarians but not toxic (EC50 > 100 mg L"1) to 
crustaceans or fish. The authors did not report whether the toxicity differed between 
compounds within different classes. 
Clearly, biologically active compounds have the potential to be acutely toxic to different 
organisms at concentrations low enough to result in environmental classifications as 'very 
toxic' or 'toxic' to aquatic organisms. There is still a difference of at least two orders of 
magnitude between these and actual measured concentrations, and it has therefore been 
suggested by several authors that greater focus should be placed on chronic toxicity testing 
of PhACs (Halling-Sorensen et al., 1998; Daughton and Temes, 1999; Daughton, 2001). 
These concerns have led to a call by the Environment Agency of England and Wales in its 
paper 'Position on Pharmaceuticals in the Aquatic Environment' (EA, 2003) to develop 
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and implement chronic toxicity testing procedures for PhACs. Several studies have drawn 
attention to the fact that aquatic vertebrates are highly sensitive to low concentrations of 
steroid oestrogens, such as ethinyloestradiol, which are well known for their potential for 
endocrine disruptive and reproductive effects (e.g. Desbrow et al., 1998). Little is known 
about the chronic effects of most other pharmaceuticals, although fish displaying intersex 
characteristics, leading to reduced reproductive success, are commonly found downstream 
from STWs in the UK (Jobling et al., 2002). 
Crane et al. (2006) recently reviewed the literature on the chronic aquatic toxicity of 
pharmaceuticals and how this should be measured. The authors concluded that currently 
relevant ecotoxicity data for PhACs are scarce, leading to large knowledge gaps regarding 
the risks that PhACs pose to the environment. Several authors have also voiced concerns 
over the potential of combination effects of mixtures of pharmaceuticals, leading to calls 
for their consideration in future chronic aquatic toxicity studies (Cleuvers, 2004; Carlsson 
et al., 2006a; Carlsson et al., 2006b). 
1.3 Environmental Fate Studies on Pharmaceuticals 
Considering the varieties and quantities of pharmaceuticals manufactured and used 
throughout the world and that many of these chemicals are designed to have profound 
physiological effects, research into the fate of pharmaceuticals in the environment is still at 
a comparatively early stage and further information is still required before any firm 
conclusions can be made. Furthermore, much of the research has been directed to the fate 
of parent drugs rather than of the excreted metabolites which are as likely to be present in 
sewage and likely to enter the environment. From the very limited number of 
investigations carried out it is apparent that the fate of PhACs is determined by both biotic 
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and abiotic processes. An overview of the major routes of degradation, depletion and 
dilution in various environmental compartments and the profile of environmental fate for 
human pharmaceuticals is given in Table 1.2 
Table 1.2 Major routes of degradation, depletion and dilution in various 
environmental compartments and the profile of environmental fate for 
human pharmaceuticals. 
DOMESTIC SEWAGE 
Processes 
Hydrolysis 
Biodegradation (aerobic and anaerobic) 
Adsorption 
Results 
Degradation 
Depletion 
Partitioning 
AQUATIC COMPARTMENT 
Processes 
Hydrolysis 
Photolysis 
Biodegradation (aerobic and anaerobic) 
Volatilisation 
Results 
Degradation 
Depletion 
SEWAGE TREATMENT WORKS (STW) TERRESTRIAL COMPARTMENT 
Processes 
Adsorption 
Hydrolysis 
Photodegradation (direct and indirect) 
Aerobic biodegradation in water 
Anaerobic biodegradation in sludge 
Results 
Degradation 
Depletion 
Partitioning 
Processes 
Aerobic and anaerobic biodegradation 
Soil photolysis 
Adsorptionldesorption 
Run-off and leaching 
Volatilisation 
Results 
Degradation 
Depletion 
Partitioning 
Dissipation 
Adapted from Velagaleti and Winberry (1998). 
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Surveys into the fate of pharmaceuticals in STWs have been conducted by a limited 
number of authors (Richardson and Bowron, 1985; Temes, 1998; Stumpf et al., 1999). 
However, none of these studies systematically analysed for degradation products and the 
lack of such information is considered an important knowledge gap. 
There are three major routes for the fate of pharmaceuticals in a STW: 
I. Mineralisation (e.g. aspirin) to water and carbon dioxide. 
(Richardson and Bowron, 1985) 
2. Sorption and biodegradation of lipophilic substances (e.g. penicillins) bound to 
solid sludge (Halling-Sorensen et al., 1998). 
3. Transfer of hydrophilic substances, often formed by metabolism (e.g. clofibric 
acid), in the aqueous phase and passage through the STW (Halling-Sorensen et al., 
1998). 
Stumpf et al. (1999) reported on the removal of seven drugs and two drug metabolites 
during passage through a Brazilian STW. Concentrations of the drugs in the raw sewage 
ranged from 0.3-1.2 J,lg L"1 depending on the individual drug. The authors found that 
effluents from the activated sludge treatment step contained significantly lower 
concentrations of the pharmaceuticals than effluents from a biological gravel filter. 
Removal rates for activated sludge treatment ranged from 34% (clofibric acid) to 83% 
(indomethacine). Indeed, clofibric acid, fenofibric acid and gemfibrozil were the only 
compounds to exhibit less than 50% removal by the activated sludge treatment step. In 
contrast, removal rates by biological filter treatment were less than 30% other than for 
indomethacine (71% removal) and ketoprofen ( 48% removal). The lowest removal rates 
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were 6% for fenofibric acid, 9% for diclofenac, 15% for clofibric acid and 15% for 
naproxen. It was uncertain whether removal was a result of adsorption or degradation 
although, due to the high polarities of the drugs under investigation, adsorption to sludge 
was expected to be low. 
Richardson and Bowron (1985) examined a number of pharmaceuticals for 
biodegradability during sewage treatment. The PhACs were selected for biodegradation 
studies on the basis of their high quantity in use, potential for toxicity or on literature 
evidence suggesting that the drug had the potential to survive sewage treatment. The 
authors found that acetylsalicylic acid (aspirin) was readily biodegradable, as was 
acetaminophen (paracetamol) after a period of acclimation, although a number of 
compounds were also identified as being 'non-biodegradable'. 
Temes (1998) similarly measured a variety of pharmaceuticals in sewage influent and final 
effluents in a German municipal STW. The elimination rates of the drugs under 
investigation during passage through the STW ranged from 7% (carbamazepine) to greater 
than 99% (salicylic acid). In general, more than 60% of the drug residues detected in the 
influent were removed by the STW. Only carbamazepine, clofibric acid, phenazone and 
dimethyl phenazone showed lower average removal rates. Fenofibrate, acetaminophen and 
metabolites of acetylsalicylate (including salicylic acid and gentistic acid) were not 
detectable in the effluent, even though up to 54 Jlg L-1 of salicylic acid was determined in 
the influent. 
A summary of the literature assessing the biodegradability of pharmaceuticals has been 
made by both Rogers (1996) and Halling-Sorensen et al. (1998). Other studies investigated 
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the fate of pharmaceuticals in laboratory-scale sewage treatment plants (Kummerer et al., 
1997; Steger-Hartrnann et al., 1997) or involved laboratory testing for biodegradability 
(Kummerer et al., 1997; Henschel et al., 1997; Temes et al., 1999). 
1.3.1 Abiotic processes 
Photodegradation is potentially a very important abiotic degradation mechanism for the 
removal of PhACs in the freshwater and the marine environment. Many PhACs contain 
aromatic rings, heteroatoms, and other functional groups that can either absorb solar 
radiation or react with photogenerated transient species in natural waters (e.g. reactive 
oxygen species and photoexcited natural organic matter). Further, some of these 
compounds also contain structural moieties, such as phenoxy, nitro, and naphthoxy groups, 
which are similar to those found in pesticides that have been found to undergo 
photodegradation (Burrows et al., 2002). The pesticides carbaryl and naproamide, for 
instance, photodegrade readily and contain the naphthoxy chromophore, which is also 
present in the pharmaceuticals propanolol and naproxen (Figure 1.3). 
Because many of the pharmaceutical pollutants in surface waters have already eluded 
biodegradation in STW, their susceptibility to photodegradation may play an important role 
in their fate, especially in sunlit waters. A review conducted by Boreen et al. (2003) 
summarised the existing literature concerning the photochemical behaviour of 
pharmaceuticals. The authors concluded that, aside from some exceptions (e.g. Packer et 
al., 2003; Tixier et al., 2003; Buser et al., 1998b, 1999; Doll and Frirnmel, 2003; 
Andrezozzi et al., 2003), the environmental photochemistry of the vast majority of PhACs 
has not been studied. Therefore investigations of the effects of sunlight on the fate of 
PhACs are justified and indeed possibly overdue. 
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Pesticides Pharmaceuticals 
Carbaryl Propanol cl 
OH 
0 
............ 0 
Napropamide Naproxen 
Figure 1.3 Structural similarities between selected pesticides and pharmaceuticals 
(Boreen et al. , 2003). 
However, the majority of photochemistry studies conducted to date (Reviewed in Chapter 
3) appear to have been conducted under experimental conditions unrepresentative of those 
encountered in the natural environment. Zika ( 1981) emphasised that ' caution must be 
used in extrapolating the results of studies where considerable deviation from the 
prevailing natural conditions have been employed'. For example, whilst a particular PhAC 
may not undergo direct photolysis in distilled water, the same cannot be said in a 
representative natural water sample. Under solar radiation, indirect photochemical 
reactions can proceed in natural water through the generation of strong oxidant species 
such as hydroxyl radicals and singlet oxygen from natural photosensitizers like humic acids 
and nitrate (Zepp, 1981 ), these species are then capable of reacting with organic 
compounds (Mill, 1999; Schwarzenbach et al. , 1993). The photochemical behaviour of 
cimetidine, avorvastatin and carbamazepine exemplifies the importance of studying the 
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reaction of pharmaceuticals with reactive oxygen species. Cimetidine undergoes 
photosensitized degradation, reacting with singlet oxygen in natural waters, but is resistant 
to degradation by direct photolysis (Latch et al., 2003b). Lam and Mabury (2005) found 
that indirect photodegradation was important in limiting the persistence of avorvastatin and 
carbamazepine in surface waters since rates of loss were greatly increased in solutions with 
humic materials. In contrast, Lin and Reinhard (2005) report a much longer half-life for 
ketoprofen in river water (tr12 4.1 hours) than in distilled water (t112 2.5 minutes), the organic 
matter present in river water was found to absorb the solar radiation, thus acting as an 
optical filter and reducing the rate of photodegradation. The observed variability of the 
effects due to the presence of naturally occurring compounds confirms that the 
photoreactivity of pharmaceuticals requires assessment on a compound by compound basis. 
Some clear discrepancies between the knowledge of environmental occurrence and 
knowledge of environmental fate of PhACs are evident. There are many compounds that 
have been detected in field samples, but for which no photochemistry data relatable to 
environmental conditions are available. In addition, the numbers of studies that report 
photodegradation rates far outweigh those that also identify photoproducts. Identification 
of products remains one of the largest needs in the area of PhAC photodegradation, due to 
the fact that the products may have an environmental impact that is as large, or larger than 
the starting contaminant (Boreen et al., 2003). 
1.4 Pharmaceuticals used in the present study 
A comprehensive investigation of the available literature, involving research into over a 
hundred pharmaceuticals detected in the environment was undertaken to establish the most 
suitable candidates for photodegradation studies. 
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The following selection criteria were devised and applied to each phannaceutical: 
• Toxicity data (availability and concentration) 
• Usage (UK Figures) 
• Previously conducted biodegradation studies 
• Previously conducted photodegradation studies 
• Metabolites (whether known and active) 
• Environmental occurrence (where and at what concentration) 
• Extent of removal in STW 
• Other possible sources of the compounds 
• Additional relevant information 
On this basis a list of thirty-one pharmaceuticals was produced. Selection data for the final 
thirty-one compounds are shown in Appendix A2. Following presentations and 
consultations with sponsors, the anti-anxiety drug, diazepam (Valiurn®) was selected for 
detailed study along with the human metabolites of diazepam, desmethyldiazepam (also 
known as nordiazepam), temazepam and oxazepam. 
The anti-depressant fluoxetine hydrochloride (Prozac®) was also initially deemed suitable 
for further study. However early into the study, a Canadian study was published which 
comprehensively investigated the photochemical kinetics and phototransformation of 
fluoxetine hydrochloride in aqueous solutions (Lam et al., 2005). Whilst this study 
provided additional justification for the original selection of fluoxetine hydrochloride 
herein, it was felt that continued investigation within the present study was now 
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unwarranted and the study was thereafter restricted to diazepam and its related metabolites. 
Results of initial studies of fluoxetine hydrochloride are thus not included here. 
1.4.1 Diazepam and its human metabolites 
Diazepam, marketed under various brand names including Valium®, Stesolid® and 
Apozeparn®, is a drug which belongs to an important class of pharmaceutical compounds 
ca!Jed benzodiazepines. The basic benzodiazepine structure (Figure 1.4) is based upon a 
seven-membered ring of carbon atoms with two nitrogens, called a 1 ,4-diazepine ring (B) 
fused to a benzene ring (A), and substituted with a phenyl ring (C) at position 5 in the 
benzodiazepine. 
9 1 N~ 
8 )3 8 
7 
4' 
Figure 1.4 Basic benzodiazepines structure showing the fused aromatic ring (A), the 
I ,4-diazepine ring (B) and the phenyl ring (C) at the 5-position. 
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The structure of diazepam, along with its scientific name (TUP AC) is given in Figure 1.5. 
Figure 1.5 
Cl 
7-chloro-1-methyl-5-phenyl- l ,4-benzodiazepin-2-one 
Diazepam (Valium®) 
Structure of diazepam (Valium®) 
In common with other benzodiazepines, diazepam exerts five major effects which are used 
therapeutically: namely anxiolytic, anticonvulsant, sedative, skeletal muscle relaxant and 
amnesic effects. These actions have made diazepam an extremely useful drug for treating 
anxiety, insomnia, seizures, alcohol withdrawal and muscle spasms. 
Although first approved for use in 1963 and manufactured by Hoffinann-La Roche, and 
reaching peak sales of 2.3 billion pills in 1978, the use of diazepam to treat a wide range of 
clinical disorders means that it is still one of the most frequently prescribed 
benzodiazepines, with over 12 million diazepam prescriptions dispensed per year in the 
United States from 1995 to 2005 (RxList, 2006). Stuer-Lauridsen et al. (2000) list 
diazepam as one of the top 20 most used pharmaceuticals in Denmark. Further recognition 
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of the importance of diazepam as a core medicine is its inclusion in the World Health 
Organisation (WHO, 1995) "Essential Drugs List", which contains a list of minimum 
medicine needs for a basic health care system. In addition to its more common uses over 
the years, physicians, psychiatrists and neurologists have discovered many new off-label 
uses for diazepam, such as the treatment of spastic paresis and palliative treatment of stiff-
person syndrome (Greenblatt et al., 1989 and references therein). 
Nearly all medically-prescribed benzodiazepines are classified as controlled substances, 
which are internationally referred to as Schedule IV drugs under the Convention on 
Psychotropic Substances. Unfortunately, their mood-altering properties combined with 
their ability to stave off the effects of opiate withdrawal have led to their widespread 
availability on the illicit drugs market in recent years. Therefore, legally obtained 
prescription figures cannot be considered to be truly representative of the total use of 
individual benzodiazepines. 
1.4.1.1 Mechanism of Action 
Like other benzodiazepines, diazepam acts by enhancing the actions of a natural brain 
chemical, GABA (gamma-aminobutyric acid). GABA is a neurotransmitter responsible for 
transmitting signals from one brain cell (neuron) to another. The signal transmitted by 
GABA is an inhibitory one: ordering the neurons to slow down or stop firing. Since about 
40% of all brain neurons respond to GABA, GABA has a general quietening influence on 
the brain. It is in effect the body's natural hypnotic and tranquilliser. Diazepam augments 
the action of GABA by binding to the GABAA receptor. Once bound, diazepam locks the 
GABAA receptor into a conformation where the neurotransmitter GABA has a much higher 
affmity for the receptor site, therefore increasing the frequency of opening of the associated 
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chloride ion (Cl} channel and hyperpolarising the membrane. This enhances the inhibitory 
effect of the available GABA, leading to sedatory and anxiolytic effects. 
1.4.1.2 Pharmacokinetics 
Diazepam is most commonly administered orally, although it can also be administered 
intravenously, intrarnuscularly, or as a suppository. Typical dosage levels range from 2-10 
mg of active ingredient. When administered orally it is rapidly absorbed and has a fast 
onset of action. Peak plasma concentrations are achieved 30 minutes to 2 hours after oral 
administration (Wishart, 2006). 
Diazepam is metabolised in the liver via the cytochrome P450 enzyme pathway (Schwartz 
et al., 1965). It has an elimination half-life of 20-100 hours, and has several 
pharmacologically active metabolites (Figure 1.6). The main active metabolite is 
desmethyldiazepam (also referred to as nordiazepam), which has an elimination half-life of 
36-100 hours (Greenblatt et al., 1989; Mikota and Plumb, 2005). Other active metabolites 
include temazepam and oxazepam which have elimination half-lives of 8-22 and 4-15 
hours (Greenblatt et al., 1989; Mikota and Plumb, 2005) respectively. These metabolites, 
along with the parent compound are conjugated with glucuronide and are excreted 
primarily in the urine. From human metabolism studies it has been estimated that 30% of 
the diazepam dose taken by patients is excreted as the parent compound, 12% as 
nordiazepam, 15% as temazepam and 32% as oxazepam (Schwartz et al., 1965). The 
remaining 11% is unidentified to date. 
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Figure 1.6 
1.4.1.3 
Metabolism of diazepam in the human body 
(Schwartz et al., 1965) 
Criteria for diazepam selection 
H~--l )-oH 
Cl - N 
Oxazepam 
Diazepam was selected for study on the basis of known therapeutic action, high usage and 
known human metabolism. Other important factors which supported selection as a viable 
candidate for environmental photodegradation studies were reports of the detection of 
diazepam in various aqueous environments at low J..Lg L-1 levels (Temes, 1998; Waggott, 
1981 ; Calamari et al. , 2003; Zuccato et al., 2000; Boreen et al., 2003) and acute toxicity 
towards Daphnia magna (LCso 4.3 mg L-1; Calleja et al., 1993) mice (LC50 720 mg kg-1) 
and rats (LC50 1240 mg kg-1; www.drugs.com, 2006). Furthermore, and importantly, 
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evidence of a susceptibility to photochemical decomposition has been reported for 
diazepam in methanol (Cornelissen et al., 1978). Clearly however such experimental 
conditions deviate considerably from those in the natural aqueous environment. 
1.5 Aims of tbe Present Study 
At the outset of the present study, it was clear that whilst several sources and exposure 
routes of pharmaceuticals into the environment had been identified, from the very limited 
number of previous investigations it was evident that the photo-reactivity of the vast 
majority of pharmaceuticals under realistic environmental conditions is not well 
understood. Furthermore, the fate of virtually all pharmaceutical metabolites remains 
unknown. Therefore, the main aims of the present study were to: 
(i) Undertake a comprehensive literature search (Chapter l) to establish the 
most suitable candidates for photodegradation studies. 
(ii) Develop an experimental system for the reproducible quantitative evaluation 
of the rate of photodegradation of diazepam and its human metabolites 
under realistic and well-controlled environmental conditions. Record rate 
constants and half-lives 
(iii) Characterise the photoproducts of diazepam irradiation and human 
metabolites under realistic and well controlled environmental conditions. 
(iv) Evaluate the role of phototransformation as a reduction mechanism for 
diazepam and its human metabolites using river catchment models. 
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The results are described in the thesis as follows: 
Chapter 2 describes preliminary investigations into the use of multi-stage electrospray 
ionisation ion trap mass spectrometry (ESI-MS") for the identification of diazepam, 
nordiazepam, temazepam and oxazepam in natural waters. Multiple stage mass 
spectrometry (MS") with positive ion detection allowed high specificity detection and 
characterisation of the target compounds. The development of a high performance liquid 
chromatographic (HPLC) method for the separation of diazepam and its human 
metabolites, nordiazepam, temazepam and oxazepam, with detection by electrospray 
ionisation mass spectrometry (ESI-MS) is also described. 
Chapter 3 describes an investigation of the photostability of diazepam to simulated 
sunlight over prolonged periods of irradiation in dilute aqueous solutions and in the 
presence of naturally occurring humic substances. The photodegradation reaction products 
were studied by high performance liquid chromatography (HPLC) separation with 
electrospray ionisation mass spectrometry (EST-MS) detection and structural 
characterisation was based on electrospray ionisation multistage mass spectrometry (ESI-
MS") and also comparison with authentic compounds where available. 
Chapter 4 describes investigations of the photostability of the known human metabolites 
of diazepam, viz: nordiazepam, temazepam and oxazepam, under environmentally relevant 
conditions in dilute aqueous solutions and in the presence of naturally occurring humic 
substances. A solid phase extraction method (SPE) was developed for extraction of the 
compounds and photoproducts from natural water samples and analysis was performed 
using the HPLCIESI-MS" methods described in Chapters 2 and 3. 
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Chapter 5 describes the application of the previously determined direct and indirect 
photodegradation kinetics for diazepam, nordiazepam, temazepam and oxazepam (Chapter 
3 and 4) to river catchment models using a computer model, GREAT-ER (ECETOC, 
1999). Maximum predicted environmental concentrations (PECs) were determined for 
each compound and the impact of phototransforrnation on the removal of each compound 
was evaluated in two river catchments representing an urban/industrial catchment (river 
Aire) and a rural catchment (river Exe) respectively, under low flow (summer) and mean 
flow (winter) conditions. 
Chapter 6 describes the experimental details. 
Chapter 7 summarises the conclusions from the present study and makes proposals for 
possible further work. 
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CHAPTER TWO 
Development of High Performance Liquid Chromatography (HPLC) 
Separation of Diazepam and its Human metabolites with Detection 
by Electrospray Ionisation Mass Spectrometry (ESI-MS) 
This chapter describes investigations into the use of electrospray ionisation multi-stage ion 
trap mass spectrometry (ESI-MS") for the detection and characterisation of diazepam and 
the human metabolites, nordiazepam, temazepam and oxazepam, in aqueous samples. The 
development of high performance liquid chromatography (HPLC) separation of diazepam 
and its human metabolites with detection by electrospray ionisation mass spectrometry 
(ESI-MS) is described. The development of a solid phase extraction (SPE) procedure for 
initial separation of PhACs, metabolites and photodegradation products from humic acid-
containing natural waters prior to examination by HPLC/ESI-MS is also explained. 
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2.1 Introduction 
The development of appropriate analytical methods for the qualitative and quantitative 
determination of pharmaceuticals and pharmaceutically active compounds (PhACs) and 
their metabolites in aqueous environments is essential for the evaluation of their potential 
environmental persistence. Typically, PhACs are present at trace concentrations of ~g L"1 
or less, frequently in the presence of large amounts of natural organic compounds, 
including humic acids. Analytes of interest are generally of low molecular weight (mass 
range 100-500 Da) and contain one or more polar or ionisable groups - often including 
hydroxyl, carboxylic, amino, sulphate/sulfonates or heterocyclic moieties. 
Analysis of PhACs in natural water often requires the development of high efficiency 
extraction and preconcentration methods for analytes prior to separation by common 
chromatographic methods, which can be difficult due to the high polarity and low volatility 
of the majority of these compounds. Potential methods of separation may also be limited 
by incompatibility with detectors. A major problem with most detectors is the lack of 
specificity for the analysis of moderately complex samples or the ability to obtain structural 
information for the identification of unknown degradation products. 
The application of advanced analytical techniques such as gas chromatography with mass 
spectrometry (GC-MS) or liquid chromatography with MS (LC-MS) to environmental 
analysis has allowed the determination of a broad range of PhACs in wastewaters 
(reviewed by Fatta et al., 2007). Recent advances in LC-MS have allowed detection of 
PhAC residues at ultra-trace levels in environmental samples (Hopfgartner et al., 2004; 
Hemandez et al., 2005). Compared with GC-MS, LC-MS can be used to determine polar 
analytes, such as PhACs, without the need for sample derivatisation. As a result, LC-MS 
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has gained popularity and is widely regarded as the preferred technique for analysis of 
PhACs and their transformation products (Petrovic and Barcelo, 2007). 
Early LC-MS interfaces included direct liquid introduction (DLI), movmg belt/wire, 
thermospray (TSP) and particle beam (PB) devices. These have been described and 
reviewed by Abian (1999) and Lemiere (2001). However it was the introduction of 
commercial atmospheric pressure ionisation mass spectrometers (API-MS: electrospray 
ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) techniques and the 
coupling of these spectrometers with high pressure liquid chromatography (HPLC) systems 
which saw LC-MS evolve into a sensitive and widely used technique. 
Of the two API techniques, ESI is particularly suitable for the analysis of PhACs in natural 
waters. ESI as the ionisation method for multi-stage mass spectrometers (multi-stage MS 
or MS", where n :.::2) allows structural information to be obtained from molecular or 
pseudomolecular ions. The removal of all but the gas phase ions whilst remaining at 
atmospheric pressure makes ESI one of the most important ionisation techniques for the 
on-line coupling of liquid phase separation techniques (LC) with MS (Smyth, 2006). A 
brief overview of ESI-MS therefore follows. Particular emphasis is given to the Finnigan 
Matt LCQ™ (Thermo Finnigan, San Jose, CA, USA) quadrupole ion trap mass 
spectrometer (QIT) which was used in the present study. 
2.2 Electospray Ionisation Mass Spectrometry (ESI-MS) 
Electrospray ionisation (ESI) is a technique by which gas-phase ions are formed from ions 
in solution by applying a high electrical potential to a capillary containing a liquid, and a 
counter electrode. Dole and eo-workers in the late 1960s were amongst the first to show 
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that gas-phase ions from polystyrene macromolecules (and later, proteins) could be 
produced from an atmospheric electrostatic spmyer interfaced with an ion spectrometer 
(Dole et al., 1968). The coupling of electrospray ionisation to mass spectrometry (ESI-
MS) was introduced by Yarnashita and Fenn (1984). A very similar, independent 
development was reported by Aleksandrov et al. (1984). However, interest in ESI was 
greatly increased when Fenn's group showed that proteins may carry multiple charges (2 to 
<1 00) and the distribution of multiply charged ions could be used to calculate accurate 
molecular weights (Fenn et al., 1989). This permitted new possibilities for MS analysis of 
high-molecular-weight compounds including proteins, peptides, and other large molecules 
on mass analysers with limited mass ranges. The importance of the technique was 
acknowledged in 2002 when John B. Fenn received a share of the Nobel Prize in 
Chemistry for his pioneering work in electrospmy ionisation (Smyth, 2006). 
2.2.1 Electrospray ionisation process 
The mechanism of electrospray ionisation (ESI) can be divided into three stages: 
l. Production of charged droplets at the electrospray (ES) capillary tip 
2. Shrinkage of the charged droplets by solvent evaporation and repeated droplet 
disintegrations 
3. Formation of gas-phase ions 
A sample solution is introduced through an electrospmy capillary to which a high potential 
is applied (3-5 kV), whilst the sampling orifice of the mass spectrometer (heated capillary 
on the LCQ ™ instrument) is maintained at low voltage (0-50 V) to create a potential 
gradient (Figure 2.1 ). Due to the applied electric field, solution ions of the same polarity 
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concentrate at the capillary tip, which because of the potential gradient, are drawn out of 
the capillary tip forming a 'Taylor Cone'. The concentration of ions of similar polarity 
increases at the liquid surface, where coulombic forces eventually overcome the surface 
tension of the liquid causing charged droplets to be emitted. The charged droplets are 
drawn down the potential gradient and vacuum gradient created by the sampling orifice of 
the high vacuum in the mass spectrometer. Solvent evaporation and shrinkage causes an 
increase in the concentration of ions of similar polarity at the surface, to a point where 
coulombic forces again overcome the surface tension of the liquid, causing droplet 
disintegration to several s~aller droplets. The process is aided by a coaxial flow of 
nitrogen (Figure 2.1) known as "Ionspray", which was introduced by Bruins et al. (1987). 
Repeated droplet disintegration leads to very small highly charged droplets, which can 
produce gas-phase ions (Cech and Enke, 2001). Electrospray ionisation is a soft ionisation 
technique which results in mostly pseudomolecular ions with very little, or no, 
fragmentation (Kebarle and Yeunghaw, 1997). 
The actual mechanisms and processes for the formation of gas-phase ions from very small 
and highly charged droplets are not fully understood and subject to much debate. Two 
basic theories have been proposed: the Dole 'charged residue model' (CRM) and the 
lribame and Thompson 'ion evaporation model' (IEM). 
In the charged residue model (CRM), proposed by Dole et al. ( 1968) and later extended by 
Rollgen et al. ( 1984), the charged droplets continue to shrink and disintegrate until a single 
ion solvated droplet is formed, from which a gas-phase ion is produced on full evaporation. 
The ion evaporation model (IRM) proposed by lribarne and Thomson (1976, 1979) allows 
for gas-phase ions to be directly emitted from a very small highly charged droplet surface 
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(< I 0 nM) due to repulsion of charged ions at the droplet surface, although the eventual fate 
of the droplets is the same as in the CRM. 
Heated stainless steel capillary 
Stainless steel electrospray capillary 
t 
+ 3-5 kV Sample solution 
High 
Atmospheric pressure 
vacuum 
Figure 2.1 Simplified diagram of the Finnigan Matt LCQ TM electrospray ionisation 
source with droplet and gas phase ion production (reproduced with 
permission from McCormack, 2003). 
2.2.2 Quadrupole Ion Trap Mass Spectrometry (QIT-MS) 
Electrospray ionisation (ESI) is a powerful analytical technique which has been interfaced 
with most mass analysers including single (Q) and triple (QqQ) quadrupole, quadrupole ion 
traps (QIT), time-of-flight (TOF), sector and Fourier transform ion cyclotron resonance 
(FT -IRC) instruments (McCormack, 2003 and references therein). The present study 
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utilised a Finnigan Matt LCQ™ QIT instrument for which a detailed report on the 
fundamentals, operation. capabilities and applications has been described by Bier and 
Schwartz (1997). The content of these excellent works are not repeated here. However, a 
brief explanation ofESI-(QIT)-MS opemtion is appropriate. 
A critical problem encountered when coupling an ESI source to a QIT mass spectrometer is 
that the analyte is dissolved in a liquid at atmospheric pressure, whilst the mass 
spectrometer functions at low pressure in a vacuum chamber. Approximately eight orders 
of magnitude lie between the atmospheric pressure of the ES ion source and the ambient 
pressure of the QIT. To overcome these significant pressure differences the ions exiting 
the ESI source are introduced to the QIT through a number of defined stages (Figure 2.2). 
The ions produced by the ESI source are focussed through a skimmer using a tube lens as a 
gating element. Ions are pulsed through the skimmer by applying a voltage (0-200 V) to 
the tube lens. The voltage is then altered to -150 V which stops transmission of the ions 
through the skimmer. The sampled ions are then collected by the first rf octapole and 
transmitted to the second rf octapole through an interoctapole lens. These efficiently 
transmit ions through chambers of lowering pressure. Uniquely, the second octapole is 
placed inside the entrance end cap of the QIT allowing transmission of ions directly to the 
ion-tmp chamber which consists of three electrodes; two hyperbolic end caps and a central 
hyperbolic ring electrode. The ion beam is allowed to enter the ion-tmp (ion injection) for 
a given amount of time, where the ions are stored (ion isolation), then allowed to exit (ion 
ejection) by increasing the m/z to the detector. The isolation of ions allows operations such 
as collision-induced dissociation (CID) MS" to be carried out on the ions over a period of 
time, within the same analyser, where further ion fragmentation can occur by collision with 
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helium (multi-stage MS or MSn, where n ~2) allowing detailed structural infonnation on 
precursor ions to be; obtained~ 
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Electrospray quad.rupole ion-trap mass spectrometer (LCQ™) developed by Finnigan Matt Corporation featuring a heated capillary and 
dual-octapole ion guides to inject ions directly into the trapping chamber. P1 - 760 Torr, P2- 1 Torr, P3 - 1 x 10-3 Torr, P4 - 2.5 x 10-5 
Torr, and Ptrap- 1-2 x 10-3 Torr (Adapted from Bier and Schwartz, 1997). 
2.2.3 ESI-MS detection and analysis of PbACs 
Liquid chromatography (LC) with mass spectrometry (MS) detection has been used for the 
analysis and determination of a broad range of PhACs in environmental matrices (Perez 
and Barcelo, 2007; Kot-Wasik et al., 2007). Specifically, the usage of an electrospray 
ionisation source (ESI) as an interface between LC and MS or MS" (i.e. the modern LC-
MS or LC-MS") has gained great popularity due to its compatibility with polar, non-
volatile and thermally labile PhACs (Hao et al., 2007 and references therein). However, 
although LC/ESI-MS detection methods for a variety of PhACs have been reported, few 
authors have reported LC/ESI-MS methods for diazepam or its related metabolites, and 
there are no reports evaluating its degradation in environmental matrices. 
M cC lean et al. ( 1999) presented methods for the separation and determination of fifteen 
I ,4-benzodiazepines by LC/ESI-MS2. The MS2 capabilities of the ion-trap allowed the 
specific detection and determination of diazepam, nordiazepam, oxazepam and temazepam 
in the hair of a patient under clinical treatment with diazepam and temazepam. 
Smyth et al. (2000) investigated the ESI and sequential product ion fragmentation of a 
range of pharmacologically significant I ,4-benzodiazepines, including diazepam, using an 
ion trap mass spectrometer. The authors successfully elucidated the fragmentation 
pathways for these compounds in non-aqueous solutions (methanol + I% acetic acid). 
Such information was concluded to be of particular value for characterisation of the 
compounds, particularly when ESI-MS" is to be used as a detector following separation by 
liquid chromatography (LC). 
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ESI-MS was investigated as a rapid means of determining benzodiazepines in various 
drinks after liquid-liquid extraction by Chen and Hu (1999). Eight benzodiazepines, 
including diazepam, were determined as protonated molecular ions and MS2 analysis was 
used to confirm identity. 
Van derV en et al. (2004) utilised LC/ESI-MS to detect diazepam in effluent samples down 
to low jlg L"1 levels in Belgian STWs. Sample preparation consisted solely of spiking of 
the samples with an internal standard (diazepam-d5) and passage of the sample over a nylon 
syringe filter, eliminating the need for sample preconcentration. However, the authors did 
not investigate the potential presence of any related metabolites or potential degradation 
products, nor were these considered when developing the methodology. 
A reverse phase LC method for the simultaneous analysis of seven benzodiazepines, 
including diazepam and its metabolite oxazepam was reported by Mikarni et al. (2005), for 
the screening of dietary supplements for adulterants. Diazepam was identified and 
determined at llg L"1 levels, using a combination of three different analytical methods: 
LC/photodiode array, thin-layer chromatography (TLC) and LC/ESI-MS. 
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2.3 Current Aims 
The aim of the work described in the present chapter was to develop an efficient LCIESI-
MS method for the separation, detection and quantitation of diazepam and its human 
metabolites and potential degradation products in water samples. In order to achieve this 
several important areas of method development required investigation: 
Firstly, ESI-MSn infusion studies of authentic standards of diazepam, nordiazepam, 
temazepam and oxazepam were conducted in order to better understand the MSn 
fragmentation pathways that might be utilised for the molecular characterisation of these 
compounds in aqueous environmental samples (Section 2.4.1 ). Subsequently, a liquid 
chromatography technique, which could be coupled to the ESI-MS detector, was developed 
to enable separation and quantitation of the individual compounds and their degradation 
products from distilled water (Section 2.4.2). 
A solid-phase extraction (SPE) was developed concurrently which allowed extraction of 
the analytes of interest from humic acids in aqueous samples prior to analysis using the 
LCIESI-MS system (Section 2.4.3). Development of the SPE system was aided by 
utilisation of the developed HPLC experimental conditions which were thought to be 
indicative of conditions needed for solid-phase extraction absorbents and elution solvents 
for extraction of analytes from humic acids. 
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2.4 Results and Discussion 
2.4.1 Evaluation of ESI-MS0 detection of diazepam and its buman metabolites 
For an initial evaluation of ESI-MS" as an analytical technique for analysis of diazepam 
and its human metabolites in aqueous solutions, authentic compounds of known 
composition were required. Authentic samples of diazepam, nordiazepam, temazepam and 
oxazepam were purchased from Sigma-Aidrich (UK). Infusion of solutions of each analyte 
(I jJg mr;Il in water : methanol : formic acid (90: 10:0.1, v/v/v) were made using a built in 
syringe pump with a Hamilton (250 j.LL) syringe (Reno CA, USA). Analytes were infused 
at 3 JlL rnin-1• The full experimental procedure is detailed in Section 6.3. 
Both positive and negative ion full scan mass spectra (± mlz 50-2000) of each analyte were 
collected and a direct comparison made. The positive ion full scan mass spectrum of 
diazepam (Figure 2.3A) shows a base ion of mlz 285.2 which corresponds to the [M+Ht 
ion, while the negative ion full scan for diazepam (Figure 2.38) shows no discernible base 
ion. It can also be seen that the detection response for diazepam, normalized (NL) to the 
base peak was two orders of magnitude higher in positive ion mode (NL: 1.19 x 106 
compared to 1.34 x 104). This trend was also observed in all (±ve) full scan spectra for the 
human metabolites of diazepam (data not shown), and therefore all subsequent analyses 
were conducted in positive ion mode. A previous study of electrospray ionisation of I ,4-
benzodiazepines, including diazepam, in non-aqueous solutions by Smyth et al. (2000) also 
concluded that these compounds only underwent electrospray ionisation in positive ion 
mode. Therefore all further full scan mass spectra (mlz 150-500), ZoomScan and collision 
induced dissociation (CID) MS" spectra for all compounds were acquired in positive ion 
mode. For MS" characterisation of the compounds the most intense peak in the mass 
spectrum, i.e. [M+Ht, was chosen for MS2 analysis, providing first generation product 
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ions in this mode. The process was repeated for MS3 and MS4 or until a reproducible 
signal was no longer seen. The most intense peak was chosen for further characterisation 
at each MS" stage. Only peaks that were entirely consistent and reproducible are reported. 
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Infusion ESI-MS mass spectra of diazepam (1 ,....g mL-1) . (A) Positive ion 
mode, full scan mlz 50-2000. (B) Negative ion mode, full scan mlz 50-2000. 
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2.4.1.1 Infusion ESI-MS0 analysis of diazepam 
The MS full scan mass spectrum of diazepam in water (Figure 2.4A) shows an ion series 
centred on the base ion (m/z 285.3) which corresponds to protonated diazepam ([M+Ht). 
The differences in the ion series were elucidated by the use of the high resolution 
'ZoomScan' (ZS) facility (ZS allows resolution of isotope peaks for up to +4 charge-state 
ions). ZoomScan analysis (Figure 2.4B) of the ion series m/z 285.3-288.3 shows a 
difference of m/z 1 between 12C and 13C isotopes (e.g. 285.1/286.1) which is consistent 
with singularly charged ions (m/z = ~/1). Additionally, the ZS spectrum shows a 3:1 ratio 
of ions with m/z 285 and 287 which is indicative of the presence of a single chlorine atom 
(viz: 35CII37CJ). An odd [M+Ht value for the ions indicates that an even number of 
nitrogen atoms are present. 
In an attempt to characterise diazepam more completely, MS" analysis of the base ion (m/z 
285.3) observed in the full scan spectrum was carried out. Highly reproducible product ion 
spectra were obtained with four CID fragmentation steps (MS4; Figure 2.5). MS2 CID 
fragmentation (Figure 2.5A) of the precursor ion (m/z 285.3) gave rise to a prominent 
product ion at m/z 257.2 and minor ions at m/z 228.2 (30%), m/z 222.3 (31%) and m/z 
182.1 (29%) resulting from in-source fragmentation of [M+Ht. From these data a 
fragmentation pathway is proposed (Figure 2.6) whereby diazepam loses the neutral 
species CO (28 u), resulting in contraction of the seven-membered ring to a six-membered 
ring (11; m/z 257). This can be followed at the MS3 stage (Figure 2.5B) by loss of chlorine 
as a radical to yield a resonance stabilised cation radical (Ill; m/z 222). Alternatively the 
six-membered ring (11; m/z 257) can lose 29 u to give a species at m/z 228 (IV). It is 
probable that the 29 u loss corresponds to a nitrogen-containing neutral molecule such as 
CH2=NH, which has been proposed in earlier El-MS (McCarley and Brodbelt, 1993) and 
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44 
Q) 
0 
c (I) 
u 
c 
::J 
.a 
<( 
Q) 
> 
:;:::; 
(I) 
a:; 
0::: 
Q) 
0 
c 
(I) 
u 
c 
::J 
.a 
<( 
Q) 
> 
:;:::; 
(I) 
a:; 
0::: 
Figure 2.4 
03 # 1 RT: 0.01-0.99 AV:1 NL:6.88E7 
T: + c Full ms [ 150.00-350.00) 
100 
90 
80 
70 
60 35CI 
50 
40 
30 Diazepam 
20 
10 
285.3 
287.3 
A 
(Full MS) 
0 i.,..#,';lh-rl+-,-,..;:.;.y;:~~~+r.4J~'PM~~ ....... ~"f~ 
150 
04 # 1 RT: 0.01-0.99 AV:61 NL: 2.62E6 
T: + Z ms [ 280.2-290.2) 
250 
m/z 
100 285.1 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0 2110.8 2112.0 282_8 283.3 280.0 
200.1 
11 
300 350 
B 
(ZoomScan) 
288.1 
218.1 280.1 
281 282 283 284 285 286 287 288 289 290 
mlz 
Positive ion ESI-MS mass spectra of diazepam (I 0 )lg mL-1) ; (A) Full scan 
m/z 150-350, MS; (B) ZoomScan of precursor ion series mlz 285.3. 
45 
100 
80 
60 
40 
154.1 
20 -
<m ---+ 
Loss of28 u 
Suggests loss of -CO 
182.1 222.3 228.2 
257.2 
258.2 
I 28S.2 o ~~~-·1 __ 16~7·0~~~--~~~~~~-~~-.2~2~~=.2=2~=-3~2~_·3==2M=.9~~=-~12~n=8 __ ll-.2 __ _ 
100 
80 
60 
40 
20 
0 
100 
80 
60 
40 -
20 
0 
228.1 
(IV) 
Loss of29 u 
(Im 
Loss of 35 u ~ 222.3 
Suggests loss of ·Cl 
154.1 
~.0 166.0 
193.2 
94.2 
221.2 
(V) 
Loss of 35 u 
Suggests loss of ·Cl 
192.1 201.0 211.1 226.1 ~.2 
I I 1 i I I I j I I I I j I I I fj I I i I j I I i I j i It I j I I I I j I 1 I I j t I , I j I 1 i I 
150 200 250 300 
Figure 2.5 
mlz 
Positive ion ESI-MS" mass spectra of diazepam: (A) MS2 spectrum of 
precursor ion mlz 285.3 (37% AA), (B) MS3 on product ion m/z 257.2 (36% 
AA) and (C) MS4 on product ion mlz 228. 1 (36% AA). 
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Figure 2.6 Proposed CID MS" fragmentation pathway for diazepam. 
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2.4.1.2 Infusion ESI-MS0 analysis of nordiazepam 
The MS full scan mass spectrum of nordiazepam in water (Figure 2.7A) shows an ion 
series centred on the base ion (mlz 271.3) which corresponds to protonated nordiazepam 
([M+Ht). As with the parent compound (diazepam; Section 2.4.1.1 ), resolution between 
the 12C and 13C isotopes in the ZoomScan spectrum (Figure 2.78) is indicative of a 
singularly charged ion and the 3: 1 ratio of mlz 271 and 273 is characteristic of the presence 
of a single chlorine atom e5Cl/37Cl). MS2 CID fragmentation (Figure 2.8A) of the 
precursor ion (mlz 271.3) produces a base ion at mlz 243.2. 
The fragmentation pathway proposed for nordiazepam (Figure 2.9) is the same as that for 
D to ill in the CID fragmentation of diazepam (Figure 2.6). The base ion in the MS2 CID 
fragmentation of the precursor ion (mlz 271.3) is proposed to be due to loss of the neutral 
species CO (28 u) and results in a resonance stabilised six-membered ring (VI; mlz 243.2). 
Loss of chlorine (35 u) as the radical occurs at the MS3 stage (Figure 2.88), yielding a 
resonance stabilised cation radical (VD; mlz 208.1 ). 
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Figure 2.9 Proposed CID MS" fragmentation pathway for nordiazepam. 
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2.4.1.3 Infusion ESI-MS" analysis of temazepam 
The MS full scan mass spectrum of temazepam in water (Figure 2.1 OA) over the mass 
range mlz 50-350, shows an ion series centred on the base ion (mlz 301.1) which 
corresponds to protonated temazepam ([M+Hf). As with the previous benzodiazepines 
(diazepam; Section 2.4.1.1 and nordiazepam; Section 2.4.1.2), the ZoomS can spectrum 
(Figure 2.1 OB) shows resolution between the 12C and 13C isotopes indicating that the 
compound is singularly charged and the 3: l ratio of mlz 301 and 303 is characteristic of the 
presence of a single chlorine atom e5Cl/37Cl). MS2 CID fragmentation (Figure 2.11A) of 
the precursor ion (mlz 301.1) yields a base ion at mlz 283.0. 
The proposed fragmentation pathway (Figure 2.12), following the analysis of the MS" 
spectra, can be deduced if temazepam first loses water (18u, -H20) to form a carbonium 
ion with the seven-membered ring intact (VIll; mlz 283.0). Subsequent MS3 CID 
fragmentation of VIll (Figure 2.11 B) results in loss of CO (28u) leading to contraction of 
the seven-membered ring to a resonance stabilised six-membered ring (IX; mlz 255.2). 
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Figure 2.10 Positive ion ESI-MS mass spectra oftemazepam (10 J..lg mL-1); (A) Full scan 
mlz 150-350, MS; (B) ZoomScan ofprecursor ion series mlz 301.1. 
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Figure 2.11 Positive ion ESI-MS" mass spectra of temazepam: (A) MS2 spectrum of 
precursor ion mlz 301.1 (40% AA), (B) MS3 on product ion mlz 283.0 (42% 
AA). 
54 
(Temazepam; m/z 301.1) 
· H,O j MS' 
(Vlll; m/z 283.0) 
-CO j MS3 
(IX; m/z 255.2) 
Figure 2.12 Proposed CID MS" fragmentation pathway for temazepam. 
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2.4.1.4 Infusion ESI-MS" analysis of Oxazepam 
The MS full scan mass spectrum of oxazepam in water (Figure 2.13A) shows an ion series 
centred on the base ion (mlz 287.2) which corresponds to protonated oxazepam ([M+H]). 
In agreement with the previous compounds (diazepam, nordiazepam and temazepam; 
sections 2.4.1.1 to 2.4.1.3), resolution between mlz 287 and 286 in the ZoornScan spectrum 
(Figure 2.13B) is consistent with a singly charged ions ~ 11 ), and the 3:1 ratio of mlz 287 
and 289 is indicative of the presence of a chlorine atom C5CU37Cl). 
MS" analysis of the base ion (m/z 287.2) observed in the full scan spectrum was carried out 
in order to elucidate the fragmentation pathway for oxazepam. Highly reproducible 
product ion spectra were obtained with four CID fragmentation steps (MS4; Figure 2.14). 
The fragmentation pathway proposed for oxazepam (Figure 2.1 5) matches that for VDI to 
IX in the CID fragmentation of temazepam (Figure 2.12). 
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Figure 2.13 Positive ion ESI-MS mass spectra of oxazepam (10 J.Lg mL-1) ; (A) Full scan 
mlz 150-350, MS; (B) ZoomScan of precursor ion series mlz 287.2. 
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Figure 2.14 Positive ion ESI-MS" mass spectra of oxazepam: (A) MS2 spectrum of 
precursor ion m/z 287.1 (25% AA), (B) MS3 on product ion mlz 269.0 (25% 
AA), (C) MS4 on product ion m/z 241.3 ( 40%AA). 
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Figure 2.15 Proposed ClD MS" fragmentation pathway for oxazepam. 
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2.4.1.5 Summary of the ESI-MS0 behaviour of diazepam and its human 
metabolites 
Examination of diazepam and its human metabolites in aqueous solutions by electrospray 
ionisation ion trap multi-stage mass spectrometry (ESI-MS") has demonstrated that the 
technique is extremely powerful for their identification and characterisation. The ESI ion-
trap mass spectral behaviour of the studied benzodiazepines (as swnmarised in Table 2.1) 
is best understood by dividing them into two structural classes (A) and (B), with each class 
having similar ESI-MS" behaviour. The classes (A) and (B) refer to the general structure 
of 1,4-benzodiazepines given in Figure 2.16. 
Cl 
Figure 2.16 General Structure of 1 ,4-benzodiazepines. 
This structural class comprises diazepam and nordiazepam which contain CH3 and H 
respectively in the 1-N position. They lose CO at MS2 and then the Cl radical at MS3. 
Diazepam also has an additional/alternative fragmentation pathway involving loss of 
CH2=NH at MS3 followed by the Cl radjcal at MS4 . 
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(B) R1 = H or CH3; R2 = OH 
This structural class contains the 3-0H-substituted benzodiazepines; temazepam and 
oxazepam, which both lose H20 at MS2 and CO at MS3. Oxazepam additionally loses the 
Cl radical at MS4 . 
Table 2.1 ESI-MS" fragmentation data for diazepam and human metabolites 
Compound m/zsignals 
MS M 52 MS3 M 54 
Diazepam 285.3 257.2 228.1 193.2 
222.3 
Nordiazepam 271 .3 243.2 208.1 
Temazepam 301 .1 283 255.2 
Oxazepam 287.2 269.1 241 .3 206.5 
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2.4.2 Development of LC conditions 
ESI-MS has been shown to be a powerful detection method for 1,4-benzodiazepines 
(Section 2.4.1 ). However, infusion ESI-MS does not allow for separation of the individual 
compounds or any potential degradation products in environmental samples. A liquid 
chromatography technique coupled to the ESI-MS detector would enable separation and 
quantitation of the individual compounds. Preliminary separation experiments were carried 
out in conjunction with Miss Clare Redshaw (Redshaw, 2007) using a HPLC-UV system 
(data not presented) before method development was conducted using the LC/ESI-MS 
system described in Section 2.2. 
2.4.2.1 Investigation of the LC separation and ESI-MS detection of 1,4-
benzodiazepines 
HPLC was carried out using a P580a binary pump (Dionex-Sofuon GmbH, Germany). 
Flow rates of 0.2 mL min-1 were used with all columns tested coupled directly to the mass 
spectrometer (ThermoFinnigan, San Jose, CA, USA). Sample injections (5 J..l.L) were made 
either manually or with an ASI 100 autosampler (Dionex-Sofuon). Full instrument and 
experimental details are given in Sections 6.2 and 6.4 respectively. Mobile phases, eluent 
compositions and gradient elution times are given in the text or with the respective figures. 
The liquid chromatography separation of diazepam and its human rnetabolites was 
investigated using a 100 x 2.1 mm, 5 JliD HyperCarb HPLC column (ThermoQuest, USA), 
a 100 x 2.1 mm, 5 J.1ID Discovery HS C18 HPLC column and (SUPLEC011\ UK) and a 150 
x 2.0 mm, 5 J..liD Gemini Cl8 HPLC column (Phenomenex®, UK). LC separation was 
carried out using a gradient elution [Time/%A] 0/80-8/0-13/0-15/80] of 0.1% formic acid 
in water (eluent A) and 0.1% formic acid in acetonitrile (eluent B). 
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Figures 2.17 A-C show LC/ESI-MS full scan mass chromatograms (base peak plot) of the 
separation of a mixture of diazepam and its human metabolites at 1 Jlg mL-1, using the 
HyperCarb, Discovery and Gemini HPLC columns respectively. The HyperCarb HPLC 
column achieved incomplete separation of the mixture under the gradient conditions 
employed (Figure 2.17 A), suggesting several competing interactions between the 
compounds and the column components and/or eluents. The Discovery C 18 (Figure 
2.17B) and Gemini C 18 (Figure 2.17C) HPLC columns achieved better separations similar 
to each other showing sharp peaks with little tailing and near baseline resolution of all of 
the compounds. All subsequent analyses of the selected benzodiazepines reported here 
utilised the Gemini column chosen for wide ranging pH stability and extended column 
lifetimes. 
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Figure 2.17 HPLCIESI-MS mass chromatograms (base peak plot) of benzodiazepine 
mixtures (1 ~g mL-1) by gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; 
A = water+ 0.1 % formic acid, B =acetonitrile+ 0.1% formic acid); 
(A) HyperCarb HPLC column (1 00 x 2.1 mm, 5 ~) 
(B) Discovery Cl8 HPLC column (lOO x 2.1 mm, 5 ~) 
(C) Gemini Cl8 HPLC column (lOO x 2.1 mm, 5 J.UU) 
Peak assignments shown in Table 2.2. 
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Table 2.2 Peak Assignments for HPLC separation of benzodiazepines in Figure 2.17 
A-C. 
Peak Letter Compound Structure 
Ox Oxazepam 
l --fo 
)-oH 
Cl --N 
N Nordiazepam 
Cl 
T Temazepam 
Cl 
D Diazepam 
Cl 
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Figure 2.18A-E shows a comparison of the separation of the 1,4-benzodiazepine mixture 
with solutions of each individual compound under identical gradient elution conditions. 
Initial identification of each compound was achieved using a comparison of retention times 
(Rt) for each peak in the benzodiazepine mixture (Figure 2.l8A) and the retention times for 
each individual compound in Figures 2.18B-E. The retention times were detennined for 
each ion mass CRt Table 2.3). Comprehensive identification of each compound was 
achieved by comparison of the full scan mass spectra (m/z 150-500) obtained for each 
individual benzodiazepine with those obtained for each peak in the mixture. 
Table 2.3 LCIESI-MS retention times for base peak plot mass chromatograms for 
protonated ions of: nordiazepam (mlz 271.3), diazepam (mlz 285.3), 
oxazepam (mlz 287 .2), temazepam (mlz 301.1) compared with a mixture of 
all four benzodiazepines. Conditions are given in Figure 2.18. 
Sample Retention Time (R1) (1 ~ mL-1) 
mlz 271.3 mlz 285.3 m/z 287.2 mlz 301.1 
Blank nd nd nd nd 
Benzodiazepine Mixture 6.16 7.17 5.92 6.69 
Diazepam nd 7.18 nd nd 
Temazepam nd nd nd 6.70 
Nordiazepam 6.17 nd nd nd 
Oxazepam nd nd 5.95 nd 
Not detected (nd) 
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Figure 2.18 LCIESI-MS chromatograms (EIC). (A) Benzodiazepine mixture (1 J,J-g mL-1) , 
(B) Diazepam standard (1 J.Lg mL-1) , (C) Temazepam standard (1 J.Lg mL-1) , 
(D) Nordiazepam standard (1 J.lg rnL-1) and (E) Oxazepam standard (1 J.lg 
mL-1) . Gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; A = water+ 0.1% 
formic acid, B = acetonitrile+ 0.1% formic acid). 
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Figure 2.19 Positive ion full scan mlz 150-500 MS of peaks B, C, D and E shown in 
Figure 2.18; (A) Diazepam at 7.18 min, (B) Temazepam at 6.70 min, (C) 
Nordiazepam at 6.17 min and (E) Oxazepam at 5.95 min. 
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2.4.2.1 Investigation of the LCIESI-MS response for diazepam: 
External Calibration 
A series of solutions (0.00 1 to 10 J.Lg mL-1) of diazepam in water were analysed by LCIESI-
MS in positive ion full scan mode (mlz 150-1 000) in order to determine appropriate 
concentrations for further evaluations. Peak retention time (R.), integrated peak areas 
(Area) and signal to noise ratios (SIN; Xcalibur software calculated) from extracted ion 
(mlz 285.2 and 287.3) chromatograms of each solution are given in Table 2.4. For 
diazepam (m/z 285.2 and 287.3) the lowest detectable peak, was obtained for the 0.01 f.lg 
mL-1 solution in extracted ion chromatogram (El C) mode. The signal to noise ratio of 7 at 
the 0.01 J.,1g mL-1 concentration for the EIC (rn/z 285.3 and 287.3) was just above the limit 
of detection (SIN = 3). Plotting the peak areas against concentration (Figure 2.20), a linear 
trend was shown for the EIC chromatograrns (R2 = 0.9950) in the concentration range 0.01 
to 10 f.lg mL-1• Only one data set was obtained because the chromatographic and mass 
spectrometer conditions were still being evaluated at this point and were subject to change; 
therefore repeatability tests and statistical analyses could not be conducted. 
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Table 2.4 Extracted ion chromatogram peak data for a series of diazepam (m/z 285.3) 
solutions; 5 J.!L injections on Gemini Cl8 column with gradient ([Time/%A] 
0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% 
formic acid). 
Diazepam Extracted ion mlz 285.3/287.3 
Concentration peak area (unit less) 
).19 mL·1 Rt Area 5/N 
10 7.03 1779966738 574 
1 7.12 306622250 236 
0.1 7.11 38113446 48 
0.01 7.12 5074184 7 
0.001 nd nd nd 
Not detected (nd) 
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Figure 2.20 Plot of the extracted (EIC) ion peak area for diazepam (m/z 285.3) solutions 
against concentration. Linear trend line and R2 value shown. Gradient 
conditions given in Table 2.4. 
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Following the promising results of the previous calibration (Figure 2.20), an investigation 
was undertaken to determine the extent of day to day variation in signal response for a 1 J,lg 
mL-1 diazepam solution in water. Aliquots of the solution were analysed in full scan mode 
(mlz 150-1 000) over a period of 10 days using identical gradient conditions to the previous 
calibration. Peak retention time (R.), integrated peak areas (Area) and signal to noise ratios 
(SIN; Xcalibur software calculated) from extracted ion (mlz 285.2 and 287.3) 
chrornatograms for the 1 J.lg mL -I diazepam solution on consecutive days are given in Table 
2.5. A plot of peak areas for the diazepam solution on each day is shown in Figure 2.21 . 
There was great random variation observed in the day to day response for the 1 J,lg mL-1 
diazepam solution indicating that the method would be unsuitable for quantitative 
determination of diazepam in further experimental studies. It was therefore decided to 
investigate the use of an internal standard for calibration of diazepam and also its 
metabolites. 
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Extracted ion chromatogram peak data for a 1 J..Lg mL-1 diazepam solution 
(m/z 285.3 and 287.3); 5 J.LL injections on Gemini C18 column with gradient 
([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = 
acetonitrile + 0.1% formic acid). 
Day Extracted ion mlz 285.3/287.3 
Rt Peak Area S/N 
(Unitless) 
1 7.17 284046268 246 
2 7.16 317597949 325 
3 7.19 305672522 210 
4 7.15 309078545 283 
6 7.17 271925577 214 
8 7.17 306471480 238 
10 7.16 321598920 279 
• • 
• • 
R2 = 0.0678 
• 
• 
----,-
2 4 6 8 10 12 
Day 
Figure 2.21 Plot of the extracted (EIC) ion peak areas for a l J..Lg mL-1 diazepam solution 
(mlz 285.3 and 287.3) monitored on consecutive days. R2 value shown. 
Gradient conditions given in Table 2.5. 
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2.4.2.2 Investigation of the LC/ESI-MS response of diazepam: 
Internal Standard Calibration 
An internal standard calibration method was developed using oxazepam-ds, selected for its 
structural similarity to the 1 ,4-benzodiazepines investigated. Deuteration was on the phenyl 
substituent (Figure 2.22A). An initial evaluation of oxazepam-d5 was made by ESI-MS 
infusion using a I 0 J.lg mL-1 solution of an authentic sample purchased from Sigma-
Aldrich. Figure 2.22A shows the positive ion MS of oxazepam-d5 in water with an ion 
series centred on the base ions (m/z 292.2) which corresponds to protonated oxazepam-d5 
([M+H]}. The base ion (m/z 292.2) was not detected in any of the mass spectra of 
diazepam, nordiazepam, temazepam or oxazepam (Section 2.4.1.1 to 2.4.1.4) and can 
therefore be used exclusively to identify the internal standard (oxazepam-d5). The 
ZoomScan spectrum (Figure 2.22B) is consistent with a singularly charged ion (~/l) and 
the 3: l ratio of mlz 292 and 294 is indicative of the presence of a chlorine atom e5CV37Cl). 
MS0 analysis of the base ion (m/z 292.2) observed in the full scan spectrum was carried out 
and compared with the fragmentation pathway for oxazepam which had previously been 
determined in Section 2.4.1.4. Comparison of the fragmentations is shown in Figure 2.23. 
The results obtained show that the deuterated (d5) analogue of oxazepam undergoes an 
identical fragmentation pattern to non-deuterated oxazepam. 
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Figure 2.22 Positive ion ESI-MS mass spectra of oxazepam-d5 (10 1-1g mL"1) ; (A) Full 
scan mlz 150-350, MS; (B) ZoomScan of precursor ion series mlz 292.2. 
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Figure 2.23 Comparison of ESI-MS" mass spectra of oxazepam (A-C) and oxazepam-d5 
(D-E). 
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As the objective was the determination and calibration of 1,4-benzodiazepines for the 
quantitation of these compounds in photodegradation studies, and not the achievement of 
the lowest possible detection limit it was determined that 0.1 to 2 J.Lg mL-1 would be 
optimum for calibration of the LC/ESI-MS procedure using the internal standard 
(oxazepam-d5) . Calibration series of solutions (0.1 to 2 J.Lg rnL-1) of diazepam, 
nordiazepam, temazepam and oxazepam, each spiked with 1 J.lg mL-1 oxazepam-d5 were 
carried out in full scan mode ( mlz 150-1 000). Each calibration was determined in triplicate 
(n=3). Average extracted ion (EIC) chromatogram peak data for each benzodiazepine are 
given in Tables 2.6 to 2.9 respectively and calibration graphs of benzodiazepine response 
against the internal standard were determined (Figures 2.24 to 2.27 respectively). 
(Extracted ion chromatograms in triplicate for each compound compared to the internal 
standard are included in Appendix A3). 
The results for each calibration showed excellent linear response across the range of 
samples analysed (0.1 to 2 J.Lg rnL-1; Figures 2.24 to 2.27 respectively) with R2 values of 
0.9995, 0.9992, 0.9989 and 0.9998 for diazepam, nordiazepam, temazepam and oxazepam 
respectively. Solvent blanks were examined by LCIESI-MS between each sample set (data 
not presented) and no sample carryover was observed in the blanks across the 
concentration range analysed. The calibrations carried out showed that an internal standard 
calibration method, using oxazepam-ds, for diazepam and its human metabolites had been 
developed. The calibration methods developed should prove valuable for quantitation of 
individual 1,4-benzodiazepines in photodegradation studies in aqueous matrices. 
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Table 2.6 Average (n=3) EIC peak data for a series of diazepam (m/z 285.3 and 287.3) 
standards against the internal standard (mlz 292.2 and 294.2), oxazepam-d5 
(IJ.!g mL-1). 5 J.!L injections on Gemini C18 column with gradient 
([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = 
acetonitrile + 0.1% formic acid). 
Diazepam Cone. 
llg ml·1 
Average Peak Area Average Peak Area 
Diazepam Internal Std. 
Average 
Ratio 
so 
2.0 
1.0 
0.5 
0.3 
0.1 
6.00 
5.00 
e 4.00 
·.c 
ea 
.. 
ea 3.00 4> 
.. 
ea 
,:,c 
ea 
2.00 4> c., 
1.00 
0.00 
0.0 
(mlz 285.3 and 287.3) (m/z 292.2 and 294.2) 
448356060 
272510633 
162306037 
108800861 
47371113 
Diazepam 
0.5 
117915066 4 .800 
115688411 2.356 
121121653 1.250 
121967793 0.700 
111190037 0.300 
y = 2.3762x + 0.0277 
R2 = 0.9995 
1.0 1.5 
-1 Concentration {J..Lg mL ) 
2.0 
0.2170 
0.0120 
0.0401 
0.1031 
0.0423 
2.5 
Figure 2.24 LC/ESI-MS calibration graph for a series of diazepam standards (0.1 to 2 Jlg 
mL-1) . Peak area ratio is the ratio of the EIC peak area of diazepam (mlz 
285.3 and 287.3) against 1 Jlg mL-1 internal standard, oxazepam-d5. 
Chromatographic conditions are given in Table 2.6. 
77 
Table 2.7 Average (n=3) EIC peak data for a series of nordiazepam (mlz 271.3 and 
273.3) standards against the internal standard (mlz 292.2 and 294.2), 
oxazepam-d5 (IJ..l.g mr1) . 5 J..l.L injections on Gemini C18 column with 
gradient ([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B 
= acetonitrile + 0.1% formic acid). 
Nordiazepam Cone. Average Peak Area Average Peak Area Average so 
Jlg ml·1 
2.0 
1.0 
0.5 
0.3 
0.1 
4.00 
3.00 1 
1.00 
0.00 
0.0 
Nordiazepam Internal Std. Ratio 
(m/z 271.3 and 273.3) (m/z 292.2 and 294.2) 
485854148 137326179 3.538 
254099734 142264986 1.786 
179651940 192302150 0.934 
102207216 150067200 0.681 
40788827 153489964 0.266 
Nordiazepam 
y = 1.7071x+0.1095 
0.5 1.0 1.5 
- I Concentration (J.lg m.L ) 
2.0 
0.269 
0.164 
0.089 
0.018 
0.009 
2.5 
Figure 2.25 LC/ESI-MS calibration graph for a series of nordiazepam standards (0.1 to 2 
Jlg rnL"1). Peak area ratio is the ratio of the EIC peak area of nordiazepam 
(m/z 271.3 and 273.3) against 1 Jlg mL"1 internal standard, oxazepam-d5• 
Chromatographic conditions are given in Table 2.7. 
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Table 2.8 Average (n=3) EIC peak data for a series of temazepam (mlz 301.1 and 
303.1) standards against the internal standard (mlz 292.2 and 294.2), 
oxazepam-d5 (1 J.Lg mr1). 5 J.LL injections on Gemini C18 column with 
gradient ([Tirne/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B 
= acetonitrile + 0.1% formic acid). 
Temazepam Cone. Average Peak Area Average Peak Area Average 
Ratio 
so 
0 
:c 
.. 
... 
.. 
J.lg ml·1 
2.0 
1.0 
0.6 
0.2 
0.1 
4.00 
3.00 
~ 2.00 
.. 
..:.: 
.. 
4.1 
Cl. 
1.00 
0.00 
0.0 
Temazepam Internal Std. 
(m/z 301.1 and 303.1) (m/z 292.2 and 294.2) 
568039340 167273770 3.40 
256539592 157185735 1.63 
172820021 165336041 1.05 
67728199 164878575 0.41 
32129217 164064829 0 .20 
Temazepam 
y = 1.6649x + 0.0374 
0.5 
R2 = 0.9989 
1.0 1.5 
-I Concentration (J.lg mL ) 
2.0 
0.2437 
0.0161 
0.0330 
0.0157 
0.0104 
2.5 
Figure 2.26 LC/ESI-MS calibration graph for a series of temazepam standards (0.1 to 2 
J.Lg mL"1). Peak area ratio is the ratio of the EIC peak area of temazeparn 
(mlz 301.1 and 303.1) against 1 J.Lg mL-1 internal standard, oxazepam-d5. 
Chromatographic conditions are given in Table 2.8. 
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Table 2.9 Average (n=3) EIC peak data for a series of oxazepam (mlz 287.2 and 
289.2) standards against the internal standard (m/z 292.2 and 294.2), 
oxazepam-ds (1 j.lg mL-1). 5 JJ.L injections on Gemini Cl8 column with 
gradient ([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B 
= acetonitrile + 0.1 % formic acid). 
Oxazepam Cone. 
~g ml-1 
Average Peak Area Average Peak Area 
Oxazepam Internal Std. 
Average 
Ratio 
so 
2.0 
1.0 
0.6 
0.2 
0.1 
3.00 
Q 2.00 
·.c 
.. 
.. 
.. 
~ 
.. 
.. 
..:.: 
.. 
~ 1.00 
0.00 
0.0 
(m/z 287.2 and 289.2) (m/z 292.2 and 294.2) 
315248342 154523786 
150005844 151164185 
92425771 151848392 
30762118 153436070 
15399471 161317087 
Oxazepam 
0.5 
y = 1.0205x - 0.0086 
R2 = 0.9998 
1.0 1.5 
- I Concentration (}.Lg mL ) 
2.0 
2.040 0.0943 
0.992 0.0874 
0.609 0.0276 
0.200 0.0062 
0.095 0.0022 
2.5 
Figure 2.27 LC/ESI-MS calibration graph for a series of oxazepam standards (0.1 to 2 
J.lg mL-1). Peak area ratio is the ratio ofthe EIC peak area of oxazepam (mlz 
287.2 and 289.2) against 1 J.lg mL-1 internal standard, oxazepam-d5• 
Chromatographic conditions are given in Table 2.9. 
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2.4.3 Solid-phase extraction (SPE) of 1,4-benzodiazepines from humic acid waters 
and analysis using LCIESI-MS. 
The advent of ESI-MS has seen application of the technique to the identification of a 
growing number of PhACs in aqueous environmental samples (recently reviewed by Kot-
Wasik et al., 2007). In Section 2.4.2 an LCIESI-MS method requiring no extraction 
procedures was developed for the separation and quantitation of diazepam and its human 
metabolites in distilled water solutions. The method is applied to direct photodegradation 
experiments conducted on the individual 1 ,4-benzodiazepines as described in Chapters 3 
and 4. However, in order for comparisons to be made with the role of indirect 
photodegradation experiments using humic acid-containjng natural waters, suitable 
extraction methods were required and investigated to determine whether diazepam, its 
human metabolites and photodegradation products could be retained and subsequently 
eluted in a minimum of solvent without decomposition and free from humic acid-derived 
interferents. Therefore following the detection and identification of several 
photodegradation products from direct photolysis experiments conducted on diazepam 
(Chapter 3, Section 3.4.2), authentic samples of two photoproducts were purchased 
(Sigrna-Aldrich) and these were utilised along with authentic 1 ,4-benzodiazepines to assess 
the suitability of SPE extraction methods. A SPE extraction procedure for recovery of 1,4-
benzodiazepines from aqueous matrices using methanol + 1% formic acid has been 
developed by Redshaw (2007) was used as a basis for development of an SPE system for 
extraction of 1 ,4-benzodiazepines and photodegradation products from humic acids. 
1 J..Lg mL-1 solutions of diazepam, nordiazepam, temazepam, oxazepam and 5-cbloro-2-
methylarninobenzophenone and 2-amino-5-chlorobenzophenone (diazepam 
pbotodegradation products, Chapter 3; Section 3.4.2.2) in aqueous solutions containing 1 
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Jig mL-1 of river Trent humic acids were prepared. Solid phase extraction of these 
solutions was carried out using Strata TM -X SPE cartridges (500mg polymeric sorbent x 
3mL, Phenomenex, Maccles:field, UK). A vacuum manifold extraction system (Isolute, 
International Sorbent Technology, Hengoed, UK) at a flow rate of approximately 5mL min-
1 was used for elution and several eluents were investigated. Full experimental details for 
the SPE procedures used are given in Chapter 6, Section 6.5. 1. 
2.4.3.1 Qualitative evaluation of SPE eluent solvents with analysis by 
LCIESI-MS 
Three eluent systems were investigated for the extraction and recovery of the solutions 
detailed above. The eluents were 6 mL of methanol, acetonitrile and rnethanol:acetonitrile 
(50: 50 v/v) with I% formic acid. Analyte fractions were reconstituted in I mL 
water:acetonitrile (1:9 v/v) before analysis using the LC/ESI-MS method developed in 
Section 2.4.2. Figure 2.27 A-D shows LC/ESI-MS full scan mass chromatograms (EIC) of 
the extraction of the humic acid-derived solutions using the different eluents compared to 
solutions in pure distilled water. SPE extraction using 6 mL methanol + I% formic acid 
(Figure 2.27 B) did not recover all the compounds from the humic acid solution whilst both 
the SPE extraction with 6 mL acetonitrile + 1% formic (Figure 2.27 C) and 6 mL of 
methanol:acetonitrile (50:50) + l% formic acid (Figure 2.27 D) achieved recovery of all 
compounds from the humic acid solution. It was therefore decided that these two eluent 
systems should be quantitatively evaluated to determine the most appropriate SPE 
extraction system for utilisation in indirect photolysis experiments (Chapters 3 and 4). 
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1,4-benzodiazeplnes 
~ 
Diazepam photoproducts 100 6 .10 1. 3 
5.&7 8.&3 ~ 
8.116 
(A) No SPE extraction 
0 
----------
100 8.10 7.18 
5.115 0.68 
(B) SPE 1 
Q) MeOH + fonnic acid 0 
c: 1.18 8.65 
IU 0 "0 
c: 
:::::1 
.0 
~ 
Q) 
> 100 0.13 7.15 
:;:::. 
IU 5.110 6.114 4i 
D:: 10.01 li (C) SPE 2 I 3.4" MeCN + fonnic acid 1.20 ~-544.211 0 ~
8.12 
7.14 100 
5.68 0.60 
e.eo (D) SPE 3 
MeOH:MeCN + fonnic acid 
0 
0 6 7 8 9 10 11 12 13 14 15 
Time (min) 
Figure 2.28 Comparison of SPE recovenes of I J.!g mL-1 I ,4-benzodiazepines and 
photodegradation products. (A) Mixture in distilled H20 , (B) SPE using 6 
mL MeOH + l% formic acid, (C) SPE using 6 mL MeCN + I% formic acid 
and (D) SPE extraction using 6 mL MeOH:MeCN (50:50 v/v) + 1% formic 
acid. 5 J.!L injections on Gemini Cl 8 column with gradient ([Time/%A] 
0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + O.I% 
formic acid). 
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2.4.3.1 Quantitative evaluation of selected SPE eluent solvents with analysis by 
LCIESI-MS 
To allow further development and optimisation of the SPE methods and to enable 
quantitation, l Jlg mL-1 standard solutions of the four I ,4-benzodiazepines and two direct 
photodegradation products of diazepam, 5-chloro-2-methylam.inobenzophenone and 2-
amino-5-chlorobenzophenone were prepared in triplicate, as described in Section 6.5.I . 
The samples were spiked with I flg mL-1 of internal standard, oxazepam-ds. Following 
SPE extraction using either 6 mL of acetonitrile + l% formic acid or 6 mL of 
methanol:acetonitrile (50: 50) + I% formic acid the samples were reconstituted in 1 mL 
water:acetonitrile (1 :9 v/v) before analysis using the LCIESI-MS gradient conditions given 
in Figure 2.28. The solutions were analysed in full scan mode (mlz 150-1000) and 
integrated peak areas (Xcalibur software calculated) determined from extracted ion 
chromatograms of the triplicate analyses of the samples. The determined peak area ratio of 
each 1 ,4-benzodiazepine standard compared to the internal standard was measured against 
the respective calibration graphs shown earlier in this Chapter (Figures 2.24 to 2.27 
respectively). Calibration graphs for each of the two photoproducts against the internal 
standard are detailed in Chapter 3, Section 3.4.2.3. The recovered concentrations were then 
converted to percentage recovery (%) and the average recoveries and standard deviations of 
the results are presented in Table 2. 10 and Figure 2.29 respectively. The results show that 
the SPE extraction method using 6 mL methanol:acetonitrile (50:50) in 1% formic acid 
showed greater recovery (71 -78%) for each of the compounds than the SPE extraction 
using acetonitrile + 1% formic acid ( 62-77% ). Therefore the extraction process using 
methanol:acetonitrile (50:50) + I% formic acid appeared to be suitable for the separation 
and recovery of I,4-benzodiazepines and available photoproducts, prior to LCIESI-MS 
analysis. 
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Table 2.10 Comparison of average recoveries (n=3) for different SPE extractions for 
1,4-benzodiazpines and selected pbotoproducts from humic acid-containing 
natural waters. 5 ~L injections on Gemini CI8 column with gradient 
([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = 
acetonitrile + 0.1% formic acid). 
SPE extraction using SPE extraction using MeOH:MeCN + 1% MeCN + 1% fonnic acid fonnic acid 
Compound 
Average% Standard Average% Standard 
recovery Deviation recovery Deviation 
Oxazepam 73% 5 71% 2 
Nordiazepam 68% 4 71% 2 
Temazepam 77% 6 74% 3 
Diazepam 67% 5 71% 2 
5-chloro-2-methylaminobenzophenone 68% 5 71% 4 
2-amino-5-chlorobenzophenone 62% 4 78% 4 
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Figure 2.29 Comparison of average recoveries (n=3) for different SPE extractions for 
1 ,4-benzodiazepines and selected photoproducts from humic acid containing 
natural waters. Gradient conditions given in Table 2.1 0. 
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2.5 Conclusions 
Examination of diazepam and its human metabolites in aqueous solutions by electrospray 
ionisation ion trap multi-stage mass spectrometry demonstrated that the technique is 
extremely powerful for compound identification and characterisation. The particular 
advantages of the ion trap multi-stage MS method are: the ability through the use of the so-
called 'ZoomScan' facility to determine the accurate mass differences between ions and 
application of CID multi-stage mass spectrometry allowing fragmentation pathways to be 
studied in up to four steps. 
Subsequently, a HPLC/ESI-MS method for the separation and quantitation of pure 
standards of diazepam and its human metabolites, nordiazepam, temazepam and oxazepam 
from aqueous solution was developed and the ESI-MS responses investigated. A sensitive, 
quantitative and specific method, involving SPE followed by HPLC/ESI-MS, has been 
developed for the determination of individual benzodiazepines and authentic standards for 
several direct photodegradation products of diazepam, identified in Chapter 3, Section 
3.4.2, at low (<1) J..lg mL-1 concentrations in humic acid-containing waters. The developed 
method was successfully applied to the extraction, separation and identification of 
photodegradation samples of diazepam and its human metabolites (nordiazepam, 
temazepam and oxazepam) in both distilled and humic acid containing natural waters. 
Details of these experiments are described in the following Chapters, 3 and 4. 
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CHAPTER THREE 
Photodegradation of Diazepam 
This chapter describes an investigation of the photostability of diazepam to simulated 
sunlight over prolonged periods of irradiation in dilute aqueous solutions and in the 
presence and absence of humic substances. The details of the laboratory photodegradation 
studies of diazepam are discussed. Two photoproducts are identified using LC-MS" and 
subsequent comparison with authentic compounds, and the structures of two further 
degradation products are proposed, based on interpretation of LC-MS data. 
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3.1 Introduction 
Factors which may detennine the environmental fate of PhACs in water include 
biodegradation, photodegradation and partitioning onto suspended solids and sediments. 
Considerable research into the effects of aerobic and anaerobic microbial degradation on 
the environmental degradation of PhACs has already been conducted (Kummerer et al., 
1997; Henschel et al., 1991; Ternes et al., 1999). In contrast, photodegradation has 
historically received less attention as a process for the removal of organic pollutants in the 
environment. This is surprising since the routine detection of a wide variety of PhACs in 
surface waters is indicative of their resistance to biodegradation in STW; hence their 
susceptibility to photodegradation may be expected to play an important role in their 
subsequent fate, especially in sunlit waters. A review conducted by Boreen et al. (2003) 
summarised the existing literature concerning the photochemical behaviour of many 
PhACs. The authors concluded that with some exceptions, the environmental 
photochemistry of the vast majority of PhACs has not been studied and that investigations 
of the effects of sunlight on the fate of PhACs are justified and indeed possibly overdue. 
PhACs studied previously are shown in Figure 3.1. (I-XVII). 
Several studies have investigated the environmental photochemistry of non-steroidal anti-
inflammatory drugs (Packer et al., 2003; Tixier et al., 2003; Buser et al., 1998b, 1999). 
These studies found that diclofenac (I) is subject to rapid photodegradation, that ketoprofen 
(U) and naproxen (lli) are possibly photodegraded. and that ibuprofen (IV) is most likely 
not degraded by direct photolysis in aquatic systems. 
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Figure 3.1 Structures of PhACs whose environmental photodegradation has been 
investigated (from Packer et al., 2003; Tixier et al., 2003; Buser et al. , 
1998b, 1999; Doll and Frimmel, 2003; Latch et al., 2003a; Andreozzi et al., 
2003; Lui and Williams, 2007). 
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Figure 3.1 continued 
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Structures of PhACs whose environmental photodegradation 
has been investigated (from Lui and Williams, 2007; Lam 
and Mabury, 2005; Kwon and Armbrust, 2004, 2005; Latch 
et al., 2003b) 
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Doll and Frimmel (2003) assessed the photodegradation of clofibric acid (V), and 
carbamazepine (VI). Each was susceptible to photodegradation. However, further 
experiments would be required for identification of the degradation products. The 
importance of product identification was emphasised by Latch et al. (2003a). The authors 
found that Triclosan (VII) was rapidly photodegraded, but identification of the degradation 
products showed that a minor photoproduct was 2,8-dichlorodibenzo-p-dioxin, a 
potentially more harmful compound from an environmental perspective (Figure 3.2). 
hOH On: ' ~ Cl Cl hv -HCI 
Triclosan 2, 8-dichlorodibenzo-p-dioxin 
Figure 3.2 Photochemical conversion of Triclosan (VII) to 2,8-dichlorodibenzo-
p-dioxin (Latch et al. , 2003a) 
The environmental photochemistry of six pharmaceuticals from different therapeutic 
classes, carbamazepine (VI), diclofenac (1), clofibric acid (V), ofloxacin (VIll), 
sulphamethoxazoJe (IX) and propranolol (X) was evaluated by Andreozzi et al. (2003). 
Results based on laboratory photolysis experiments conducted in distilled water at 25°C 
allowed degradation half-lives (t1n) to be calculated for each pharmaceutical. 
Carbamazepine (VI) and Clofibric acid (V) are characterised by calculated half-lives 
approaching 100 days, whereas under the same conditions sulphamethoxazole (IX), 
diclofenac (1), ofloxacin (VIII) and propranolol (X) undergo faster degradation with t1n 
92 
respectively of 2.4, 5.0, 10.6, and 16.8 days. The authors concluded that 'structural 
variability will likely lead to variabiJity in photolysis rates'. 
The photostabiJity of propranolol (X) was also investigated in distilled water at 
concentrations ranging from 0.0003-10 mg L·' by Liu and Williams (2007). The measured 
direct photolysis half-lives for propranolol (X), along with two other P-blockers, atenolol 
(XI) and metoprolol (XII) were 16, 350 and 630 hours respectively. ln agreement with 
Andreozzi et al. (2003), the authors concluded that propranolol (X) was unlikely to be 
persistent in natural waters. Additionally, major direct photolysis products were identified 
from propranolol (X) that led to a proposed reaction pathway, involving ring oxidation, 
rearrangement and deoxygenation. Future work is needed to investigate indirect photolysis 
of atenolol (XI) and metoprolol (XD) in surface waters in order to understand the overall 
persistence of these PhACs in the environment. 
A nwnber of publications have suggested that humic substances have sensitising effects on 
photodegradation. 'Humic substances' is a generic term referring to humic acids, fulvic 
acids and the water insoluble fraction, humin (Malcolm, 1985). These terms are derived 
from their mode of isolation (Aiken, 1985). Humic acids are insoluble in water at low pH 
( <2) and can therefore be precipitated from solution and filtered. They form the major 
extractable component of soil humic substances. Zepp et al. (1985) compared the 
photosensitising effect of humic substances isolated from different origins and used the 
transformation of simple organic compounds to probe the mechanism and kinetics of this 
process. The authors concluded that absorption of sunlight by humic substances can lead 
to the rapid photosensitised reactions of certain pollutants. Equally Lam and Mabury 
(2005) found that indirect photodegradation was important in limiting the persistence of 
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atorvastatin (XIII) and carbamazepine {VI) in surface waters. Rates of loss were greatly 
increased in solutions with humic materials. 
The effect of humic substances on the photodegradation of a range of selective serotonin 
reuptake inhibitors (SSRis), has been studied by several researchers. Kwon and Armbrust 
(2004) compared the photolysis of paroxetine (XIV) in aqueous solutions, synthetic humic 
water and lake water. Paroxetine (XIV) was degraded completely within 4 days in various 
aqueous solutions, with a half life of between 11 to 16 hours. The half lives of paroxetine 
(XIV) in synthetic humic water and two lake waters were slightly longer. In addition, the 
authors detected and identified two photoproducts using LC-MS. One photoproduct was 
found to be photolytically unstable, being degraded after 12 to 18 hours of irradiation. 
However, the second photoproduct was found to be persistent to further photodegradation. 
The authors concluded that paroxetine (XIV) is a relatively photolabile drug that has a 
possibility of photodegradation by sunlight in surface waters. The same authors also 
reported labomtory photolysis studies of another SSRI, citalopram (XV) (Kwon and 
Armbrust, 2005). Photodegradation in distilled water was negligible; less than 0.5% at pH 
7 over the 30 day exposure period. The rate of degradation increased substantially in 
synthetic humic water and natuml waters (half-lives 14 and 43 days) indicating 
photosensitisation by humic acid or other materials in water. Additionally, two 
photoproducts were detected over the irradiation period and their structures identified. 
Another SSRI, fluoxetine (XVI), was investigated by Lam and Mabury (2005). Fluoxetine 
(XVI) was shown to degrade in distilled water when exposed to simulated sunlight with a 
half life of 55 hours. The mte of degradation in a various synthetic field waters was found 
to be considerably faster, with half-lives ranging from 6 to 22 hours. Photodegradation 
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products resu1ting from 0-dealkylation and defluorination of fluoxetine (XVI) were 
identified using LC-MS0 • 
Latch et al. (2003b) observed that cimetidine (XVII) undergoes photosensitized 
degradation, reacting with singlet oxygen in natural waters, but is resistant to degradation 
by direct photolysis. In contrast, Lin and Reinhard (2005) report a longer half-life for 
ketoprofen (11) in river water (t1n 4.1 hours) than in distilled water (t1n 2.5 minutes), the 
organic matter present in river water was found to absorb the solar radiation, thus acting as 
an optical filter and reducing the rate of photodegradation. The observed variability of the 
effects due to the presence of naturally occurring compounds confirms that the 
photoreactivity ofPhACs requires assessment on a compound by compound basis. 
3.1.1 Solar Radiation 
When considering the photochemical transformations of PhACs within environmental 
water bodies it is necessary to first understand the spectral distribution and intensity of 
sunlight impacting on the various media Solar spectral distribution, transmission through 
the Earth's atmosphere and transmission of sunlight through the water body, will all have 
an impact on rates of photodegradation. 
As sunlight passes through the Earth's atmosphere, intensity is diminished, or attenuated, 
by scattering from water droplets, atmospheric particles and aerosols, and through 
absorption by atmospheric gases, in particular ozone. The transmittance of light decreases 
with decreasing wavelength (UV and visible region). There is a rapid decrease between 
280 and 320 nm such that there is little light transmitted below 300 nm. Low wavelength 
radiation such as UV -B is highly energetic and is responsible for the photodegradation of 
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many chemicals (Zepp, 1977), which emphasises the need to use a light source that is 
closely related to natural sunlight when laboratory simulations of photodegradation are 
made. 
The intensity of natural radiation will also vary according to the angular height of the sun 
such that it decreases from midday to sunset and from winter and to a certain degree from 
the equator to higher latitudes. The latter has a more marked effect in winter months. 
The scattering of sunlight by water droplets and air-borne particulates also tends to increase 
at decreasing wavelengths (UV-B). This scattered light can also contribute to the total 
amount of light incident on the earth's surface and is termed defuse light. Light impacting 
on a water body consists of a mixture of direct and diffuse or scattered radiation. 
3.1.2 Transfer from air to water 
When sunlight impacts on the surface of water, part is reflected at an angle equal to the 
angle of incidence and part passes into the water body and is refracted. The fraction 
reflected is on average approximately 10% (Leifer, 1988). The intensity of sunlight in 
water is attenuated by absorption and scattering. In "pure" water, absorption is primarily 
due to water itself and light can penetrate to great depths. In inland water bodies, such as 
lakes and rivers, the presence of dissolved natural organics such as humic substances, 
results in light attenuation due to both absorption and scattering. Once again, absorption is 
wavelength dependent and tends to increase with decreasing wavelength from the visible to 
the UV region of the spectrum. Therefore chemicals that only show absorbance in the UV-
low visible region will be effected more than those which show strong absorbance at higher 
wavelengths. 
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The attenuation of light due to the effect of scattering is in general less important than 
attenuation due to absorption in natural water bodies and is only of significance in 
particularly turbid lake and river waters. Photodegradation rates in water are therefore 
dependent on the intensity of the light source, the attenuation by the water body and the 
absorption characteristics of the pollutant. 
3.2 Experimental Approach 
To construct an appropriate laboratory simulated photodegradation study a number of 
experimental conditions need to be considered. Use of the most appropriate light source 
and filter system is essential, as is the use of quartz glass sample tubes which allow 
maximum transmission of light across the wavelengths used. In order to obtain accurate 
kinetic data and minimise losses of test chemicals from the reaction vessels by processes 
other than photodegradation it is necessary to maintain sample vessels at a constant 
temperature. Potential losses of test chemicals through volatilisation or biodegradation can 
be avoided through the use of sterile conditions (Paalme, 1990) and minimising the 
head space in sample vessels (Literathy, 1989). Although difficult to avoid, losses due to 
hydrolysis can be evaluated simply by using dark controls alongside samples (i.e. vessels 
containing test chemicals which are not exposed to light). Any losses due to hydrolysis can 
then be corrected for in photodegradation rate calculations. 
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3.2.1 Selection of light source 
While exposing samples to natural sunlight may be applicable in some regions (e.g. U.S.), 
it is less practical in the majority of countries (e.g. U.K.) since the prevalent meteorological 
conditions do not permit reproducible experimentation. Selection of a suitable artificial 
light source is therefore advantageous, also allowing many of the other environmental 
parameters (e.g. tempemture) to be controlled. 
Severn! light sources have been used previously for photodegmdation experiments on 
PhACs. These light sources can emit either a continuous spectrum (xenon arc lamps and 
fluorescent daylight lamps) or predominantly a line spectrum (low, medium and high 
pressure mercury arc lamps). These have been reviewed by Gould (1989) and Boreen el al. 
(2003). Most of these sources emit light at the low end of the UV-visible region (i.e. 
wavelengths below 300 nm) which although more energetic are largely absorbed by ozone 
in the atmosphere. For photochemical reactions taking place at the Earth's surface 
wavelengths greater than 300 nm are most important. Therefore artificial light sources 
have to be filtered using optically stable borosilicate glass filters (EPA guidelines, 1996) in 
order to simulate natural light. A comparison of the spectm of different labomtory light 
sources with natural light (Roof, 1982) is shown in Figure 3.3. 
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Comparison of the spectral intensities of different laboratory light sources 
with natural light (Roof, 1982). 
The spectrum of a filtered xenon arc lamp shows particularly good agreement with natural 
light over the relevant UV-visible wavelengths (Figure 3.3; 250-800 run). A comparison of 
xenon, medium pressure mercury and fluorescent lamps with natural sunlight for the 
photodegradation of three P AHs was reported by Zepp (1982) who observed that the 
degradation rates obtained using the xenon lamp were closest to natural sunlight. Equally, 
Yager ( 1988) reported a comparison of use of a filtered xenon lamp with use of natural 
daylight for aqueous photodegradation studjes. The authors concluded that the xenon lamp 
provided data comparable to those obtained with natural light. The US Environmental 
Protection Agency (EPA guidelines, 1996) advise the use of a filtered xenon lamp for 
evaluating the contribution of phototransformation to the removal of organic pollutants 
from the environment. 
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The intensity of the radiation source is one of the most critical factors associated with 
laboratory photodegradation studies. In order to compare degradation rates between 
studies and to be able to extrapolate these to environmental conditions, it is essential to 
measure accurately the intensity of the light source. Chemical actinometers and 
mdiometers are often employed for lamp calibmtion. Both have advantages and 
disadvantages. 
Chemical actinometers are photochemical reactions which have been calibmted with light 
sources of known flux and have well defmed quantum yields at particular wavelengths. 
They are used to measure the integmted light intensity incident on a sample within a test 
vessel during irradiation with either natural or artificial light. 
Chemical actinometers have the advantage that they undergo the same experimental regime 
as the test sample and can give an accurate measure of light intensity. Their 
photodegmdation properties are well characterised and understood. The main disadvantage 
of chemical actinometers is that they may not absorb light at the same wavelength as the 
chemical under test, particularly as most useful actinometers absorb light in the 250-400 
nm region (Leifer, 1998). 
Radiometers are far easier and more convenient to use than chemical actinometers. They 
give a measure of total light incident on the sample vessels and can easily be used to 
compare light intensity of lamps with natural daylight for the estimation of environmentally 
relevant photodegradation mtes (Parker and Leahey, 1998). Unfortunately the equipment 
is relatively expensive and not particularly portable for use with field studies. However 
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when laboratory studies are to be made, a spectra-radiometer may be conveniently used to 
calibrate the lamp source. 
3.2.2 Temperature control 
The temperature used for experiments should ideally be representative of natural 
environments, allowing extrapolation of the results to prevailing natural conditions. The 
photodegradation rate constant may be affected by temperature as described by the 
Arrhenius equation. Therefore maintenance of constant temperature for experiments is also 
necessary to ensure the reliability of kinetic data. Leifer ( 1988) suggested the sample 
temperature should be maintained to within 2°C of the chosen experimental temperature. 
3.2.3 Otber experimental considerations 
The incorporation of dark controls in laboratory experiments is essential since these will 
demonstrate the degree of degradation not caused by irradiation (i.e. due to hydrolysis or 
biodegradation in water). In practice this requires a sample tube to be bench stored, 
wrapped in foil to exclude light, for the duration of the photolysis study. An initial 
evaluation can be used to determine whether hydrolysis makes a significant contribution to 
degradation over the exposure period of the experiment. If it does not, the dark control 
only requires conflfDlatory analysis at the end of the exposure period. However, in 
instances where hydrolysis is considered an issue, analysis of the dark control for each 
irradiation time period is required and the measured concentration of test chemical 
corrected for to reflect photodegradation only. 
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3.3 Photodegradation Experiments 
All photodegradation experiments herein used essentially the same apparatus and 
conditions, but differed by the exposure time and the make up of the photolysis solutions, 
which were either in distilled water or distilled water spiked with humic acids (1 llg mL-1 
where appropriate)- Full experimental details for the preparation of solutions for labomtory 
photodegmdation studies are given in Chapter 6_ Following irmdiation. samples were 
wmpped in foil and stored refrigemted until required. Aliquots were spiked with internal 
standard (oxazepam-ds) and analysed by LC/ESI-MS using the conditions developed in 
Chapter 2. Gmdient conditions are described with the relevant figures. 
3.3.1 Humic acids 
The humic acids used m this study were provided by Or M Hayes, University of 
Birmingham following isolation from the river Trent (North East UK) using filtmtion, 
adsorption chromatogmphy (XAD-8 and XAD-4 resin) and ion chromatogmphy to purify 
and fractionate samples into humic, fulvic and hydrophilic acids (Watt et al., 1996). Since 
the structures of humic acids are unknown, they tend to be characterised by their elemental 
composition and aromatic content. The humic acids used in this study have been 
characterised previously in terms of carbon, nitrogen and oxygen content and degree of 
aromaticity (Zhou et al., 1994). 
3.3.2 Exposure Apparatus 
Labomtory photodegmdation studies experiments were conducted using a xenon lamp. Full 
instrument details are given in Chapter 6, Section 6.6.1. Radiation from the xenon arc 
lamp or reflected from the UV mirror above the lamp, passes through a quartz glass filter 
which has a UV cut-off at approximately 290 nm. The parabolic reflector ensures even 
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distribution of the filtered UV-Visible light over the whole sample tray. A schematic 
diagram of the xenon lamp/filter system and the laboratory arrangement for the Suntest 
photolysis unit, water cooled sample tube holder and chiller unit, respectively are shown in 
Figures 3.4, 3.5 and 3.6. 
Sample solutions and the dark control were placed in up to five 25 x 2 cm (o.d.) quartz 
tubes, each with a sample volume of 50 mL. The control sample differed from the samples 
in that it was sealed from the light using aluminium foil. Samples and the control were 
placed in the stainless steel tank, partially filled with glycerol as coolant. Ali, (1992) used 
water as coolant but found that this tended to evaporate on prolonged irradiation, offering 
inadequate temperature control and therefore recommend glycerol as a suitable coolant. 
Samples were maintained at constant temperature by circulating coolant from the chiller 
unit through a reservoir surrounding the tank. A data logger attached to a digital 
thermometer probe was used to monitor the sample temperature at the centre of the tank at 
mid depth glycerol. The sample tank was positioned under the Suntest unit, such that it 
made a light tight seal, and held using a lab jack. 
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I Xenon burner 
2 UV mirror 
3 Visible light mirror 
4 QuartZ-glass dish with 
reflecting coating 
UV and visible 
radiation 
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6 Parabolic reflector 
7 Sample level 
+ 
Figure 3.4 Schematic diagram of the xenon lamp/filter system. 
(Ali, 1992) 
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Xenon lamp source 
Cooled exposure tank 
Lab jack 
Chiller unit 
Figure 3.5 Experimental set-up for photolysis studies 
Xenon lamp source 
Cooled exposure tank 
Photolysis tubes 
(Length: 25 cm) 
Figure 3.6 Close up view of experimental set-up for photolysis studies 
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3.4 Results and Discussion 
3.4.1 Calibration of lamp source 
The xenon lamp and cooling system for the stainless steel tank were operated for 1 hour 
prior to the start of the calibration experiment to allow both to equilibrate. The radiation 
intensity of the xenon lamp was measured at seven different locations of the sample tank as 
depicted in Figure 3. 7, using a spectroradiometer which integrated total energy between 
240-800 nm. Full instrument details are given in Chapter 6, Section 6.6.2. These 
measurements were made to determine if the radiation was uniformly received across the 
sample tray. The radiation intensity of the lamp was measured at all radiation intensity 
settings of the instrument, rating from maximum setting (8) to the lowest setting (I). 
I Xenon Arc Lamp 
·~ 
(Back) 
1 3 
7 
Coolant out - 2 4 6 
Coolant in 
(Front) 
Figure 3.7 Location of radiation intensity measurements taken under Xenon lamp 
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Figure 3.8 shows the results for the measured radiation intensity in W m-2 and the lamp 
potentiometer setting (1-8). The results are shown as mean radiation intensity values(± cr, 
n=7). Results confirm that there is an approximately linear relationship between increasing 
lamp potentiometer setting and radiation intensity. Little variation of radiation intensity at 
different parts of the sample tank was found, indicating consistent incident light across the 
sample tank. 
The sample tank was subjected to an average radiation intensity of 502 W m-2 from the 
maximum radiation setting (8) of the lamp. This value differs in comparison with the 
quoted instrument maximum value of 765 W m-2, (Heraeus Instruments GmbH, Germany; 
Chapter 6, Section 6.6.1 ). However, the quoted value should be treated with caution as it 
refers to irradiance without additional filters, whilst the values obtained in the current study 
were for the instrument fitted with a UV filter to cut out radiation below 290 run. 
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Relationship between mean radiation intensity and lamp potentiometer 
setting (points indicate mean; error bars represent ± cr, n=7) 
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3.4.2 Photolysis of Diazepam in the absence and presence of river Trent humic acids 
A series of calibration solutions of diazepam (0.1 to 2 ~ mL-1) , spiked with 1 J.lg mL-1 of 
oxazepam-d5 (internal standard) and analysed in triplicate by LCIESI-MS in full scan mode 
(m/z 150-1 000) were previously shown, in Chapter 2, to give a good linear response across 
the range of standards analysed (R2 = 0.9995). The calibration graph of response is shown 
in Figure 3.9 as mean peak area ratio values(± cr, n=3). This was used to determine the 
concentration of diazepam in various photolysed samples. 
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• 
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Figure 3.9 
Diazepam 
0.5 
y = 2.3762x + 0.0277 
R2 = 0.9995 
1.0 1.5 
-I Concentration (l!g mL ) 
2.0 2.5 
LCIESI-MS calibration graph for aqueous solutions of diazepam (0.1 to 2 
J.lg mL-1). Peak area ratio is the ratio of peak area of diazepam (m/z 285.3 
and 287.3) to 1 J.Lg mL-1 internal standard (oxazepam-d5) . (Points indicate 
mean ratio; error bars represent ± cr, n=3). Gradient elution ([Time/%A] 
0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1 % 
formic acid); 150 x 2.0 mm, 5 J.lffi Gemini C18 HPLC column. 
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3.4.2.1 Degradation and half lives 
The concentrations of diazepam remaining after irradiation in aqueous solutions in the 
absence and presence of humic acids (1 flg mL-1) are shown in Table 3.1 A concentration 
of 1 flg mL-1 humic acids is considered environmentally realistic for river waters 
(Thurman, 1985). 
Table 3.1 Effects of irradiation on photolysis of diazepam in the absence and presence 
of 1 flg mL-1 river Trent humic acids. 
Diazepam in water 
Time 
(hours) 
0 
24 
48 
72 
96 
2 16 
Average 
Concentration 
(J.lg mL·1) 
1.03 
0.78 
n.d 
0.60 
0.55 
0.25 
n.d = Not Determined 
%of initial 
100 
76 
n.d. 
59 
53 
24 
Diazepam in the presence of 
I J.lg mL"I humic acids 
Average 
Concentration %of initial 
(J.lg mL·1) 
0.98 100 
0.63 63 
0.27 27 
0.21 2 1 
0.08 8 
n.d n.d 
Dark controls for each experiment were analysed at the same time intervals as the 
irradiated samples and were found to be equal to the starting concentration in each case, 
indicating degradation was due to photolysis only. The decline in diazepam concentration 
with increasing irradiation time for each experiment followed first order kinetics and can 
be represented by the equation: 
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Where C1 is the concentration at time t and C0 is the initial concentration. Therefore 
diazepam photodegradation kinetics can be described as first order: 
Ln [C,/Co] = -kp t 
and the first order photodegradation mte constant kp can be determined from the slope of a 
graph of Ln [CtfCo] vs irmdiation time (Figure 3.1 0). The first order photodegradation mte 
constants (kp) were 0.0067 and 0.0251 hr-1 for experiments without and with humic acids 
respectively. The halflife (t112) was determined from the equation: 
t 112 = Ln 2 I kp 
This gave a t112 value of 103.4 and 27.6 hours for diazepam photodegradation in pure water 
and with humic acids respectively. Comparison of the data suggests that river Trent humic 
acids sensitise the photolysis of diazepam, shortening the half life by a factor of 4. 
110 
0.0 
-1.0 
-2.0 
Slope = -0.025h: + 0.035 
R1 = 0.9781 
' ' 
: I '. Abiotic 
' ! ' 
'. : Control 
..... - _, 
Slope= -0.0067x + 0.0335 
R1 = 0.9943 
K., = -0.0067 b-1 Half Life = 103 hours 
K, = -0.0251 h-1 Half Life = 28 hours 
-3 .0 -1-----,------.------,------,----- -, 
0 50 100 150 200 250 
Irradiation Time (hours) 
Figure 3.10 Changes in concentration of diazepam with increasing irradiation time in 
pure water ( • ) and river Trent humic acids ( • ). Points indicate mean 
values; error bars represent ± cr, n =3. Abiotic control shown in circle 
(mean ± cr, n=3). 
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3.4.2.2 Analysis of diazepam degradation products 
Analysis of the LC/ESI-MS chromatograms (Figure 3.11) of the photodegraded samples 
indicated that one major (peak I) and two minor degradation products (peaks 11 and Ill) 
were formed. Undegraded diazepam was also present. 
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Figure 3.11 LC/ESI-MS extracted ion chromatograms (EIC) of (a) diazepam sample 
before irradiation, (b) after 48 hours irradiation, (c) after 96 hours 
irradiation, (d) after 216 hours irradiation. Gradient elution ([Time/%A] 
0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% 
formic acid); 150 x 2.0 mm, 5 J.U11 Gemini C 18 HPLC column. 
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In an attempt to identifY the diazepam degradation products, ESI-MS" spectra were 
obtained for each photoproduct derived from diazepam after irradiation in water for 216 
hours. Based on molecular weight and molecular ion isotope contribution information, 
structures were postulated for each of the observed degradation products. These were 
supported by MS" daughter ion analysis of the molecular ions derived from each of these 
products and comparison with authentic compounds where available. 
Figure 3.12 compares the molecular ions observed in the ESI-MS full scan mass spectrum 
(mlz 150-350) obtained for diazepam, mlz 285.3 (Figure 3.12A) after irradiation in water 
for 216 hours and the ESI-MS full scan mass spectrum derived from a 1 11g mL"1 diazepam 
solution in water (Figure 3.12B). Both MS spectra were obtained under identical LC/ESI-
MS conditions. The observed LC retention times for irradiated diazepam and an authentic 
diazepam solution were 7.18 and 7.17 minutes respectively, indicating that the compounds 
were identical. Conclusive evidence was gained from comparison of the ESI-MS spectra 
which were identical. Both spectra showed a base ion at mlz 285.3 which corresponds to 
protonated diazepam ([M+H]l and also an ion at mlz 287.3. These ions show a 3:1 ratio 
(mlz 285.3 to 287.3) which is indicative of the presence of a chlorine atom. 
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Figure 3.12 Comparison of the ESI-MS full scan mass spectrum (mlz 150-350) derived 
from diazepam after irradiation in water for 216 hours (A) and a 1 )lg mL-1 
diazepam solution in water (B). Gradient elution ([Time/%A] 0/80-8/0-
13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% fonnic 
acid); 150 x 2.0 mm, 5 mm Gemini C18 HPLC column. 
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Photoproduct I 
Based on inspection of the mass spectrum derived from the compound producing the most 
intense remammg peak (1), the benzophenone derivative, 5-chloro-2-
methylaminobenzophenone was proposed as a photoproduct (Figure 3.13A). The full scan 
mass spectrum of peak I (Figure 3.13A) showed a base ion at mlz 246.2 which corresponds 
to protonated 5-chloro-2-methylaminobenzophenone ([M+HJ). The base ion was 39 mass 
units lower than protonated diazepam (m/z 285.3) and consistent with a compound 
produced by the loss of -C2HN from diazepam. Inspection of the molecular ion isotope 
(m/z 248.2) indicated the presence of chlorine. Figure 3.138 shows the daughter ion 
spectrum (MS2) derived from ion mlz 246.2. The characteristic ion at mlz 228.1 suggests 
loss of water, resulting in contraction to a resonance stabilised five-membered ring. The 
daughter ion spectrum (MS3) derived from ion mlz 228 is shown in Figure 3.13C. Loss of 
chlorine as the radical is characterised by the ion at m/z 193.3, which is 35 mass units 
smaller. 
Interpretation of the sequential fragmentation observed for peak I (Figures 3.13 A-C) gave 
strong support for the proposed structure, 5-chloro-2-methylaminobenzophenone (1). 
Further structural support was obtained by comparison with an authentic sample of 5-
chloro-2-methylaminobenzophenone (Sigma-Aldrich, U.K.). Figure 3.14 compares the LC 
chromatograms of a diazepam solution following 216 hours irradiation and an authentic 
sample of I f.lg mL·1 5-chloro-2-methylaminobenzophenone in water. The observed LC 
retention times for peak I in the irradiated diazepam sample and the authentic compound 
were 10.02 and 9.99 minutes respectively, which is within instrument variability and 
indicates that the compounds were likely to be the same. Figure 3.15 compares the ESI-
MS" fragmentation pathway for peak I, from the irradiated diazepam solution and an 
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Figure 3.13 (A) Mass spectrum derived from peak I (Figure 3.110) from photolysis of 
diazepam for 216 hours; (B) Daughter ion spectrum (MS2) of mlz 246 (Peak 
n formed by photolysis of diazepam for 216 hours; (C) Daughter ion 
spectrum (MS3) derived from m/z 228. 
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Figure 3.14 Comparison of LC-MS chromatograms of diazepam solution following 216 
hours irradiation and an authentic sample of 1 )lg mL-1 5-chloro-2-
methylamino benzophenone. Gradient elution ([Time/%A] 0/80-8/0-13/0-
15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% formic acid); 
150 x 2.0 mm, 5 )liD Gemini C18 HPLC column. 
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Figure 3.15 Comparison of ESI-MS, MS2 and MS3 spectra for: Peak I from diazepam 
solution following 216 hours irradiation (A-C) and an authentic solution of 
5-cWoro-2-methylaminobenzophenone (D-F). 
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Formation of the benzophenone derivative, 5-chloro-2-methylamino benzophenone (I) 
under photochemical stress is postulated to occur through opening of the diazepinone ring, 
by initial breakage of either the amide functionality or the C=N bond, followed by 
elimination of H2NCH2C02H after rearrangement (Figure 3.16). The same photoproduct 
was also reported by Comelissen et al. (1978), who investigated the photodegradation of 
diazepam in methanol using a mercury arc lamp (254 run). Several studies also refer to the 
formation of 5-chloro-2-methylaminobenzophenone by acid hydrolysis of diazepam 
(Cabrera et al. , 2005; Nudelman and De Waisbaum, 1995). However, no degradation 
products were observed in the dark controls conducted in the current study and this 
supports the proposal that the compound was a photodegradation product under conditions 
used herein. Indeed, the experimental conditions employed by the previous authors deviate 
considerably from those expected to be encountered in natural water systems (l.OM HCI, 
methanol:water mixtures and high temperatures, 75-80°C). Photodegradation thus appears 
to be an important transformation mechanism for diazepam in the aqueous environment. 
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Figure 3.16 Proposed scheme for the formation of photoproduct I from diazepam in 
water. 
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Photoproduct D 
The full scan mass spectrum (m/z 150-350) of the component labelled peak 11 (Figure 
3.17 A) shows a base ion at m/z 244.3 and a minor ion at m/z 229. Comparison of this 
spectrum with the full scan mass spectrum of photoproduct I, 5-chloro-2-
methylaminobenzophenone (Figure 3.13A) show that it is 2 mass units lower, suggesting 
loss of H2. The minor ion at m/z 229 is 15 mass units smaller than the apparent molecular 
ion m/z 244, suggesting loss of a methyl group. The daughter ion spectrum (MS2) derived 
from m/z 244 is shown in Figure 3.178. The loss of chlorine is characterised by the ion at 
mlz 209.2, which is 35 units lower. The compound is tentatively identified as 4-chloro-10-
methylacridin-9-one (ll). 
Formation of 4-chloro-1 0-methylacridin-9-one (11) under photochemical stress is 
postulated to occur from the primary photoproduct, 5-chloro-2-methylaminobenzophenone 
(1). Loss of molecular hydrogen from 5-chloro-2-methylaminobenzophenone in aqueous 
solution would yield the proposed intermediate, which subsequently reacts with the a-
hydrogen of the second phenyl ring resulting in 4-chloro-1 0-methylacridin-9-one (ll; 
Figure 3.18). To confirm that the pathway was indeed due to photolysis, rather than 
hydrolysis, photodegradation studies were required on an authentic sample of the primary 
photoproduct, 5-chloro-2-methylaminobenzophenone (1), and are described in section 
3.4.3. 
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Figure 3.17 (A) Mass spectrum derived from peak D (Figure 3.11D) from photolysis of 
diazepam for 216 hours; (B) Daughter ion spectrum (MS2) of mlz 244 
(Peak D) formed during photolysis of diazepam for 216 hours. 
123 
Cl 
Cl 
Cl 
(I) 
hv ~ -H, 
0 
(D) 
Figure 3.18 Proposed scheme for the formation of photoproduct D, 4-chloro-10-
methylacridin-9-one from photoproduct I, 5-chloro-2-methylamino 
benzophenone in water. 
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Photoproduct Ill 
Interpretation of the full scan mass spectrum (mlz 100-350) derived from the remaining 
photodegradation product, peak ID (Figure 3.19A) showed a singly charged molecular ion 
at m/z 232.2, which is 14 mass units lower than the molecular ion of photoproduct I (mlz 
246, Figure 3.13A), and consistent with the loss of -CH2• Therefore 2-amino-5-cWoro 
benzophenone was proposed as the structure of photoproduct Ill and is shown in Figure 
3.19A. The molecular ion m/z 232.2 was selected for ESI-MS" studies. The daughter ion 
spectrum (MS2) derived from the molecular ion (m/z 232.2) is shown in Figure 3.198. The 
fragment ion at mlz 154.1 suggests loss of a phenyl group. The daughter ion spectrum 
(MS3) derived from ion mlz 154 is shown in Figure 3.19C. The characteristic ion at mlz 
126 suggests loss of -CO. 
Further structural evidence for photoproduct lll was obtained by comparison with an 
authentic sample of 2-amino-5-chlorobenzophenone. Figure 3.20 compares the LC-MS 
chromatograms of a diazepam solution following 216 hours irradiation and an authentic 
sample of I J.lg mL-1 of 2-amino-5-chlorobenzophenone in water. The observed LC 
retention times for Peak m and the authentic compound were found to be comparable 
(8.85 and 8.89 minutes, respectively). Conclusive structural assignment was obtained by 
comparison of the ESI-MS" fragmentation pathways for Peak Ill (from the irradiated 
diazepam solution) and the authentic sample of 2-amino-5-cWorobenzophenone (Figure 
3.21 A-F). ESI-MS" analysis of Peak ill, from the photodegraded diazepam sample 
(Figure 3.21 A-C) yielded identical fragmentations to that obtained for the authentic 
solution of2-arnino-5-cWorobenzophenone (Fi1:,rure 3.21 D-F). 
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Formation of the degradation product, 2-amino-5-chlorobenzophenone (peak Ill) is 
postulated to occur as a result of N-demethylation of the primary photoproduct (1), 5-
chloro-2-methylaminobenzophenone. A proposed scheme for its formation is shown in 
Figure 3.22. This photoproduct (Ill) was also reported by Comelissen et al. (1978), who 
investigated the photodegradation of diazepam in methanol using a mercury arc lamp (254 
nm) and in acid hydrolysis studies on diazepam conducted by Cabrera et al. (2005) and 
Nudelman and De Waisbaum, (1995). Further stability studies on photoproduct I (5-
chloro-2-methylaminobenzophenone) were required to determine whether product m (2-
amino-5-chloro benzophenone) was formed via hydrolysis or photolysis under the 
conditions used in the present study, the results of these investigations are discussed in 
Section 3.4.3. 
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(I) (11) 
hv 
(Ill) 
Figure 3.22 Proposed scheme for the formation of pbotoproduct m, 2-amino-5-
chlorobenzopbenone from the primary photoproduct (I), 5-chloro-2-
methylaminobenzophenone. 
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Photodegradation appears to be an important transformation mechanism for diazepam in 
the aqueous environment. Under the experimental conditions used herein, three 
degradation products (1, D and ID) were identified. Based on the assignments presented, a 
proposed scheme for the formation of all three degradation products from diazepam in 
water is shown in Figure 3.23 and the structures are also listed in Table 3.2. 
The pnmary degradation product, 5-chloro-2-methylarninobenzophenone (I) was not 
detected in any of the blank samples thus indicating its formation was due to 
photodegradation, under the current experimental conditions. Both degradation products 11 
and Ill (namely 4-chloro-1 0-methylacridin-9-one and 2-amino-5-chlorobenzophenone) 
were proposed to result from photodegradation of photoproduct I. However, to confirm 
that both products were formed from photolysis rather than hydrolysis of photoproduct I, 
photolysis experiments were required on both 5-chloro-2-methylaminobenzophenone (I) 
and 2-amino-5-chlorobenzophenone for which authentic samples were available. These 
results of these experiments are discussed in Sections 3.4.3 and 3.4.4 respectively. 
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5-chloro-2-methylaminobenzophenone 
Diazepam (I) 
Cl 
(11) 
4-chloro-1 0-methylacridin-9-one 
(ID) 
2-amino-5-chlorobenzophenone 
Figure 3.23 Proposed scheme for the formation of three degradation products: (I) 5-
chloro-2-methylaminobenzophenone, (11) 4-chloro-1 0-acridin-9-one and 
(Ill) 2-amino-5-chlorobenzophenone resulting from the photodegradation of 
diazepam in water. 
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Peak 
Diazepam 
11 
Ill 
Table 3.2 Identification of Diazepam photoproducts 
Molecular ion 
(M+1) 
285 
246 
244 
232 
35CI 
""a 
""a 
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Structure Identification Methods 
• Reference Compound 
(Sigma-Aldrich) 
• LC/ESI-MS" 
• Reference Compound 
(Sigma-Aldrich) 
• LCIESI-MS" 
• Comeilson et al., ( 1978) 
• LCIESI-MS" 
• Reference Compound 
(Sigma-Aldrich) 
• LCIESI-MS" 
• Comeilson et al., ( 1978) 
3.4.2.3 Calculations of estimated concentrations of diazepam and 
photoproducts 
The LC/ESI-MS calibration method for diazepam, developed in Chapter 2 (Section 2.4.2.2) 
gave an excellent linear response for peak area ratios of I J..Lg mL-1 oxazepam-d5 (internal 
standard) compared to a series of diazepam standards of known concentration (O.I to 2 J..Lg 
mL-1) and has already been used to determine the concentration of diazepam in various 
photolysed samples (Section 3.4.2). However, it should not be assumed that the various 
photoproducts have similar ESI ion responses to diazepam. It was thus necessary to prepare 
calibration graphs for photoproducts I and m for which authentic compounds were 
available. This was not possible for photoproduct n as no authentic compound was 
available. Solutions of known concentrations (O.OI - 1 J..Lg mL-1) of each photoproduct and 
the internal standard (I J..Lg mL-1, oxazepam-d5) were examined in triplicate (n=3) by 
LCIESI-MS and calibration graphs of response were drawn (Figure 3.24 and 3.25). These 
were used to determine the concentration of the corresponding products in various 
photolysed samples. 
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Figure 3.24 LC-MS calibration graph for aqueous solutions of (0.1 to I fl.g mL-1) of 
diazepam Pbotoproduct I. Peak area ratio is the ratio of peak area of 5-
chloro-2-methylarninobenzophenone to 1 fl.g mL-1 of internal standard 
(oxazepam-d5). Data points indicate mean ratio values (n=3); error bars 
represent ± cr, n =3. 
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Figure 3.25 LC-MS calibration graph for aqueous solutions of (0.1 to 1 fl.g mL-1) of 
diazepam Pbotoproduct DI. Peak area ratio is the ratio of peak area of 2-
amino-5-chloro benzophenone to 1 1-1g mL-1 of internal standard (oxazeparn-
d5). Data points indicate mean ratio values (n=3); error bars represent ± cr, n 
=3. 
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Figure 3.26 shows the changes in concentration with irradiation time for diazepam and 
degradation products in pure water. Results are averaged concentrations from experiments 
conducted in triplicate (n=3 ). The sum of the concentrations of unchanged diazepam and 
the degradation products was approximately equal to the initial diazepam concentration, 
thus an approximate mass balance was achieved suggesting that few other degradation 
products had formed. 
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Figure 3.26 Change in concentration of diazepam in pure water, the photodegradation 
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3.4.3 Photolysis of diazepam degradation product (1), 5-chloro-2-methylamino 
benzophenone in water 
Based on the experimental evidence for diazepam photodegradation in water (Section 
3.4.2) it was decided to undertake photostability studies on photoproduct I, 5-chloro-2-
methylamino benzophenone, in order to better determine the pathway for diazepam 
degradation. Solutions of 1 f.lg mL-1 5-chloro-2-methylaminobenzophenone (I) were 
prepared in triplicate (n=3) in distilled water and irradiated with a Heraeus Suntest xenon 
lamp, using the method described in Chapter 6. The calibration graph of the peak area 
ratio of known concentration of 5-chloro-2-methylarninobenzophenone (I) and the 
internal standard described in Section 3.4.2.2 (Figure 3.24) was used to determine the 
concentrations of 5-chloro-2-methylaminobenzophenone (I) in the various photolysed 
samples. 
3.4.3.1 Degradation and half life 
The effect of irradiation on solutions of 5-chloro-2-methylaminobenzophenone (I) m 
water is shown in Table 3.3. Dark controls (abiotic) for the photolysis experiment were 
analysed in triplicate at the beginning and end of the experiment (0 and 216 hours 
respectively) and were found to be equal to the starting concentration in each case, 
indicating degradation was due to photolysis only. The decline in 5-chloro-2-
methylaminobenzophenone concentration with increasing irradiation showed a greater 
correlation with zero order kinetics (R2 = 0.9836; Figure 3.27) rather than 151 order 
kinetics (R2 = 0.9445; data shown in Appendix A4, Figure A.5). Calculation of the 
photodegradation rate constant (kp) was based on zero order kinetics whereby the 
photodegradation rate constant (kp) was independent of concentration: 
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Where C1 is the concentration at time t and C0 is the initial concentration. The 
photodegradation rate constant (kp) is determined from the slope of a plot of [C1/C0] vs 
irradiation time (Figure 3.27). The zero order rate constant was 0.0032 hr-1 for 5-chloro-2-
methylaminobenzophenone in distilled water. The half life was determined to be 156 
hours. 
Table 3.3 Effect of irradiation on the photolysis of diazepam degradation product (1), 
5-chloro-2-methylaminobenzophenone in water. Average concentration 
values are the mean values for I (n=3). 
Product I 
Time (5-chloro-2-methylamino benzophenone) 
(hours) 
Average Concentration 
% ofinitial (J.lg mL·•) 
0 1.00 100 
24 0.90 90 
48 0.87 87 
72 0.81 81 
96 0.65 65 
144 0.58 58 
216 0.30 30 
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Figure 3.27 Change in concentration of diazepam degradation product I, 5-chloro-2-
methylaminobenzophenone with increasing irradiation time in pure water. 
(Data points indicate mean (n=3); error bars represent ± cr, n=3). Abiotic 
control shown in circle (mean ± cr, n=3). 
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3.4.3.2 Analysis of 5-cbloro-2-metbylaminobenzopbenone (I) pbotodegradation 
products in water. 
Figure 3.28 presents the LC-MS chromatograms from 0 to 216 hours for one of the three 
replicate solutions of 1 J.Lg mL"1 5-chloro-2-methylaminobenzophenone (I) analysed. Two 
degradation products were observed in the LC-MS chromatograms of the irradiated 
samples, and were labelled 11 and Dl. Undegraded 5-chloro-2-rnethylaminobenzophenone 
Cn was also present. No degradation products were detected in the dark controls. 
Photoproducts D and m 
Identification of the degradation products of 5-chloro-2-methylaminobenzophenone (I) was 
based on the LC/ESI-MS full scan mass spectra (mlz 150-300) obtained for each 
photoproduct peak derived from the irradiated samples in water after 216 hours. These are 
shown in Figure 3.29. Further structural information was given by the MS" daughter ion 
analyses of the molecular ions derived from each ofthe products, summarised in Table 3.4. 
The proposed structures for photoproducts ll and m were 4-chloro-1 0-methylacridin-9-
one Cin and 2-amino-5-chlorobenzophenone (111) respectively. Both of these 
photoproducts were also identified as photoproducts of djazepam photolysis in water 
(Section 3.4.2.2). Therefore identification of the photoproducts was aided by reference to 
the LC/ESI-MS chromatograms and ESI-MS" fragmentation patterns of the photoproducts 
found in diazepam photolysis experiments in water and comparison with authentic 
compounds (Figure 3.30). This experiment thus revealed that in the absence of diazepam, 
products D and lll are secondary photoproducts formed from the photolysis of the primary 
photoproduct (I), 5-chloro-2-methylarrunobenzophenone. A proposed scheme for the 
formation of photoproducts n and m from 5-chloro-2-methylarninobenzophenone (I) is 
shown in Figure 3.31. Since an authentic compound for 2-amino-5-chlorobenzophenone 
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m was available it was decided to carry out photolysis experiments on 2-amino-5-
chlorobenzophenone (lll) to confirm the relationship between the photoproducts. The 
results are presented in Section 3.4.4. 
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Figure 3.28 LC/ESI-MS extracted ton chromatograms (EIC) of (A) 1 Jlg mL-1 
photoproduct I sample before irradiation, (B) after 48 hours irradiation, (C) 
after 96 hours irradiation, (D) after 144 hours irradiation, and (E) after 216 
hours irradiation. Gradient elution ([Time/%A] 0/80-8/0-1 3/0-15/80; A = 
water + 0.1% formic acid, B = acetonitrile + 0.1% formic acid); 150 x 2.0 
mm, 5 J.Lm Gemini C 18 HPLC column. 
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Figure 3.29 ESI full scan mass spectra (m/z 150-300) of products formed by the 
photolysis of 5-cWoro-2-methylaminobenzophenone (I) in water for 
216 hours. 
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Figure 3.30 Comparison of the LC/ESI-MS chromatograms of (A) l 1-lg mL-1 5-chloro-
2-methylaminobenzophenone (I) sample after 216 hours irradiation, (B) 1 
j.lg rnL-1 diazepam sample after 216 hours irradiation and (C) authentic 
sample of 1 j.lg mL-1 5-chloro-2-methylaminobenzophenone (I) and also 2-
amino-5-chlorobenzophenone (Ill). Gradient elution ([Time/%A] 0/80-8/0-
13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% formic 
acid); 150 x 2.0 mm, 5j.lm C18 Gemini HPLC column. 
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Table 3.4 ESI-MS" fragmentation data for 5-chloro-2-methylarninobenzophenone (I) 
and its photoproducts (D and DI). 
Compound m/z significant ions 
MS MS2 MS3 
5-chloro-2-methylaminobenzophenone (l) 246.1 228.2 193.3 
228.2 
4-chloro-1 0-methylacridin-9-one (ll) 244.3 209.3 
229.2 
2-amino-5-chlorobenzophenone (Ill) 232.1 154.1 126.0 
105.0 
146 
5-chloro-2-methylaminobenzophenone 
(I) 
yH3 
;:::('" 
Cl 6 
hv 
(11) 
(lli) 4-chloro-1 0-methylacridin-9-one 
2-amino-5-chlorobenzophenone 
Figure 3.31 Proposed scheme for the formation of photoproducts 11 and Ill from the 
photolysis of the primary photodegradation product, of diazepam, 5-chloro-
2-methylaminobenzophenone (I) in water. 
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3.4.3.3 Calculations of the estimated concentration of 5-cbloro-2-
methylaminobenzopbenone (I) and pbotoproducts (11 and lll) 
The concentration of 5-chloro-2-rnethylaminobenzophenone (I) was measured by reference 
to the calibration graph (Figure 3.24). In the absence of an authentic sample for 
degradation product 11, its concentration was estimated by reference to the calibration 
graph for 2-amino-5-chlorobenzophenone (Ill) (Figure 3.25), whilst the concentration of 
photoproduct m was measured by reference to calibration graph (Figure 3.24). Figure 
3.32 shows the changes of concentration with irradiation time. The sum of the 
concentrations of unchanged 5-chloro-2-methylaminobenzophenone (I) and the 
degradation products, accounted for 70% of the initial concentration following 216 hours 
irradiation. This suggested that either some of the degradation products of 5-chloro-2-
methylaminobenzophenone (I) have much weaker LC-MS responses, or that some products 
are not amenable to analysis by LC-MS. 
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Figure 3.32 Change in concentrations of 5-chloro-2-methylaminobenzophenone (I) in 
pure water and of the photodegradation products (II and ID) and the sum 
of all identified degradation products with increasing irradiation time. 
Points indicate mean concentration values (n=3); error bars represent ± a, 
n=3. 
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3.4.4 Photolysis of diazepam degradation product 2-amino-5-chlorobenzophenone 
(Ill) in water 
Based on the photodegradation experiments conducted on diazepam (Section 3.4.2) and 
its primary photodegradation product 5-chloro-2-methylaminobenzophenone (I) in 
aqueous solution (Section 3.4.3), it was decided to undertake photostability studies on 
photoproduct Ill, 2-amino-5-chlorobenzophenone, to better determine the pathway for 
diazepam degradation. Standard solutions of l J.lg mL-1 2-amino-5-chlorobenzophenone 
(ID) were prepared in triplicate (n=3) in distilled water and irradiated using a Heraeus 
Suntest xenon lamp, using the method described in Chapter 6. The concentration of 2-
amino-5-chlorobenzophenone in various photolysed samples was measured by reference 
to the calibration graph for 2-amino-5-chlorobenzophenone (Figure 3.25). 
3.4.4.1 Degradation and half Ufe 
The effect of irradiation on solutions of 2-amino-5-chlorobenzophenone (ID) in water is 
shown in Table 3.5. Dark controls (abiotic) for the photolysis experiment were analysed 
in triplicate at the beginning and end of the experiment (0 and 144 hours respectively) and 
were found to be equivalent to the starting concentration, indicating degradation was due 
to photolysis only. The decline in 2-amino-5-chlorobenzophenone concentration with 
increasing irradiation showed a greater correlation with zero order kinetics (R2 = 0.9829; 
Figure 3.33) rather than 151 order kinetics (R2 = 0.9616; data shown in Appendix A5, 
Figure A.6). Calculation of the photodegradation rate constant (kp) was based on zero 
order kinetics whereby the photodegradation rate constant (kp) was independent of 
concentration: 
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Where C1 is the concentration at time t and C0 is the initial concentration. The 
photodegradation rate constant (kp) is determined from the slope of a plot of [Ct/C0 ] vs 
irradiation time (Figure 3.33). The zero order rate constant was 0.0042 hr-1 for 2-amino-5-
chlorobenzophenone in distilled water. The half life was determined to be 123 hours. 
Table 3.5 Effect of irradiation on the photolysis of diazepam degradation product 
(lll), 2-amino-5-chlorobenzophenone in water. Average concentration 
values are the mean values for m (n=3). 
Product m 
Time (2-amino-5-cblorobenzopbenone) 
(hours) 
Average Concentration 
%of initial (J!g mL-') 
0 1.01 lOO 
24 0.88 87 
48 0.84 83 
72 0.76 75 
120 0.48 48 
144 0.41 41 
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Figure 3.33 Change in concentration of diazepam degradation product m, 2-a.mino-5-
chlorobenzophenone with increasing irradiation time in pure water. (Data 
points indicate mean (n=3)~ error bars represent ± cr, n=3). Abiotic control 
shown in circle (mean ± cr, n=3). 
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3.4.4.2 Analysis of 2-amino-5-chlorobenzopbenone (lll) photodegradation product 
in water 
Figure 3.34 presents the LC-MS chromatograms from 0, 72 and 144 hours for one of the 
three replicate solutions of 1 J.Lg mL.1 2-amino-5-chlorobenzophenone (Ill) analysed. Only 
one degradation product was observed in the LC-MS chromatograms and was labelled peak 
IV. Photoproduct peak IV was found to have a retention time of 7.01 minutes. 
Undegraded 2-amino-5-chlorobenzophenone (ID) was also detected. 
Photoproduct IV 
Identification of the 2-amino-5-chlorobenzophenone (Ill) degradation product was based 
on the full scan mass spectra (m/z 150-350) obtained for product IV derived from the 
irradiated samples in water after 144 hours. The full scan mass spectrum (m/z 150-350) of 
the component labelled peak IV (Figure 3.35B) shows a base ion at m/z 230.3. 
Comparison of this spectrum with the full scan mass spectrum of 2-amino-5-
chlorobenzophenone (Ill) (Figure 3.35A) show that it was 2 mass units lower, suggesting 
loss of -H2• The MS2 daughter ion spectrum derived from mlz 230.3 is presented in Figure 
3.35C. Loss of chlorine is supported by the fragmentation which is 35 units lower. The 
ESI-MS" fragmentations are summarised in Table 3.6. Formation of photoproduct IV 
appeared to be analogous to photoproduct (11), 4-chloro-1 0-methylacridin-9-one, detected 
in the photolysis experiments conducted on 5-chloro-2-methylaminobenzophenone (1), 
additional support for the interpretation was given by comparison to the fragmentation 
pattern of 4-chloro-10-methylacridin-9-one (11) presented in Section 3.4.3.2. Therefore the 
photoproduct was tentatively identified as 4-chloro- I 0-acridin-9-one (IV). A scheme for 
the formation of 4-chloro-1 0-acridin-9-one (IV) from 2-amino-5-chloro-benzophenone 
(Ill) under photochemical stress can be postulated. A similar scheme to the formation of 
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degradation product ll from photoproduct I is proposed (see Figure 3 .18), involving loss of 
molecular hydrogen yielding an intermediate, which subsequently reacts with the o-
hydrogen of the second phenyl ring resulting in the monochlorinated acridinone, 4-chloro-
1 0-methylacridin-9-one (IV). A scheme for the proposed formation of IV from ID is given 
in Figure 3.36. 
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Figure 3.34 LC/ESI-MS extracted ion chromatograms (EIC) of (A) 1 J..Lg mL-1 
photoproduct m sample before irradiation, (B) after 72 hours irradiation, 
(C) after 144 hours irradiation. Gradient elution ([Time/%A] 0/80-8/0-13/0-
15/80; A = water + 0.1% formic acid, B = acetonitri le + 0.1% formic acid); 
150 x 2.0 mm, 5 J..liil Gemini C18 HPLC column. 
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Figure 3.35 ESI full scan mass spectra (m/z 150-300) of (A) 2-amino-5-
chlorobenzophenone (Ill) in water after 144 hours; (B) MS of 
photoproduct IV formed from irradiation of 2-amino-5-
ch.lorobenzophenone for 144 hours and (C) Daughter ion spectrum 
(MS2) of m/z 230.3 (Peak IV) formed during photolysis of 2-arnino-5-
chlorobenzophenone (lll) for 144 hours. 
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Figure 3.36 Proposed scheme for the formation of photoproduct IV, 4-chloro-1 0-
acridin-9-one from photoproduct m, 2-amino-5-chlorobenzophenone in 
water. 
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Table 3.6 ESI-MS" fragmentation data for 2-amino5-cWoro-benzophenone (Ill) and 
photoproduct (IV). 
Compound 
2-amino-5-chlorobenzophenone (Ill) 
4-chloro-1 0-acridin-9-one (IV) 
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m/z significant ions 
MS 
232.1 
230.3 
154.1 
105.0 
195.4 
126.0 
3.4.4.3 Calculations of the estimated concentration of 2-amino-5-chloro-
benzophenone (I) and photoproduct (IV) 
The concentration of 2-amino-5-chlorobenzophenone (Ill) was measured by reference to 
the 2-amino-5-chlorobenzophenone (ID) calibration curve (Figure 3.24). In the absence of 
an authentic sample for the degradation product (IV), 4-chloro-1 0-acridin-9-one, an 
attempt to estimate its concentration was made using the 2-amino-5-chlorobenzophenone 
(Ill) calibration curve. Figure 3.37 shows the changes of concentration with irradiation 
time. Only 0.04 J..Lg mL-1 of 4-chloro-1 0-acridin-9-one was estimated to be formed, which 
equates to 4% of the starting concentration of 2-amino-5-chlorobenzophenone (Ill). This 
suggests that either photoproduct IV had a much weaker LC-MS response, or that some 
products are not amenable to analysis by LC-MS. It should also be emphasised that the 
concentration of photoproduct IV was estimated; a calibration graph of an authentic sample 
is required to determine the concentration more accurately. 
159 
1.20 
.l! 
0 
-
1.00 
.s ~ B 
~ B I 
N bJ) 
.... :1. 0.80 e '-' 
c 
" 
.2 c e 
-
c ~ 
" "' 
.c 0.60 
-c Q, ~ e 
= 
:;! 
e 
..8 u 0.40 
'0 e 
" 
.s .... 
~ .c 
·~ u 
<11 0.20 
~ 
0.00 
0 20 40 60 80 100 120 
Irradiation Time (Eioun) 
I-+-2-•mloo-5-'h lomb'"'"P"'"""' (Ill) l L -- Photoproduct IV 
140 160 
0.10 
.... 
u 
:::s 
'0 
e 
0.08 "' Q, 
e 
.... 
e 
.c 
~ 
.... ~ 
0.06 e ~ c 
e B 
:c bJ) ~ :1. 
'-
.... '-' 
c > 
" 0.04 u ..... 
c 
Q 
u 
'0 
" .... 
0.02 ~ 
.§ 
.... 
<11 
~ 
0.00 
Figure 3.37 Change in concentrations of 2-amino-5-chlorobenzophenone (Ill) in pure 
water and of its photodegradation product (IV) with increasing irradiation 
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represent ±_a, n=3). 
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3.4.5 Confirmation of 4-chloro-1 0-acridin-9-one (IV) as a photodegradation 
product of diazepam in water. 
Degradation product IV, 4-chloro-10-acridin-9-one was only detected in aqueous solutions 
of irradiated 2-amino-5-chlorobenzophenone (Ill) and not in irradiation experiments 
conducted on diazepam or its pnmary photoproduct (I) 5-chloro-2-
methylaminobenzophenone, at 1 J.lg mL"1 starting concentrations respectively. Since only 
4% (0.04 J.lg mL"1) of product IV was detected in irradiated solutions of an authentic 
sample of photoproduct m, at a starting concentration of I J.lg mL-1, its absence in 
photolysis experiments on diazepam and 5-chloro-2-methylaminobenzophenone (I) was 
unsurpnsmg. Less than 0.1 J.lg mL"1 of the photochemical precursor, · 2-amino-5-
chlorobenzophenone (Ill) was detected in both the experiments on diazepam and also the 
primary photoproduct (1). Therefore it was decided to undertake photolysis experiments on 
diazepam and an authentic sample of its primary photoproduct (I) at starting concentrations 
of 6 J.lg mL-1, in anticipation of a greater signal response for photoproduct IV, thereby 
perhaps enabling detection of IV. The experimental details for preparation and irradiation 
of these solutions are given in Chapter 6. 
Figure 3.38 compares LC chromatograms for solutions of 6 J.lg mL-1 diazepam after 216 
hours irradiation (Figure 3.38A), 6 J.lg mL-1 5-chloro-2-methylaminobenzophenone (I) after 
144 hours irradiation (Figure 3.388) and 1 J.lg mL-1 2-amino-5-chlorobenzophenone (ID) 
after 144 hours irradiation (Figure 3.38C) in water. The observed LC retention times for 
the peaks labelled IV in each sample were 6.80, 6.79 and 6.89 respectively. Identification 
of degradation product IV was based on the LC/ESI-MS" mass spectra (m/z 150-350) 
derived from peak IV in each irradiated solution. The MS" data is summarised in Table 3.7. 
Comparison of the results suggests that the component labelled peak IV in each experiment 
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was 4-chloro-1 0-acridin-9-one (IV). These experiments give further evidence for the 
identification of degradation products I, 11, ID and IV following photolysis of diazepam in 
water. A scheme is proposed in Figure 3.39 for the formation of these products from 
diazepam in water. 
Table 3.7 Comparison of the ESI-MSn fragmentation data for the component labelled 
peak IV detected in irradiated samples of diazepam, primary photoproduct 
(I) and secondary photoproduct (DI). 
Peak IV from: 
Irradiated diazepam in water 
Irradiated 5-chloro-2-methylaminobenzophenone (I) 
Irradiated 2-amino-5-chlorobenzophenone (ID) 
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mlz significant ions 
MS 
230.3 
230.3 
230.3 
195.3 
195.4 
194.3 
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Figure 3.38 EIC chromatograms comparing the formation of photoproducts in (A) 6 11g 
mL-1 diazepam; (B) 6 Jlg mL-1 5-chloro-2-methylaminobenzophenone (I) 
and (C) 1 11g mL-1 2-amino-5-chlorobenzophenone (Ill) after 2 16 and 144 
hours respectively. Gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; A = 
water + 0.1% formic acid, B = acetonitrile + 0.1% formic acid); 150 x 2_0 
mm, 5 J..llil Gemini C8 HPLC column. 
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Figure 3.39 Proposed scheme for the formation of photoproducts I, 11, m and IV 
following the irradiation of diazepam in water 
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3.6 Conclusions 
Simulation of solar irradiation methodology has been successfully established using a 
calibrated 1.8 kW filtered xenon lamp. Quantitative determination of the photodegradation 
of diazepam in aqueous solutions with and without humic acids was achieved using the 
LC/ESI-MS method developed in Chapter 2 of this study. The photodegradation was 
found to follow first-order kinetics. The rate constants (kp) were 0.0067 and 0.0251 hr-1 for 
experiments without and with humic acids, and half lives (tlfl) were calculated to be 103 
and 28 hours respectively. The addition ofhumic acids (1 J..lg rnL-1) isolated from the river 
Trent, UK, was found to sensitise the photolysis of diazepam and therefore resulting in a 
faster rate of degradation. Photodegradation has thus been shown to be an important 
transformation mechanism for diazepam in aqueous solutions. 
The optimised LC/ESI-MS analytical conditions described in Chapter 2 were successfully 
used for the separation, concentration and tentative identification of degradation products 
derived from photolysis of diazepam in aqueous solution. The structural fragmentation 
patterns obtained using optimised LC-MS" parameters were then successfully applied to 
confinn the structures of four proposed degradation products (1, ll, lll and IV). 
Identification of degradation products I and ID was aided by comparison with authentic 
samples of each compound. Photodegradation studies conducted on authentic samples of 
degradation products I and ID proved invaluable in elucidating the pathway for the 
formation of all four photodegradation products in aqueous solutions. Two unique 
diazepam photoproducts, 11 and IV, have been identified for the first time based on their 
ESI-MS" fragmentation pathways and are proposed to be the acridinone derivatives, 4-
chloro-1 0-methylacridin-9-one (11) and 4-chloro-1 0-acridinone (IV). The established 
irradiation method has proved to be reliable and valid for the irradiation of diazepam in 
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aqueous solutions and has been applied to photodegradation studies of the three known 
human metabolites of diazepam, namely nordiazepam, temazepam and oxazepam in water, 
described in Chapter 4. 
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CHAPTER FOUR 
Photodegradation of the human metabolites of diazepam in the presence 
and absence of humic acids 
This chapter describes investigations of the photostability of the human metabolites of 
diazepam; nordiazepam, temazepam and oxazepam, to simulated sunlight over prolonged 
periods of irradiation in dilute aqueous solutions and in the presence of humic substances. 
Details of laboratory photodegradation studies for each metabolite are discussed. Several 
photoproducts are identified using authentic compounds, and structures of other novel 
degradation products are proposed based on LC-MS" identification. 
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4.1 Introduction 
To date research into the environmental fate of PhACs has been exclusively directed 
towards the fate of parent drugs. Thus far, little consideration has been given to potential 
excreted metabolites, which may also be present in sewage and may then reach natural 
surface waters. Therefore, in order to evaluate comprehensively the persistence of a 
pharmaceutical potential excreted human metabolites also need to be considered. In the 
human body, pharmaceuticals can be transformed to one or more metabolites and excreted 
as a mixture of parent compound and metabolites, in which the parent compound is often 
the minor component. For example, clofibric acid is well known to be the principal and 
active metabolite ofthe three lipid regulators: clofibrate, ethofibrate and fenofibrate and its 
persistence should be considered along with the parent compounds (Daughton and Temes, 
1999). 
From human metabolism studies on diazepam, it has been estimated that 30% of the 
diazepam dose taken by patients is excreted as the parent compound, 12% as nordiazepam, 
15% as temazepam and 32% as oxazepam (Schwartz et al., 1965). The remaining 11% is 
unidentified. The chemical structures for diazepam and these metabolites are shown in 
Figure 4.1. 
l-fo 
,>-oH 
Cl Cl Cl Cl -- N 
Diazepam Nordiazepam Tcmazepam Oxazepam 
Figure 4.1 Structures of diazepam and its human metabolites; nordiazepam, temazepam 
and oxazepam. 
168 
Since these compounds are structurally related to diazepam, investigation of the 
photostability of each metabolite may also further support schemes proposed for 
photodegradation pathways of the parent compound diazepam. 
4.2 Current Aims 
The aim of the work described in the current chapter was to investigate the photostability 
of: nordiazepam, temazeparn and oxazepam in pure water and also in the presence of an 
environmentally relevant concentration of humic acids (1 J.l.g mL-1). The previously 
developed LCIESI-MS method (Chapter 2) was applied to a variety of photodegraded 
samples in order to establish appropriate rate constants and half-lives which could be 
applied to river catchment models (GREAT-ER, UK) for predicted environmental 
concentrations of these metabolites. Identification of a variety of photoproducts was 
achieved with reference to the degradation products determined for diazepam and two of 
the photodegradation products, 5-chloro-2-methylarninobenzophenone (I) and 2-amino-5-
chlorobenzophenone (ID) in Chapter 3 of the current study. 
4.3 Results and Discussion 
All photodegradation experiments conducted on the human metabolites of diazepam used 
essentially the same apparatus and conditions, but differed by the exposure time and the 
make up of the photolysis solutions, either in distilJed water or distilled water spiked with 
humic acids (1 J.l.g mL-1 where appropriate). Full experimental details for the preparation of 
solutions for laboratory photodegradation studies are given in Chapter 6. Following 
irradiation, samples were wrapped in foil and stored refrigerated until required. Aliquots 
were spiked with internal standard (oxazepam-d5) and analysed by LCIESI-MS using the 
conditions developed in Chapter 2. Gradient conditions are described with the relevant 
figures. 
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4.3.1 Photolysis of nordiazepam in the absence and presence of humic acids 
A series of calibration solutions of nordiazepam (0.1 to 2 J.lg mL-1), spiked with 1 J,lg mL-1 
of oxazepam-d5 (internal standard) and analysed in triplicate by LC/ESI-MS in full scan 
mode (mlz 150-1000) were previously shown, in Chapter 2, to given a linear response 
across the range of samples analysed (R2 = 0.9992). The calibration graph of response is 
shown in Figure 4.2 as mean peak area ratio values(± cr, n=3). This was used to determine 
the concentration of nordiazepam in various photolysed samples. 
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2.0 2.5 
LCIESI-MS calibration graph for aqueous solutions of (0.1 to 2 J.tg mL-1) of 
nordiazepam. Peak area ratio is the ratio of peak area of nordiazepam (mlz 
271.3 and 273.2) to 1 J,lg mL-1 internal standard (oxazepam-ds). (Points 
indicate mean ratio; error bars represent ± cr, n=3). Gradient elution 
([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = 
acetorutrile + 0.1% formic acid); 150 x 2.0 mm, 5 J.lm Gemini C18 HPLC 
column. 
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4.3.1.1 Degradation and half-lives 
The photostability of nordiazepam to simulated sunlight over 192 hours of irradiation in 
dilute aqueous solutions in the presence and absence of 1 ~g mL-' humic acids (river 
Trent) was investigated. Photolysis samples were prepared as described in Chapter 6. 
Table 4.1 compares the average concentration of nordiazepam in the absence and presence 
of humic acid aqueous solutions respectively, over the irradiation period. Dark controls 
(abiotic) for the photolysis experiments were analysed in triplicate at the beginning and 
end of each experiment (0 and 192 hours respectively) and were found to be equivalent to 
the starting concentration in each case, suggesting degradation was due to photolysis only. 
The decline in nordiazepam concentration with increasing irradiation time for each 
experiment followed first order kinetics (described in Chapter 3, Section 3.4.2.1). The first 
order photodegradation rate constants kp were determined from the slope of a graph of Ln 
[CtfCo] vs irradiation time (Figure 4.3). 
The frrst order photodegradation rate constants (kp) were 0.0036 h-1 and 0.0147 h-1 for 
nordiazepam photolysis experiments in pure distilled water and with humic acids 
respectively. Half lives (t,n) were calculated as 193 and 47 hours for nordiazepam 
photodegradation in pure water and with humic acids respectively. The results suggest 
that the rate of nordiazepam photodegradation increased in the presence of humic acids 
compared to pure water under the experimental conditions used herein. This is reflected in 
a shorter half life for photodegradation of nordiazepam in the presence of humic acids (193 
> 47 hours). 
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Table 4.1 
Time 
(hours) 
0 
24 
48 
72 
96 
144 
192 
Effects of irradiation on photolysis of nordiazepam m the absence and 
presence of 1 J.lg m.L-1 humic acids. 
Nordiazepam in water Nordiazepam in the presence of (l J,Jg mL-1) humic acids 
Average Average 
Concentration %of initial Concentration %of initial 
(J,Jg mL-1) (JJg mL-1) 
1.04 100 1.00 100 
0.99 95 0.76 76 
0.87 83 0.49 49 
0.85 81 0.34 34 
0.76 73 0.26 26 
0.65 62 n.d. n.d. 
0.52 50 n.d. n.d. 
(n.d. = Not Determined) 
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Figure 4.3 Changes in concentration of nordiazepam with increasing irradiation time in 
pure water ( • ) and river Trent humic acids ( •) Points indicate mean values; 
error bars represent ± cr, n =3). Abiotic control shown in circle (mean± cr, n 
=3). 
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4.3.1.2 Analysis of nordazepam degradation products 
Analysis of the LC/ESI-MS chromatograms (Figure 4.4) of the photodegraded samples of 
nordiazepam (1 J,J.g mL"1) in water indicated that one major (peak lll) and one very minor 
degradation product (peak IV) were formed. Undegraded nordiazepam was also present. 
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Figure 4.4 LC/ESI-MS mass chromatograms (extracted ion chromatograms) of 
nordiazepam photolysis over time by gradient elution ([Time/%A] 0/80-8/0-
13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% formic 
acid); 150 x 2.0 mm, 5 ~m Gemini C18 HPLC column. 
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ESI-MS" spectra were obtained for all peaks detected in the LC-MS chromatograms 
derived from nordiazepam after irradiation in water for 192 hours in order to identify the 
nordiazepam degradation products Ill and IV. Based on molecular weight and molecular 
ion isotope contribution infonnation, structures were postulated. These were supported by 
MS" daughter ion analysis of the molecular ions derived from each peak and comparison 
with authentic compounds where available. Further support was achieved through 
comparisons with the photodegradation products previously identified from investigations 
of the photostability of diazepam, viz: 5-chloro-2-methylarninobenzophenone (I) and 2-
amino-5-chlorobenzophenone (Ill) to simulated sunlight, described in Chapter 3. 
Figure 4.5 compares the molecular ions observed in the ESI-MS full scan mass spectrum 
(mlz 150-350) derived for nordiazeparn, mlz 271.3 after irradiation in water for 192 hours 
(Figure 4.4A) and the ESI-MS full scan mass spectrum obtained from a 1 llg mL-1 
nordiazepam in water (Figure 4.4B). Both MS spectra were obtained under identical 
LC/ESI-MS conditions. The LC retention times for irradiated nordiazepam and an 
authentic nordiazepam sample suggested that the compounds were identical (6.41 and 6.44 
minutes respectively). Conclusive evidence was achieved from assessment of the ESI-MS 
full scan mass spectra, which were identical. Both spectra showed a base ion at mlz 271.3 
which corresponds to protonated nordiazepam ([M+H]} and also a smaller ion at mlz 
273.3. The ratio ofthese ions, 3:1 (m/z 271.3 to 273.3) are indicative ofthe presence of a 
single chlorine atom. 
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MS spectrum of 
Nordiazepam nordiazepam after 192 
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Comparison of the ESI-MS full scan mass spectrum (mlz 150-350) derived 
from nordiazepam after irradiation in water for 192 hours (A) and a 1 11g 
mL-1 nordiazepam in water (B). Gradient elution ([Time/%A] 0/80-8/0-
13/0-15/80; A = water + 0.1% fonnic acid, B = acetonitrile + 0.1% formic 
acid); 150 x 2.0 mm, 5 f.liD Gemjni C18 HPLC column. 
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Photoproduct ill 
Based on inspection of the mass spectrum derived from the most intense peak (UI), the 
benzophenone derivative, 2-amino-5-chlorobenzopbenone was proposed as photoproduct 
lll (Figure 4.6). 2-amino-5-chlorobenzophenone (01) was identified as a secondary 
photoproduct of diazepam photolysis in water (Section 3.4.2.2). The full scan mass 
spectrum of peak ID (Figure 4.5A), shows a base ion at mlz 232.2 corresponding to 
protonated 2-amino-5-chlorobenzophenone ([M+H]). This base ion was 39 mass units 
lower than protonated nordiazepam (mlz 271.3) and is consistent with the net loss of -
C2NH. Inspection of the molecular ion isotope (mlz 234.2) and its ratio relative to mlz 
232.2 (3: I) indicated the presence of a single chlorine atom. 
The molecular ion at mlz 232.2 was selected for ESI-MS" studies. The daughter ion 
spectrum (MS2) derived from mlz 232.2 is shown in Figure 4.5B. The fragment ion at mlz 
154.1 suggests loss of a phenyl group. The daughter ion spectrum (MS\ obtained for ion 
m/z 154 is shown in Figure 4.5C and the ion present at mlz 126.0 is consistent with loss of 
- CO. 
Identification of photoproduct m was aided by reference to the ESI-MS" fragmentation 
pathway of an authentic sample of2-amino-5-chloro-benzophenone (Figure 4.7). Both the 
ESI-MS" fragmentation pathways derived from peak m and the authentic sample produced 
identical fragmentations, further supporting the identification of 2-amino-5-
chlorobenzophenone as the primary photoproduct of nordiazepam in water. 
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(A) Mass spectrum derived from peak DI (Figure 4.3D) from photolysis of 
nordiazepam for 192 hours; (B) Daughter ion spectrum (MS2) of mlz 232 
(Peak Ill) formed during photolysis of nordiazepam for 192 hours; (C) 
Daughter ion spectrum (MS3) of mlz 232 (Peak Ill) formed during 
photolysis of nordiazepam for 192 hours. 
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Table 4.2 Comparison of the LC chromatograms and the ESI-MS" fragmentation 
pathways derived from peak m detected in a nordiazepam solution 
following 192 hours irradiation and an authentic 2-amino-5-
chlorobenzophenone sample. 
1nl Std ¥' Nordiazepam 
Peak ID 
1 
6.0 7.0 8.0 9.0 
l11T11 (lrin) 
Authentic 
2-amioo-5-cbloro 
~ozopbeooot 
(1 ~~g mL·1) 
8 .0 7.0 
llmo(lrin) 
8.0 9.0 
mlz significant ions Peak Ill from photolysis of Nordiazepam for 192 hours 
Authentic 
2-amino-5-chlorobenzophenone 
{1 IJ9 mL-1) 
MS 232.2 
154.1 
105.0 
126.0 
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232.2 
154.1 
105.1 
126.0 
The formation of the benzophenone derivative, 2-amino-5-chJorobenzophenone (III) under 
photochemical stress is postulated to occur through opening of the diazepinone ring by 
initial breakage of either the amide functionality or the C=N bond, followed by elimination 
of H2NCH2C02H after rearrangement (Figure 4.7). The same photoproduct was 
determined to be a secondary photoproduct of diazepam (Section 3.4.4.2). Formation from 
nordiazepam is postulated to be analogous to the formation of photoproduct I from 
diazepam. Photodegradation thus appears to be an important transformation for 
nordiazepam in the aqueous environment. 
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Figure 4.7 Proposed scheme for the formation of photoproduct ID, 2-arnino-5-
chlorobenzophenone from nordiazepam in water. 
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Photoproduct IV 
Figure 4.8A shows a minor degradation product (peak IV) in one of the LC/ESI-MS 
chromatograms of a 1J . .tg mL-1 sample of nordiazepam in water after 192 hours irradiation. 
The proposed structure for photoproduct IV was 4-chloro-1 0-acridin-9-one. This 
compound was identified as a photoproduct of 2-amino-5-chlorobenzophenone (ID) 
photolysis in distilled water (Section 3.4.4). Therefore identification of photoproduct IV 
was aided by comparison with the full scan mass spectra of photoproduct IV found in the 
photolysis of 2-amino-5-chlorobenzophenone (Ill) (Figure 4.8). Both full scan mass 
spectra gave base ions at mlz 230 and molecular ion isotopes at mlz 232, consistent with the 
presence of a single chlorine atom. However, reproducible ESI-M" daughter ion spectra 
could not be obtained for the base ion (mlz 230) derived from irradiated nordiazepam. 
Therefore, it was decided to irradiate a higher concentration of nordiazepam (6 llg mL-1) in 
water using the same irradiation conditions in anticipation of a more prominent signal 
response for peak IV, thus allowing reproducible ESI-MS" spectra to be obtained. 
Figure 4.9 presents the LCIESI-MS chromatograms from 0, 96 and 192 hours irradiation 
for a solution of 6 J.tg mL-1 nordiazepam in water. Two degradation products were detected 
in the irradiated samples and were labelled fll and IV. Undegraded nordiazepam was also 
present. No degradation products were detected in the dark controls. Figure 4.10 shows 
the full scan mass spectra (mlz 150-350) of peak IV derived from irradiated 2-amino-5-
chlorobenzophenone (Ill) and from irradiated nordiazepam, 6 llg mL-1 starting 
concentration. The spectra were found to be consistent and support the identification of 
photoproduct IV. Additional support was obtained through comparison of the ESI-MS" 
fragmentation pathway for photoproduct IV from both experiments, summarised in Table 
4.4. Both the ESI-MS" fragmentation pathways derived from peak IV yielded identical 
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fragmentations (MS2), thereby enhancing support for the identification of 4-chloro-1 0-
acridin-9-one as a photoproduct of nordiazepam photolysis in water. 
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Figure 4.8 Comparison of the ESI-MS full scan mass spectra (m/z 150-350) of peak IV 
derived from nordiazepam after irradiation in water for 192 hours (A) and 4-
chloro- l 0-acridin-9-one (photoproduct IV detected in the photolysis 
experiments conducted on 2-arnino-5-chlorobenzopbenone (Ill) and 
described in Chapter 3, Section 3.4.4.2). 
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Figure 4.9 LC/ESI-MS mass chromatograms (extracted ion plots) of 6 J.1g mL-1 
nordiazepam photolysis over time by gradient elution ([Time/%A] 0/80-8/0-
13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1 % formic 
acid); 150 x 2.0 mm, 5 J.1ID Gemini C18 HPLC column. 
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Figure 4.10 (A) MS of peak IV formed from photolysis of 2-amino-5-
chlorobenzophenone (Ill); (B) MS of peak IV formed during photolysis of 
6 j.lg mL-1 nordiazepam for 192 hours and (C) Daughter ion spectrum (MS2) 
of mlz 230 (Peak IV) formed during photolysis of 6 j.lg mL-1 nordiazepam 
for 192 hours. 
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Table 4.3 Comparison of the LC chromatograms and the ESI-MS" fragmentation 
pathways derived from peak IV detected in a 6 Jlg mL-1 nordiazepam 
solution following 192 hours irradiation and peak IV derived from 
photolysis of an authentic 2-amino-5-chlorobenzophenone (DJ) sample. 
m nordiazepam 
2-amino-5-i:bloro fl A benzopbenone -+ 
Peak IV Peaklll 
A Peak IV A_ \____ 
. .J 
--6.0 7.0 8.0 9.0 10.0 6.0 7.0 8.0 9.0 
Time(min) nme(min) 
Peak IV from photolysis of 6 ~ mL·1 Peak IV from photolysis of 1 ~ mL·1 
m/z significant ions nordiazepam for 192 hours 2-amino-5-chlorobenzophenone (ill) 
for 144 hours 
MS 230.3 230.3 
195.4 195.4 
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Formation of 4-chloro-1 0-acridin-9-one (IV) under photochemical stress is postulated to 
occur from the primary photoproduct, 2-amino-5-chlorobenzophenone (ID). Loss of 
molecular hydrogen from 2-amino-5-chlorobenzophenone in aqueous solution would yield 
the proposed intermediate, which could potentially react with the a-hydrogen of the second 
phenyl ring forming 4-chloro-1 0-acridin-9-one (IV). A proposed scheme for the formation 
of IV is given in Figure 4.11 . To confirm that the pathway was indeed due to photolysis, 
rather that hydrolysis, photodegradation studies were undertaken on an authentic sample of 
the primary photoproduct, 2-amino-5-chlorobenzophenone (ID) and have been described in 
section 3.4.4.2. 
188 
H 
I~ J):N, H 
Cl CO + + 6 
H 
(Ill) 
hv lH, 
Cl 
hv 1-H+ 
Cl 
0 
(IV) 
Figure 4.11 Proposed scheme for the formation of photo product IV, 4-chloro-1 0-
acridin-9-one from photoproduct m, 2-amino-5-chlorobenzophenone in 
water. 
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Photodegradation appears to be an important transformation mechanism for nordiazepam in 
the aqueous environment. Under the experimental conditions used herein, two degradation 
products (Ill and IV) were identified. Based on the assignments presented, a proposed 
scheme for the formation of both degradation products from diazepam in water is shown in 
Figure 4.12 and the structures are also listed in Table 4.4. 
The primary degradation product, 2-amino-5-chlorobenzophenone (Ill) was not detected in 
any of the blank samples thus indicating formation was due to photodegradation, under the 
current experimental conditions. Degradation product IV (4-chloro-10-acridin-9-one) was 
proposed to resuJt from photodegradation ofphotoproduct m. The photodegradation of2-
amino-5-ch1orobenzophenone (lli) yielded the same photoproduct, which supports this 
assignment (Section 3.4.4.2). 
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Figure 4.12 Proposed scheme for the formation of photoproducts m and IV from 
nordiazepam in water. 
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Based on the assignments presented, the proposed photodegradation products of 
nordiazepam photolysis in water are shown in Table 4.4 
Table 4.4 Identification of Nordiazepam photo products 
Peak 
Nordiazepam 
111 
IV* 
Molecular ion 
JM+lJ 
271 
232 
230 
Structure Identification Metbods 
• Reference Compound 
(Sigma-Aidrich) 
• LC/ESI-MS• 
• Reference Compound 
(Sigma-Aidrich) 
• LC/ESI-MS• 
• Corneilson et al., ( 1978) 
• LC/ESI-MS• 
(* confmned by ESI-MS" data from analysis of an irradiated solution of 6 J..lg mL-1 
nordiazepam) 
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4.3.1.3 Calculation of the estimated concentrations of nordiazepam and 
photoproducts 
The concentration of nordiazepam in water was measured by reference to the nordiazepam 
calibration curve shown in Figure 4.1. Photoproduct Ill, 2-amino-5-chlorobenzophenone 
was measured by reference to the 2-amino-5-chlorobenzophenone (DJ) calibration curve 
(Chapter 3, Figure 3.24). Photoproduct IV, 4-chloro-10-acridin-9-one was only present in 
one sample after 192 hours irradiation and therefore did not to allow a reliable estimate of 
its concentration to be made. 
Figure 4.13 shows the changes of concentration with irradiation time for nordiazepam, (1 
f.!g mL-1 starting concentration) and degradation product m, 2-amino-5-
chJorobenzophenone in water. Results are averaged concentrations from experiments 
conducted in triplicate (n=3). The sum of the concentrations of unchanged nordiazepam 
and 2-amino-5-chlorobenzophenone (Ill) was found to be approximately equal to the 
initial nordiazepam irradiation, suggesting that few other degradation products had formed. 
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4.3.2 Photolysis of temazepam in the absence and presence of humic acids 
A series of calibration solutions oftemazepam (0.1 to 2 Jlg mL-1), spiked with 1 Jlg mL-1 of 
oxazepam-ds (internal standard) and analysed in triplicate by LCIESI-MS in full scan mode 
(mlz 150-1 000) were previously shown (Chapter 2) to give an excellent linear response 
across the range of standards analysed (R2 = 0.9989). The calibration graph of response is 
shown in Figure 4.14 as mean peak area ratio values (± a, n=3). This was used to 
determine the concentration of temazepam in various photolysed samples. 
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Figure 4.14 LCIESI-MS calibration graph for aqueous solutions of (0.1 to 2 f.lg mL-1) of 
temazepam. Peak area ratio is the ratio of peak area of temazepam (mlz 
301.1 and 303.1) to 1 Jlg mL-1 internal standard (oxazepam-d5). (Points 
indicate mean ratio; error bars represent ± a, n=3). Gradient elution 
([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = 
acetonitriJe + 0.1% formic acid); 150 x 2.0 mm, 5 ~m Gemini C 18 HPLC 
column. 
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4.3.2.1 Degradation and calculation of half-lives 
The photostability of temazepam (starting concentration of 1 11g mr1) to simulated 
sunlight over 96 hours of irradiation in diJute aqueous solutions in the presence and 
absence of 1 11g rnL-1 humic acids (river Trent) was investigated. Photolysis samples were 
prepared as described in Chapter 6. Table 4.5 compares the average concentration of 
temazepam in the absence and presence of humic acid aqueous solutions respectively, over 
the irradiation period. Dark controls (abiotic) for the photolysis experiments were 
anaJysed in triplicate at the beginning and end of the experiment (0 and 96 hours 
respectively) and were found to be comparable to the starting concentration in each case, 
suggesting degradation was due to photolysis onJy. The decline in temazepam 
concentration with increasing irradiation time for each experiment followed first order 
kinetics (described in Chapter 3, Section 3.4.2. 1 ). The fust order photodegradation rate 
constants (kp) were determined from the slope of the graph of Ln [CtfCo] vs irradiation 
time (Figure 4.15). 
The first order photodegradation rate constants (kp) were 0.0194 h-1 and 0.0096 h-1 for 
temazepam photolysis experiments in pure water and in the presence of humic acids 
respectively. HaJf Lives (t112) were caJcuJated as 36 and 72 hours for temazepam 
photodegradation in pure water and with humic acids respectively. The results suggest that 
the rate of temazepam photolysis was reduced in the presence of humic acids compared to 
pure water under the experimentaJ conditions used herein. This is reflected in an 
approximate doubling the half life (32 > 66 hours). 
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Table 4.5 Effect of irradiation on photolysis of temazepam (1 f.lg mL"1 starting 
concentration) in the absence and presence of 1 f.lg mL"1 humic acids 
(concentrations are expressed as mean values, n=3). 
Temazepam in water Temazepam in the presence of 
Time 
(1 11g mL-1) humic acids 
(boors) Average Average 
Concentration %of initial Concentration %of initial 
(llg mL"1) (j!g mL-1) 
0 1.03 100 1.00 100 
24 0.67 65 0.63 63 
48 0.40 39 0.56 56 
72 0.27 26 0.48 48 
96 0.16 16 0.36 36 
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Figure 4.15 Changes in concentration of temazepam with increasing irradiation time in 
pure water (• ) and river Trent humic acids (•) Points indicate mean values; 
error bars represent ± cr, n =3. Abiotic control shown in circle (mean± cr, n 
=3). 
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4.3.2.2 Analysis of temazepam degradation products 
Identification of temazepam degradation products was achieved after prolonged irradiation 
of 6 llg mL-1 starting concentration of temazepam in distilled water. Figure 4.16 presents 
the LC-MS chrornatograms for 0 to 96 hours irradiation for a solution of 6 J..Lg mL-1 
temazepam analysed. Eight degradation products were observed in the LC-MS 
chromatograms of the irradiated samples. These were labelled I, 11, Ill, V, VI, VD, VIII 
and IX respectively. Undegraded temazepam was also present. No degradation products 
were detected in the dark controls. 
Having demonstrated the presence of degradation products following irradiation of 
temazepam, mlz values corresponding to each of the observed degradation product peaks 
were extracted from the full scan data. The mlz values corresponding to each of these 
peaks are shown in Table 4.6. Figure 4.17 presents the extracted ion chromatograms for 0 
to 96 hours irradiation for a 6 J..Lg mL-1 solution of temazepam analysed. In addition to the 
peaks corresponding to degradation products a small peak at the same retention time as 
temazepam was observed. This was due to in-source fragmentation of protonated 
temazepam, which gave rise to a low intensity (~18%) ion at mlz 255.3 (Figure 4.18). This 
ion is very similar to the extracted mlz value (253.3) corresponding to degradation product 
VII (Table 4.6) and resulted in its detection. 
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Figure 4.16 LC-MS mass chromatograms (total ton chromatograms) of temazepam 
photolysis over time by gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; A 
= water + 0.1% formic acid, B = acetonitri le + 0.1% formic acid); 150 x 2.0 
mm, 5 Jlm Gemini C18 HPLC column. 
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Table 4.6 The m/z values (effectively protonated molecular ions) corresponding to 
temazepam photodegradation products. 
Degradation product 
n 
m 
V 
VI 
vn 
vm 
XI 
Peak retention time 
(m in) 
10.06 
7.80 
8 .79 
9.16 
7.89 
6.38 
7.03 
3.90 
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mlz value 
246.2 
244.3 
232.2 
212.2 
198.2 
256.3 
256.3 
289.2 
100 I V 
80 Temazepam ""... V Ill 
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Figure 4.17 Extracted ion chromatograms (masses used are given in Table 4.6) LC-MS 
mass chromatograms of temazepam degradation products over time by 
gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic 
acid, B = acetonitrile + 0.1% formic acid); 150 x 2.0 mm, 5 Jlm Gemini Cl8 
HPLC column. 
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In an attempt to identify the temazepam degradation products, ESI-MS" spectra were 
obtained for each photoproduct derived from temazepam at each sampling point. Based on 
molecular weight and molecular ion isotope contribution information, structures were 
postulated for each of the observed degradation products. These were supported by MS" 
daughter ion analysis of the molecular ions derived from each of these products and 
comparison with authentic compounds where avaiJable. The relationship between the 
photoproducts identified (Figure 4.26) was determined through a combination of (a) 
independent photolysis results (e.g. photolysis of I and 01) and (b) the 'concentration-time' 
profiles plotted in Figures 4.27, 4.28 and 4.29. 
Figure 4.18 compares the molecular ions observed in the ESI-MS full scan mass spectrum 
(mlz 150-350) derived for temazepam, mlz 301.1 (Figure 4.18A) after irradiation in water 
for 96 hours and the ESI-MS fulJ scan mass spectrum obtained from I Jig mL-1 temazepam 
in water (Figure 4.18B). Both MS spectra were obtained under identical LC/ESI-MS 
conditions. The LC retention times for irradiated temazepam and an authentic temazepam 
sample suggested that the compounds were identical (6.66 and 6.65 minutes respectively). 
Conclusive evidence was obtained from comparison of the ESI-MS full scan mass spectra, 
which were very similar. Both spectra showed a base ion at mlz 301.1 which corresponds 
to protonated temazepam ([M+Ht) and also a smaller ion at mlz 303 .I. The ratio of these 
ions, 3:1 (mlz 301.1 to 303.1) are indicative of the presence of a single chlorine atom. The 
full scan mass spectra of the sample derived from irradiated temazepam (Figure 4.18A) 
also contained minor ions at mlz 283.1 (12%) and mlz 255.3 (22%) which are attributed to 
in-source fragmentation of [M+Ht. 
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Figure 4.18 Comparison of the ESI-MS full scan mass spectrum (mlz 150-350) derived 
from temazepam after irradiation in water for 96 hours (A) and l Jlg mL-1 
temazeparn in water (B). Gradient elution ([Time/%A] 0/80-8/0-13/0-
15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% formic acid); 
150 x 2.0 mm, 5 J..UU Gemini C 18 HPLC column. 
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Photoproducts I. ll and m 
Identification of the degradation products I, ll and m was based on the LC/ESI-MS full 
scan spectra (m/z 150-350) obtained for each photoproduct peak derived from irradiated 
temazepam samples. These are shown in Figure 4.19. Further structural information was 
given by the MS" daughter ion analyses for the molecular ions derived from each of the 
products, summarised in Table 4.7. The proposed structures for photoproduct peaks I, ll 
and m were 5-chloro-2-methylaminobenzophenone (1), 4-chloro-1 0-methylacridin-9-one 
(D) and 2-amino-5-chlorobenzophenone (ID) respectively. All three of these 
photoproducts were also identified as photoproducts of photolysis of diazepam in water 
(Section 3.4.2.2). Identification was aided by reference to the LC/ESI-MS chromatograms 
and ESI-MS" fragmentation pathways found for the photoproducts of diazepam and 
comparison with authentic samples of 5-chloro-2-methylarninobenzophenone (I) and 2-
amino-5-chlorobenzophenone (DJ), shown in Figure 4.21. 
A proposed scheme for the formation of photoproducts I , ll and m from photolysis of 
temazepam in water is shown in Figure 4.21 . The formation of photoproducts I, n and Ill 
is proposed to occur in a si.mjlar manner to those of diazepam following irradiation 
(Section 3.4.2.2). Both diazepam and temazepam possess a methyl group on N-1 of the 
diazepin-2-one ring, which is present in the common photoproduct, 5-chloro-2-
methylaminobenzophenone (1). This compound has been previously shown to undergo 
phototransformation to products n and m, which have both been detected in the 
temazepam samples. 
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Figure 4.19 ESI full scan mass spectra (m/z 150-350) of products from photolysis of 
temazepam after 96 hours irradiation. 
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Table 4.7 ESI-MS" fragmentation data for temazepam photoproducts I, 0 and ID. 
Compound mlz significant ions 
MS MS2 MS3 
Temazepam 301.1 283 .0 255.2 
283. 1 255.3 
255.3 
5-chJoro-2-methylaminobenzophenone (I) 246.1 228.2 193.3 
228.2 
4-chJoro-1 0-methylacridin-9-one (II) 244.3 209.3 
229.2 
2-amino-5-chlorobenzophenone (Ill) 232. 1 154.1 126.0 
105.0 
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Figure 4.20 Comparison of the LC/ESI-MS chromatograms of (A) 6 J.Lg mL-1 
temazepam sample after 96 hours irradiation, (B) I J.Lg mL-1 diazepam 
sample after 216 hours irradiation and (C) authentic sample of 1 J.Lg mL-1 
5-chloro-2-methylaminobenzophenone (I) and 1 J.l.g mL-1 2-amino-5-chloro 
benzophenone (UI). Gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; A = 
water + 0.1% formic acid, B = acetonitrile + 0.1% formic acid); 150 x 2.0 
mm, 5J.Lffi C18 Gemini HPLC column. 
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Figure 4.21 Proposed scheme for the fonnation of photoproducts I, 11 and m from the 
photolysis of 6 J.Lg mL-1 temazeparn in water. 
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Photoproduct V 
The fuJI scan mass spectrum (mlz 100-350) of the component labelled peak V (Figure 
4.22A) shows a base ion at mlz 212.2 and a minor ion at mlz 194.3. Comparison of this 
spectrum with the full scan spectrum of the identified photoproduct (I) 5-cbloro-2-
methylarninobenzophenone (Figure 4.19A) show that it is 34 mass units lower, suggesting 
replacement of chlorine with hydrogen. The daughter ion spectrum (MS2) derived from 
mlz 212 is shown in figure 4.22B. The loss of phenyl is characterised by the ion at mlz 
134, which is 78 mass units smaller (mlz 212 > 134, [M-Ph]). The compound is 
tentatively identified a 2-methylaminobenzophenone (V). Formation of degradation 
product V is thought to occur from temazepam rather than via dechlorination of the 
primary photoproduct (1), 5-chloro-2-methylaminobenzophenone, since product V has not 
been observed in photolysis experiments of either diazepam or photoproduct I. 
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Figure 4.22 (A) MS of peak V formed from photolysis of temazepam; (B) Daughter ion 
spectrum (MS2) of mlz 2 12 (Peak V) formed after photolysis of 6 )lg mL-1 
temazepam for 48 hours. 
2 1 1 
Photoproduct VI 
The full scan mass spectrum (m/z 1 00-350) of the component labelled peak VI (Figure 
4.23A) shows a base ion at mlz 198.2 and a minor ion at m/z 194.3. Comparison of this 
spectrum with the full scan spectrum of the identified photoproduct (I) 2-amino-5-
cblorobenzophenone (Figure 4.20B) show that it is 34 mass units lower, suggesting 
replacement of chlorine with hydrogen. The daughter ion spectrum (MS2) derived from 
mlz 198 is shown in figure 4.23B. The loss of phenyl is characterised by the ion at mlz 120 
which is 78 mass units less. The compound is tentatively identified as 2-
aminobenzophenone (VI). Formation of degradation product VI is proposed to occur via 
demethylation of product V, 2-metbylaminobenzopheone. 
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Figure 4.23 (A) MS of peak VI formed from photolysis oftemazepam; (B) Daughter ion 
spectrum (MS2) of mlz 198 (Peak VI) formed after photolysis of 6 ~g mL-1 
temazepam for 96 hours. 
213 
Pbotoproducts VD and Vlli 
The full scan spectra (m/z 100-300) of the components labelled VD and Vlll are shown in 
Figure 4.24A and 4.248 respectively. Both full scan spectra show ion series centred on the 
base ion m/z 256.3. The ratio of mlz 256.3 to 258.2 present in both spectra confirms the 
presence of a single chlorine atom (ratio 3: 1, mlz 256 > 258) in each proposed structure 
respectively. Further structural information was given by the MS" daughter ion analyses 
for the molecular ions derived from each of the products. The daughter ion spectra (MS2) 
derived from products VD, mlz 256.3 and Vlll, mlz 256.3 are shown in Figures 4.24C and 
4.24D respectively. Loss of chlorine from both product VII and VID is characterised by 
the ion at mlz 221.2, which is 35 mass units lower. Since both products exhibit the same 
molecular ions and identical MS2 fragmentations it is difficult to distinguish between them 
and further work is required for identification of these minor degradation products 
(discussed in Chapter 7). 
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Figure 4.24 (A) MS of peak VD formed from photolysis oftemazepam; (B) MS of peak 
VIll formed from photolysis of temazepam; (C) Daughter ion spectrum 
(MS2) of mlz 256.3 (Peak VD) formed after photolysis of temazepam; (D) 
Daughter ion spectrum (MS2) of mlz 256.3 (Peak VIII) formed after 
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Photoproduct IX 
The full scan mass spectrum (m/z 100-350) of the component labelled peak IX (Figure 
4.25A) shows a base ion at mlz 289.2 and a minor ion at 231.4 (27%). Also observed was a 
molecular ion isotope (mlz 291.1). The ratio of these ions, 3:1 (m/z 289.2 > 291.1) 
indicates the presence of a single chlorine atom. The daughter ion spectrum (MS2) derived 
from mlz 289 is shown in Figure 4.25B. The loss of 58 mass units is characterised by the 
ion at mlz 231. Further investigation is required to enable elucidation of photoproduct IX 
and is proposed in Chapter 7. 
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Figure 4.25 (A) MS of peak IX fanned from photolysis oftemazepam; (B) Daughter ion 
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Based on the assignments presented, the proposed photodegradation products of 
temazepam photolysis in water are shown in Table 4.8 
OH 
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H3q 0 
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Figure 4.26 Proposed scheme for the formation oftemazepam degradation products 
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Table 4.8 Identification of Temazepam photoproducts 
Molecular ion 
(M+1) 
301 
246 
244 
232 
212 
Cl 
Cl 
Cl 
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Structure Identification Methods 
• Reference Compound 
(Sigma-Aidrich) 
• LC/ESJ-MS" 
• Reference Compound 
(Sigma-Aidrich) 
• LC!ESI-MS" 
• Corneilson et al., ( 1978) 
• LC/ESl-MS" 
• Reference Compound 
(Sigma-Aidrich) 
• LC/ESI-MS" 
• Corneilson et al., ( 1978) 
• LC/ESI-MS" 
Table 4.8 continued Identification of Temazepam photoproducts 
Peak Molecular ion Structure Identification Methods [M+1] 
VI 198 ~ "'<:::: • LC/ESI-MS• 0 ==-- /, 
H 
VII 256 I • LC/ESI-MS• ~0 ~ Cl 
I 
VIII 256 ~OH • LC/ESI-MS• 
Cl 
~ 
I 
IX 289 1~0H • LC/ESI-MS• NH 
Cl 
I 
~ 
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4.3.2.3 Calculations of the estimated concentrations of temazepam 
photoproducts 
The concentration oftemazepam in water (starting concentration 1 J.lg mL-1) was measured 
by reference to the temazepam calibration curve shown in Figure 4.14. Photoproducts I 
and m, were measured by reference to the 5-chloro-2-methylaminobenzophenone (I) and 
2-amino-5-chlorobenzophenone (Ill) calibration graphs respectively (Chapter 3, Figure 
3.24 and Figure 3.25 respectively). The 5-chloro-2-methylaminobenzophenone calibration 
graph was also used to estimate the concentration of Photoproduct V, 2-
methylaminobenzophenone, in the absence of an authentic sample. The 2-amino-5-
chlorobenzophenone calibration graph was used to estimate the concentration of 
photoproducts VI, VII, VIU and IX respectively. 
Figure 4.27 shows the changes of concentration with irradiation time for temazepam, 1 J.lg 
mL-1 starting concentration, and its degradation products Ill, 2-amino-5-
chlorobenzophenone in water. Results are averaged concentrations from experiments 
conducted in triplicate (n=3). Since only a small recovery of photoproducts was 
determined for temazepam at 1 J.lg mL-1, the peak area ratios of all the photoproducts 
detected at 6 j.lg mL-1 starting concentration are displayed in Figures 4.28 and 4.29. As 
authentic standards were not available for some of the compounds and indeed some of the 
products were not unambiguously identified it was not possible to calculate the formation 
of these individual degradation products. Identification of the primary and secondary 
photoproducts and their relationship to each other (Figure 4.26) was determined using a 
combination of (a) independent photolysis experiment results and (b) the 'concentration-
time' profiles plotted in Figures 4.27, 4.28 and 4.29. 
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Figure 4.27 Change in concentration oftemazepam (• ), and photodegradation products I 
( .A ) and V ( • ) with increasing irradiation time (temazepam starting 
concentration 1 )..lg mL-1). Points indicate mean concentration values (n=3); 
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4.3.3 Photolysis of oxazepam in the absence and presence of humic acids 
A series of calibration solutions of oxazepam (0.1 to 2 Jlg mL"1), spiked with 1 Jlg mL-1 of 
oxazepam-d5 (internal standard) and analysed in triplicate by LC/ESI-MS in full scan mode 
(mlz 150-1 000) were previously shown, in Chapter 2, to given a linear response across the 
range of standards analysed (R2 = 0.9998). The calibration graph of response is shown in 
Figure 4.30 as mean peak area ratio values (± cr, n=3). This was used to determine the 
concentration oftemazepam in various photolysed samples. 
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Figure 4.30 LC/ESI-MS calibration graph for aqueous solutions of (0.1 to 2 11g mL-1) of 
oxazepam. Peak area ratio is the ratio of peak area of oxazepam (mlz 287.2 
& 289.2) to 1 Jlg mL"1 internal standard (oxazepam-d5) . (Points indicate 
mean ratio; error bars represent ± cr, n=3). Gradient elution ([Time/%A] 
0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile+ 0.1% 
formic acid); 150 x 2.0 mm, 5 J.Lm Gemini Cl8 HPLC column. 
224 
4.3.3.1 Degradation and calcula.tion of half lives 
The effect of irradiation on oxazepam concentrations in water and in the presence of 1 Jlg 
mL-1 humic acids in water are shown in Table 4.9. Photolysis samples were prepared as 
described in Chapter 6. Dark controls (abiotic) for the photolysis experiments were 
analysed in triplicate at the beginning and end of the experiment (0 and 96 hours 
respectively) and were found to be equivalent to the starting concentration in each case, 
indicating degradation was due to photolysis only. The decline in oxazepam concentration 
with increasing irradiation time for each experiment followed first order kinetics (described 
in Chapter 3, Section 3.4.2.1 ). The first order photodegradation rate constant kp were 
determined from the slope of the graph of Ln [CtfCo] vs irradiation time (Figure 4.31 ). 
The first order photodegradation rate constants (kp) were 0.0214 and 0.0105 hr-1 for 
oxazepam photolysis experiments without and with humic acids respectively. The half 
lives (t112) were calculated to be 32 and 66 hours for oxazepam photodegradation in pure 
water and with humic acids respectively. Interpretation of the data suggests that the rate of 
oxazepam photolysis is reduced in the presence of humic acids compared to pure water. 
This is reflected in a doubling the halflife (32 > 66 hours). 
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Table 4.9 
Time 
(hours) 
0 
24 
48 
72 
96 
Effect of irrailiation on photolysis of oxazepam in the absence and presence 
of I J.Lg mL-1 humic acids. 
Oxazepam in water Oxazepam in the presence 
of (1 11g mL-1) humic acids 
Average Average 
Concentration %of initial Concentration %of initial 
(llg mL·') (llg mL-1) 
0.98 100 1.00 100 
0.56 57 0.67 67 
0.33 34 0.60 60 
0.22 23 0.42 42 
0.12 12 0.3 1 3 1 
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Figure 4.31 Changes in concentration of oxazepam with increasing irradiation time in 
pure water ( • ) and river Trent humic acids ( •) Points indicate mean values; 
error bars represent ± cr, n =3. Abiotic control shown in circle (mean± cr, n 
=3). 
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4.3.3.2 Analysis of oxazepam degradation products 
Identification of oxazepam degradation products was achieved after prolonged irradiation 
of a 6 llg mL-1 starting concentration of oxazepam in distilled water. Figure 4.32 presents 
the LC-MS chromatograms for 0 to 96 hours irradiation for a solution of 6 11g mL-1 
oxazepam analysed. Seven degradation products were observed in the LC-MS 
chromatograms of the irradiated samples. These were labelled m, IV, X, XI, XII, XIIl, 
XIV respectively. Undegraded oxazepam was also present. No degradation products were 
detected in the dark controls. 
Having demonstrated the presence of degradation products following irradiation of 
oxazepam, m/z values corresponding to each of the observed degradation product peaks 
were extracted from the full scan data. The mlz values corresponding to each of these 
peaks are shown in Table 4.1 0. Figure 4.33 presents the extracted ion chromatograms for 0 
to 96 hours irradiation for a 6 J.lg mL-1 solution of oxazepam. In addition to the peaks 
corresponding to degradation products a small peak due to oxazepam was also observed. 
This was attributed to in-source fragmentation of oxazepam as observed in the full scan 
mass spectrum for irradiated oxazepam presented in Figure 4.34. 
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Figure 4.32 LCIESI-MS mass chromatograms (total ion chromatograms) of oxazepam 
photolysis over time by gradient elution ([Time/%A] 0/80-8/0-13/0-15/80; 
A = water + 0.1 % formic acid, B = acetonitrile + 0.1% formic acid); 150 x 
2.0 mm, 5 Jlm Gemini C18 HPLC column. 
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Table 4.10 Extracted ion mlz values (effective]y protonated molecular ions) 
corresponding to oxazepam degradation product peaks. 
Degradation product 
peak 
Ill 
IV 
X 
XI 
XII 
xm 
xrv 
Peak retention time 
(mln) 
8.89 
6.87 
5.95 
5.09 
8.45 
7.23 
3.53 
230 
mlz value 
232.2 
230.2 
257.2 
223.2 
241 .3 
271 .3 
273.3 
100 X 
80 
60 (A) 24 Hours 
40 
20 
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Figure 4.33 LC/ESI-MS mass chromatograms (extracted ion chromatograms; masses 
used are given in Table 4.1 0) of oxazepam photolysis over time by gradjent 
elution ([Time/%A] 0/80-8/0-13/0-15/80; A = water + 0.1% formic acid, B 
= acetorutrile + 0.1% formic acid); 150 x 2.0 mm, 5 J..Lm Gemini C18 HPLC 
column. 
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In order to identify the oxazepam degradation products, ESI-MS" spectra were obtained for 
each photoproduct derived from oxazepam at each sampling point. Based on molecular 
weight and molecular ion isotope contribution information, structures were postulated for 
each of the observed degradation products. These were supported by MS" daughter ion 
analysis of the molecular ions derived from each of these products and comparison with 
authentic compounds where available. The relationship between the photoproducts 
identified (Figure 4.42) was determined through a combination of (a) independent 
photolysis results (e.g. photolysis of Ill) and (b) the 'concentration-time' profiles plotted in 
Figures 4.43, and 4.44. 
Figure 4.34 compares the molecular ions observed in the ESI-MS full scan mass spectrum 
(m/z 150-350) derived from oxazepam, mlz 287.2 (Figure 4.34A) after irradiation in water 
for 96 hours and the ESI-MS full scan mass spectrum obtained from a l f.lg mL-1 oxazepam 
standard in water (Figure 4.34B). Both MS spectra were obtained under identical LC/ESI-
MS conditions. The LC retention times for irradiated oxazepam and an authentic 
oxazepam sample suggested that the compounds were identical (5.92 and 5.95 minutes 
respectively). Conclusive evidence was obtained from comparison ofthe ESI-MS full scan 
mass spectra, which were very similar. Both spectra showed a base ion at mlz 287.2 which 
corresponds to protonated oxazepam ([M+H]) and also a smaller ion at mlz 289.2. The 
ratio of these ions, 3:1 (m/z 287.2 to 289.2) are indicative of the presence of a single 
chlorine atom. The full scan mass spectra of the sample derived from irradiated oxazepam 
(Figure 4.34A) also contained minor ions at mlz 269.1 (23%) and mlz 241.3 (15%) which 
are attributed to in-source fragmentation of [M+Ht. 
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Figure 4.34 Comparison of the ESI-MS full scan mass spectrum (m/z 150-350) derived 
from oxazepam after irradiation in water for 96 hours (A) and a I 11g mL-1 
oxazepam standard in water (B). Gradient elution ([Time/%A] 0/80-8/0-
13/0-15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% formic 
acid); 150 x 2.0 mm, 5 Jlffi Gemini Cl 8 HPLC column. 
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Photoproducts DI and IV 
Identification of the degradation products m and IV was based on the LC/ESI-MS full 
scan spectra (m/z 150-350) obtained for each product peak derived from irradiated 
oxazepam samples. These are shown in Figure 4.35. Further structural information was 
given by the MS" daughter ion analyses for the molecular ions derived from each of the 
products, swnmarised in Table 4.12. The proposed structures for product peaks m and IV 
were 2-amino-5-chlorobenzophenone (ID) and 4-chloro-1 0-acridin-9-one (IV) 
respectively. Both products have already been identified as photoproducts of photolysis of 
nordiazepam in water (Section 4.3.1 .2). Identification was aided by reference to the 
LC/ESI-MS chromatograms and ESI-MS" fragmentation pathways found for the 
photoproducts of nordiazepam and comparison with an authentic sample of 2-amino-5-
chlorobenzophenone (lll), shown in Figure 4.35. 
A proposed scheme for the fonnation of photoproducts Ill and IV from photolysis of 
oxazepam in water is shown in Figure 4.37 
234 
100 
80 
60 
40 
20 
0 
100 
80 
60 
40 
20 -
0 
Oxazepam&X 
XIV 
XJ 
XIII 
XII 
61J.9 mL-1 oxazepam 
sample after 96 hours 
irradiation 
0 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
232.2 
(A) MS of Peak m 2-amino-5-chlorobenzophenone (ill) 
1!141 34.2 
272.7 
21 .I I·~· .... = •••••• 201.1 IU mo 2"1 3 243.3 21149 71 '-7 n.a 2800 2!18.1 3087 11u mt 3385 34U __ , 
230.3 
(B) MS ofPeak II 4-chloro-1 0-acridin-9-one (IV) 
+ 
THl I H 
232.3 Cl D?O 0 
0 
• 252.1 J 2563 296.8 3Q2.7 301.1 )117 lJOI 34lA 
241.3 1 I 2el.7 21111 2 llll . ~~~~1·'~111,~ lip,IJI,I,II~"'·j~jijjitr 
150 200 250 300 350 
m/z 
Figure 4.35 ESI full scan mass spectra (m/z 150-350) of products from photolysis of 
oxazepam (96 hours irradiation). 
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Table 4.11 MS spectra for ill and IV degradation products detected for photolysis of 
oxazepam in water. 
Compound mlz significant ions 
MS MS2 MS3 MS4 
Oxazepam 287.2 269. 1 241.3 206.5 
269. 1 
2-amino-5-chlorobenzophenone (TTI) 232. 1 154.1 126.0 
105.0 
4-chloro-1 0-acridin-9-one (IV) 230.3 195.4 
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Figure 4.36 Comparison of the LC/ESI-MS chromatograms of (A) 6 Jlg mL-1 oxazepam 
sample after 96 hours irradiation, (B) 1 1-lg mL-1 nordiazepam sample after 
192 hours irradiation and (C) authentic sample of I 1-lg mL-1 2-amino-5-
chlorobenzophenone (lll). Gradient elution ([Time/%A] 0/80-8/0-13/0-
15/80; A = water + 0.1% formic acid, B = acetonitrile + 0.1% formic acid); 
150 x 2.0 mm, 51-lffi C l8 Gemini HPLC column. 
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Figure 4.37 Proposed scheme for the fonnation of photoproducts Ill and IV from 
photolysis of oxazepam in water. 
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Photoproduct X 
Based on inspection of the full scan mass spectrum derived from the component labelled 
peak X, a 4-phenylquinazoline derivative, 6-chloro-4-phenyl-2(1H)-quinazolinone was 
proposed as degradation product X and is depicted in Figure 4.38. The full scan mass 
spectrum of product X (Figure 4.38A) showed a singly charged molecular ion at mlz 257.3 
which corresponds to protonated 6-chloro-4-phenyl-2(1H)-quinazolinone ([M+H]l. This 
base ion was 30 mass units lower than protonated oxazepam (mlz 287.3) and consistent 
with loss of -CH20. Inspection of the molecular ion isotope (m/z 259.4) indicated the 
presence of a single chlorine atom (3: 1; mlz 257 > 259). The daughter ion spectrum (MS2) 
derived from mlz 257.3 is shown in figure 4.388. The loss of phenyl was characterised by 
the ion at mlz 179.1 , which is 78 mass units smaller (m/z 257 > 179, [M-Ph]). 
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Figure 4.38 ESI full scan mass spectra (m/z 150-350) of degradation product X from 
photolysis of oxazepam (96 hours irradiation). 
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Photoproduct XI 
Based on inspection of the fuJI scan mass spectrum derived from the component labelled 
peak XI, 4-phenyl-2(1H)-quinazolinone was proposed as degradation product XI and is 
depicted in Figure 4.39. The full scan mass spectrum of product XI (Figure 4.39A) showed 
a singly charged molecuJar ion at mlz 223.3 which corresponds to protonated 4-phenyl-
2(1 H)-quinazolinone ([M+H]). Thls base ion was 35 mass units lower than protonated 6-
chloro-4-phenyl-2(1 H)-quinazolinone (m/z 257.3) and consistent with loss of -Cl. No 
molecular ion isotope was observed and is consistent with the loss of chlorine. The 
daughter ion spectrum (MS2) derived from mlz 223.3 is shown in Figure 4.398. The loss 
of phenyl was characterised by the ion at mlz 145.1, whlch is 78 mass units less. 
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Figure 4.39 ESI full scan mass spectra (m/z 150-350) of degradation product XI from 
photolysis of oxazepam (96 hours irradiation). 
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Photoproduct XII 
Based on inspection of the full scan mass spectrum derived from the component labelled 
peak XD, 6-chloro-4-phenylquinazoline was proposed as degradation product XII and is 
depicted in Figure 4.40. The full scan mass spectrum of product XD (Figure 4.40A) 
showed a singly charged molecular ion at mlz 241.3 which corresponds to protonated 6-
chloro-4-phenylquinazoline ([M+H]l. This base ion was 16 mass units lower than 
protonated 6-chJoro-4-phenyl-2(1 H)-quinazolinone (mlz 257.3) and consistent with 'loss' 
of -0 . Inspection of the molecular ion isotope (m/z 243.3) indicated the presence of a 
single chlorine atom (3:1; mlz 241 > 243). The daughter ion spectrum (MS2) derived from 
mlz 241.3 is shown in Figure 4.40B. The loss of phenyl was characterised by the ion at mlz 
163.1, which is 78 mass units less. 
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Figure 4.40 ESI full scan mass spectra (mlz 150-350) of degradation product XD from 
photolysis of oxazepam (96 hours irradiation). 
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Photoproducts XIll and XIV 
Based on inspection of the full scan mass spectrum derived from the components labelled 
peaks XITI and XIV, structures were proposed for the two degradation products (Figure 
4.41). The fuJI scan mass spectra for products XIII and XIV (Figure 4.41A and 4.41B) 
show singly charged molecular ions at mlz 271.2, and 273.2, respectively. These base ions 
are 16 and 14 mass units lower than protonated oxazepam (mlz 287.3) and are consistent 
with ' loss' of -0 and -CH2, respectively. Inspection of the relevant molecular ion isotopes 
(m/z 273.2 and 275.3) indicated the presence of single chlorine atoms in each compound. 
Both the daughter ion spectra (MS2) derived for the corresponding molecular ions (mlz 
271.2 and 273.2) are shown in Figure 4.4lC and 4.41D. Loss of water is characterised by 
the ions at mlz 253.2 and 255.2 respectively. 
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Figure 4.41 ESI full scan mass spectra (mlz 1 50-350) of degradation products XIll and 
XIV from photolysis of oxazepam (96 hours irradiation). 
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A scheme is proposed for the formation of the degradation products resulting from the 
photolysis of oxazepam (Figure 4.42) 
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Figure 4.42 Proposed scheme for the formation of oxazepam (6 rng mL-1 starting 
concentration) degradation products. 
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Based on the assignments presented, the proposed photodegradation products of oxazepam 
photolysis in water are shown in Table 4.13 
Table 4.13 Identification of oxazepam photoproducts 
Peak 
Oxazepam 
m 
IV 
X 
XI 
Molecular ion 
(M+1] 
287 
232 
230 
257 
223 
Structure 
Cl 
Cl 
Cl 
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Identification Methods 
• Reference Compound 
(Sigma-Aidrich) 
• LCIESI-MS" 
• Reference Compound 
(Sigma-Aidrich) 
• LC/ESI-MS" 
• Comeilson et al., (1978) 
• LC/ESI-MS" 
• LC/ESI-MS" 
• LC/ESI-MS" 
Table 4.13 continued 
Peak 
xn 
xm 
XJV 
Molecular ion 
[M+1] 
241 
271 
273 
Identification of oxazepam photoproducts 
Structure Identification Methods 
• LC/ESI-MS" 
• LC/ESI-MS" 
Cl 
• LC/ESI-MS" 
Cl 
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4.3.2.3 Calculations of the estimated concentrations of oxazepam 
pbotoproducts 
The concentration of oxazepam in water (starting concentration 1 f.lg mL-1) was measured 
by reference to the oxazepam calibration curve shown in Figure 4.30. Photoproduct lll 
and XII were measured by reference to the 2-amino-5-chlorobenzophenone (lli) 
calibration graph respectively (Chapter 3, Figure 3.25). 
Figure 4.43 shows the changes of concentration with irradiation time for oxazepam, 1 f.lg 
mL-1 starting concentration, and degradation products m, 2-arnino-5-chlorobenzophenone 
and XII, 6-chloro-4-phenylquinazoline, in water. Results are averaged concentrations from 
experiments conducted in triplicate (n=3). Since only a small recovery of photoproducts 
was determined for oxazepam at 1 f.lg mL-1 the peak area ratios of all the photoproducts 
detected at 6 f.lg mL-1 starting concentration are displayed in Figures 4.44 and 4.45. As 
authentic standards were not available for some of the compounds it was not possible to 
calculate the formation of these individual degradation products. Elucidation of the order 
of formation of the various photoproducts and their relationship to each other (Figure 4.42) 
was determined using a combination of (a) independent photolysis experiment results and 
(b) the 'concentration-time' profiles plotted in Figures 4.43 and 4.44. 
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4.4 Conclusions 
Simulation of solar irradiation has been successfully established using a calibrated 1.8 kW 
filtered xenon ]amp. Quantitative determination of the photodegradation of known human 
metabolites of diazepam viz: nordiazepam, temazepam and oxazepam, in aqueous solutions 
with and with out humic acids was made using the LC/ESI-MS method developed in 
Chapter 2 of the present study. The rate constants (kp) ranged from 0.036 to 0.0214 hr-1 in 
water (nordiazepam, temazepam and oxazepam respectively) and in humic acids were 
0.0096 to 0.0147 hr _,,respectively. The addition of humic acids was found to sensitise the 
photolysis of nordiazepam and therefore resulted in a faster rate of degradation. This same 
effect was observed for diazepam (Chapter 3, Section 3.6). However, for the hydroxylated 
metabolites temazepam and oxazepam, the opposite trend was observed; the presence of 
humic acids slowed the rate of photodegradation. Apparently, for the first time 
photodegradation in pure distilled water and also containing an environmentally relevant 
concentration of humic acids has been shown to be an important transformation mechanism 
for human metabolites of an important drug. 
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CHAPTER FIVE 
Modelling the impact of phototransformation on predicted environmental 
concentrations (PECs) of diazepam and its human metabolites in 
UK rivers 
This chapter describes the use of the computer modelling program GREAT-ER (Geo-
referenced Regional Exposure Assessment Tool for European Rivers) to evaluate the relative 
significance of phototransformation as a potential removal process for benzodiazepine PhACs 
in the rivers Exe and Aire, UK. The previously determined direct and indirect 
photodegradation kinetics for diazepam, nordiazepam, temazepam and oxazepam (Chapter 3 
and 4) were applied to the river catchment models. Maximum predicted environmental 
concentrations (PECs) were determined for each compound under low flow (summer) and 
mean flow (winter) conditions. 
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5.1 Introduction 
There is currently uncertainty surrounding the persistence of phannaceutically active 
compounds (PhACs) and their depletion mechanisms in natural surface waters such as rivers. 
Hence predictions of the fate of PhACs are often poor. Most PhACs of humans and other 
animals are released to surface waters via STWs, either as parent compounds or metabolites. 
During conventional wastewater treatment, biodegradation and adsorption to sludge are 
predominant mechanisms in removing PhACs from sewage effluents (Sedlak and Pinkston, 
200 I; Zwiener and Frimmel, 2003). In natural surface waters, whilst biodegradation may still 
be important (Sanderson et al., 2005), it is likely that abiotic processes, such as 
phototransformation may actually have a greater impact on reducing predicted concentrations 
of PhACs in the water phase. 
Recently there has been increased interest in the phototransformation of PhACs under 
environmentally relevant conditions (e.g. Lin and Reinhard, 2005; Lam and Mabury, 2005). 
Some PhACs have been found to degrade by phototransformation, with calculated half-lives in 
water ranging from minutes to hours (Andreozzi et al., 2003 Cunningham et al., 2004; Lui and 
Williams, 2007). This time scale is much shorter than the current persistence criteria of 40 
days (EMEA, 2005), thus suggesting the importance of studying phototransformation of 
PhACs in natural surface waters. 
River catchment models, such as GREAT-ER (Europe) and PhATE™ (US) have been 
developed recently and used for predicting the environmental concentrations of some 
pharmaceuticals (Schowanek and Webb, 2002; Cunningham et al., 2004; Robinson et al., 
2007). In the models, laboratory photodegradation kinetic data can be incorporated to evaluate 
the contribution of phototransformation as a reduction mechanism for PhACs in natural 
255 
surface waters. To date this has only been applied to propranolol (Robinson et al., 2007), 
ethinyl oestradiol, paracetamol, aspirin, dextropropoxyphene, clofibrate and oxytetracycline 
(Schowanek and Webb, 2002). 
The aim of the present investigation was to apply the phototransformation kinetic data for 
diazepam and each of the common human metabolites, determined in Chapters 3 and 4, to 
river catchment models using the computer model GREAT-ER. Two UK river catchments 
were selected, an urban/industrial river catchment (Aire-Calder, Yorkshire) and a rural river 
catchment (Exe, Devon). Maps for the Aire-Calder and Exe catchments are given in Figures 
5.1 and 5.2 respectively. Comparisons were made between predicted removals of the 
pharmaceuticals using direct and indirect photodegradation kinetic data determined in the 
current study. 
Figure 5.1 
• Discharge sites 
" River Netwofl( 
Huddersfield 
Aire-Calder river catchment map (adapted from GREAT-ER v2.0 software) 
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• Discharge sites 
River Network 
., .. 
Figure 5.2 River Exe catchment map (adapted from GREAT-ER v2.0 software) 
5.2 The GREAT-ER model for Aire and Exe river catchments in the UK 
The GREAT-ER (Geo-referenced Regional Exposure Assessment Tool for European Rivers) 
system was developed and validated by ECETOC (European Centre for Ecotoxicology of 
Chemicals), as an accurate aquatic chemical exposure prediction tool for use within 
environmental risk assessment schemes. Full experimental details for GREAT-ER and the 
river catchments used in the present study are given in Chapter 6. 
Unlike compartment screemng level models, GREAT-ER predicts concentrations over a 
spatially referenced domain (ECETOC, 1999). Both river catchments, Aire and Exe were 
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based on hydrological data for the catchments and Micro LOW FLOWS software (ECETOC, 
1999). In this study the GREAT-ER v2.0 software was used for all simulations but is simply 
referred to as GREAT-ER in the text. 
GREAT -ER contains a range of chemical fate models of differing complexities (Boeije, 1999; 
Boeije and Koonnann, 2003). These models incorpomte chemical loss in sewers, removal in 
STWs and the removal in the rivers. The model incorpomtes data on the populations served 
by each individual STW in the catchment to calculate the chemical load processed by each 
STW and the subsequent discharge to rivers. Since the interest of the present study was the 
removal of PhACs in the rivers, GREAT-ER was used in the highest complexity mode 
(complexity mode 3). This mode allows phototransfonnation and other degradation processes 
to be simulated explicitly by different sub-models, in contrast to combining all degmdation 
process (e.g. biodegradation, volatilisation) in a single overall reaction rate constant. 
5.3 Emission and degradation data for GREAT -ER simulations 
5.3.1 Estimated discharges of diazepam and its buman metabolites 
The estimated UK use of diazepam for 2004 was 1146.24 kg yr"1 (IMS Health, 2005), 
corresponding to an avemge consumption mte of 19.9 mg capita"1 annum·'. From human 
metabolism studies it is estimated that 30% of the diazepam dose taken by patients is excreted 
as the parent compound (Schwartz et al., 1965), which equates to 5.97 mg capita"' annum·' 
passing into STWs. Additionally, 12% of the dosage is excreted as nordiazepam (2.39 mg 
capita·' annum"1), 15% as temazepam (2.89 mg capita"1 annum"1) and 32% as oxazepam (6.43 
mg capita"' annum"1) respectively. The remaining 11% is unidentified to date. 
258 
5.3.2 Volatilisation 
For diazepam and each of its human metabolites: nordiazepam, temazepam and oxazepam, 
volatilisation was considered to be negligible due to their low vapour pressure and respective 
Henry's Law constants, and was therefore not modelled. 
5.3.3 Sorption 
The fate of various pharmaceuticals, including diazepam within STWs was the subject of an 
extensive modelling study conducted by the POSEIDON project team (Temes, 2004). They 
concluded that sorption was not a relevant process for the removal of diazepam (k.J <I 00 L kg 
SS"1). In light of these findings sorption of diazepam was considered to be negligible and 
therefore not modelled. 
5.3.4 Biodegradation and removal in STWs 
The fate of diazepam in sewage treatment plants is somewhat uncertain, mainly due to the 
variation of treatment practices in different countries and the variability in microbial 
populations. Loftler et al. (2005) recently investigated the biodegradation of pharmaceuticals, 
including diazepam in water and sediment samples. Samples were taken over I 00 days and 
the data were then used to generate dissipation times of up to one year. When radio-labelled 
diazepam samples were examined after 100 days, 95% of the radioactivity remained as 
diazepam. Therefore biodegradation was included in the modelling, with 5% removal of 
diazepam from influents. In the absence of specifically measured data for the metabolites the 
same level of removal (5%) was applied. 
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5.3.5 Phototransformation 
The laboratory-measured direct photolysis kinetics in water and indirect photolysis kinetics in 
aqueous solutions containing humic acids (1 flg mL-1) determined for diazepam, nordiazepam, 
temazepam and oxazepam in the current study (Chapters 3 and 4) are summarised in Table 5.1. 
At environmentally relevant concentrations (I flg mL"1, i.e. optically dilute solutions) and 
temperatures (25°C), the photodegradation data fit well to first order degradation kinetics with 
reaction rate constants between 0.0036 and 0.0251 h-1 and R2 between 0.9446 and 0.9989 
(Chapters 3 and 4). 
Table 5.1 Laboratory-measured direct and indirect photolysis kinetics of diazepam, 
nordiazepam, temazepam and oxazepam. 
Concentration Time Range Rate Constant Half life Compound Photolyels (f.L9 ml) (h) (h"'l (h) 
Diazepam Direct 1.0 0-218 0.0067 103 
Diazepam Indirect 1.0 0-96 0.0251 28 
Nordlazepam Direct 1.0 0. 192 0.0038 193 
Nordlazepam Indirect 1.0 0-98 0.0147 47 
Temazepam Direct 1.0 0-96 0.0194 38 
Temazepam Indirect 1.0 0·96 0.0096 72 
Oxazepam Direct 1.0 0-96 0.0214 32 
Oxazepam Indirect 1.0 0-96 0.0105 66 
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5.4 Results and Discussion 
5.4.1 Predicted environmental concentrations (PECs) for diazepam and buman 
metabolites in tbe Aire-Calder catchment (UK) from tbe GREAT -ER computer 
model 
Simulations were carried out to predict concentrations for diazepam and each of the human 
metabolites in the Aire-Calder catchment (an urban/industrial river catchment), with no 
phototransformation, direct phototransformation and indirect phototransformation under low 
flow and under mean flow conditions (equivalent to summer and winter river flows 
respectively). The results are shown in Figures 5.3 to 5.6. 
The maximum predicted environmental concentration (PEC) values determined for diazepam 
and each of its human metabolites are given in Table 5.2 and were highest under low flow 
conditions when phototransformation was not included. The maximum PEC value for 
diazepam was 39.5 ng L-1• This was comparable with the values measured in surface waters 
previously reported in the range 3.3 to 23.5 ng L- 1 (Calamari el al., 2003; Waggott, 1981; 
Temes, 1998; Zuccato el al., 2000). Removal rates for diazepam were greatest as a result of 
indirect phototransformation under low flow conditions ( 14% removal). This same trend was 
reflected for nordiazepam (7% removal). However, for the hydroxylated metabolites, 
temazepam and oxazepam, removal rates were greater under direct phototransformation low 
flow conditions; 12% and 10% removal respectively. 
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Maximlim .PE€ values. a:nd. <removal rates for diiiZepam :and ItS human 
mefubolitestin the,riverAire: using direct and indirect phototransforrnation data 
detenTiined in the CtiiTent study\( Chapter 31 and 4): 
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Figure 5.3 Predicted diazepam concentrations m nver Aire from GREAT-ER for 
simulations: (A) river Aire low flow and (B) river Aire mean flow. (No 
phototransformation ( • ), direct phototransformation ( •) and indirect 
photo transformation ( • ). 
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Figure 5.5 Predicted temazepam concentrations m nver Aire from GREAT -ER for 
simulations: (A) river Aire low flow, (B) river Aire mean flow (No 
phototransforma6on ( .& ), direct phototransformation (•) and indirect 
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Figure 5.6 Predicted oxazepam concentrations in river Aire from GREAT-ER for 
simulations: (A) river Aire low flow and (B) river Aire mean flow. (No 
phototransformation ( • ), direct phototransformation ( •) and indirect 
phototransformation ( • )). 
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5.4.2 PECs of diazepam and its buman metabolites in tbe river Exe (UK) from 
GREAT-ER 
Simulations were carried out to predict concentrations for diazepam and each of its human 
metabolites in the river Exe (a rural river catchment), with no phototransfonnation, direct 
phototransformation and indirect phototransformation under low flow and mean flow 
conditions (equivalent to summer and winter river flows respectively). The results are shown 
in Figures 5.7 to 5.10. 
The maximum PEC values determined for diazepam and each of its human metabolites in the 
river Exe are given in Table 5.3. The results show that the PECs were highest under low flow 
conditions when phototransfonnation was not included. Since the river Exe is a rural river 
catchment with a much smaller population the lower PEC values are to be expected when 
compared to the river Aire, a large urban/industrial catchment. 
Removal rates for the parent compound, diazepam were largest, as a result of indirect 
phototransformation under low flow conditions (34% removal). This same trend was reflected 
for the demethylated metabolite nordiazepam (31% removal). However the highest removals 
for hydroxylated metabolites, temazepam and oxazepam were found to occur as a result of 
direct phototransformation under low flow conditions, 33% and 37% respectively. 
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5.5 Conclusions 
The modelling predictions suggest that phototransformation may be an important process 
for removing diazepam and excreted human metabolites of diazepam from natural 
riverine and lacustrine environments. The impact of phototransformation on the removal 
of diazepam and its metabolites in two specific river systems is predicted to be greater 
under low flow rather than under mean flow conditions. This is proposed to be due to 
lower turbidity and increased residence time for the PhACs in the rivers. Thus, based on 
the modelling conducted herein, the best criteria for phototransformation as an effective 
removal process would be long, shallow rivers with low flow and low turbidity. 
The GREAT-ER model has been shown to be a useful tool for predicting the 
concentrations of specific pharmaceuticals in rivers and offers the ability to investigate 
the significance of different biotic and abiotic processes e.g. phototransformation on the 
removal of PhACs from natural waters (e.g. Schowanek and Webb, 2002; Robinson el 
al., 2007). The results presented herein demonstrate the potential impact of both direct 
and indirect photolysis on PEC values for diazepam and its human metabolites. 
Determination of indirect phototransformation rates have been shown to be essential for 
improving the models and PECs, provide data essential to developing more realistic 
environmental risk assessment of PhACs. Based on these simulations, the next steps in 
the risk assessment process would be to generate chronic aquatic toxicity data for each 
compound to allow calculation of PNEC (Predicted no-effect concentration) and 
subsequently PEC/PNEC ratios. 
273 
Experime_nta) Procedures 
This chapter describes the e~~rimenta] procedures.c<mducte<li and the a;nalysesmerforme<i 
asipart,ofthis sfudy 
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6.1 General Laboratory Procedures 
All glassware was acid washed in 10% Nitric Acid (overnight), rinsed thoroughly with 
distilled water (x 3), and oven dried (110 °C; overnight). Glassware was covered with 
aluminium foil during storage, and rinsed with distilled water (x 3) immediately prior to 
use. 
All laboratory and liquid chromatography solvents were HPLC gradient grade (Fisher 
Scientific, UK). Electrospray ionisation-mass spectrometry (ESI-MS0 ) solvents were 
Chromosolv® LC-MS grade (Reidel-de Haen, Sigma Aldrich, UK). Solvent purity was 
routinely monitored through analyses of blanks. 
6.1.1 Authentic Compounds 
Diazepam, nordiazepam, temazepam, oxazepam, oxazepam-d5, 5-chloro-2-
methylarninobenzophenone and 2-amino-5-chlorobenzophenone were purchased from 
Sigma-Aidrich, UK. 
6.1.2 Humic Aeids 
The humic acids used m this study were provided by Dr M Hayes, University of 
Birmingham following isolation from the river Trent (North East UK) using filtration, 
adsorption chromatography (XAD-8 and XAD-4 resin) and ion chromatography to purify 
and fractionate samples into humic, fulvic and hydrophilic acids (Watt et al., 1996). Since 
the structures of humic acids are unknown, they tend to be characterised by their elemental 
composition and aromatic content. The humic acids used in this study have been 
characterised previously in terms of carbon, nitrogen and oxygen content and degree of 
aromaticity (Zhou et al., 1994). 
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6.2 Instrument Details 
6.2.1 Electrospray Ionisation-Multistage Mass Spectrometry (ESI-MSj 
Mass spectrometry analysis was carried out using a Finnigan MAT LCQ TM 
(ThermoFinnigan San Jose, CA, USA) bench top mass spectrometer fitted with an 
electrospray interface. Data was acquired and processed with Xcalibur 1.0 spl software. 
General ESI-MSn conditions were: source voltage, (±) 4.5 kV; capillary voltage, (±) 0-50 
kV (auto tune function on ion of interest); capillary temperature, 200 °C; nitrogen sheath 
gas flow rate, 60 (arbitrary units). 
6.2.2 High Performance Liquid Chromatography (HPLC) 
High performance liquid chromatography (HPLC) was carried out using a P580A binary 
pump (Dionex-So:ftron GmbH, Germering, Germany). A 200 JJL min"1 flow rate was sent 
to the Finnigan MAT LCQTM mass spectrometer (ThermoFinnigan San Jose, CA, USA). 
6.3 Infusion Electrospray Ionisation-Multistage Mass Spectromctry (ESI-MS0 ) of 
authentic compounds. 
Mass spectrometry analysis was carried out using a Finnigan MAT LCQ™ 
(ThermoFinnigan San Jose, CA, USA) bench top mass spectrometer fitted with an 
electrospray interface. Data were acquired and processed with Xcalibur 1.0 spl software 
for the benzodiazepine samples with a full scan range of mlz 150-2000. Infusion of analyte 
solutions was carried out using a built in syringe pump with a Hamilton 1725N (250 JJL) 
syringe (Reno CA, USA). Instrument tuning and mass calibration were carried out and 
checked using the automatic calibration procedure (tuning and calibration solutions 
caffeine (Sigma-Aldrich, St. Louis, MO, USA) in water:methanol:forrnic acid (50:50: I, 
v/v/v)). Analytes were infused at 3 JJL min"1 (water:methanol:formic acid; 90:10: v/v), with 
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0.1% fonnic acid modifier added to promote protonation of benzodiazepines. Source 
voltage, (±) 4.5 kV; capillary voltage, (±) 0-50 kV (auto tune function on ion of interest); 
capillary temperature, 200 °C; nitrogen sheath gas flow rate, 60 (arbitrary units). Positive 
and negative ion ( +) MS" analysis of selected ions was perfonned in the ion trap by 
collision induced dissociation (CID) with helium damping gas. MS" ion isolation widths, 
relative activation amplitudes and activation Qs were optimised to obtain high response and 
stability of the base peak fragment ion. High-resolution ZoomScan TM (ZS) was recorded 
for all ions of interest. All spectral data was recorded and averaged over a one-minute 
acquisition time. 
6.3.1 Stock solutions of authentic compounds 
Stock solutions for all compounds (7 mg) were prepared by dissolution in methanol:water 
(50:50 v/v) and made up to 7 mL. Dilutions of the stock solutions were made using HPLC 
gradient grade water. 
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6.4 High Performance Liquid Chromatography/ Electrospray Ionisation-
Multistage Mass Spectrometry (HPLC/ESI-MS0 ) 
High performance liquid chromatography (HPLC) was carried out using a P580A binary 
pump (Dionex-Softron GmbH, Germering, Germany). A 200 IlL min-1 flow rate was sent 
to the mass spectrometer. HPLC columns investigated were an I 00 x 2.1 mm, 5 Jlffi 
HyperCarb HPLC column (ThermoQuest, USA), a 100 x 2.1 mm, 5 Jlffi Discovery HS Cl8 
HPLC column (Supleco®, UK) and a 150 x 2.0 mm, 5 mm Gemini Cl8 HPLC column 
(Phenomenex®, UK). For all three columns, the optimum solvent conditions were found 
to require a gradient mix of water (A) and acetonitrile (B), both containing formic acid 
(0.1 %). The gradient elution program is detailed in Table 6.1 and allowed good (i.e. 
separation in <15 min) retention and resolution of compounds and most degradation 
products with symmetrical peaks with low tailing. 
Table 6.1 HPLC Gradient Elution Program 
(A) (B) 
Time (mln) Aqueous phase Organic phase 
Water+ 0.1% formic acid Acetonitrile+ 0.1% formic acid 
0.00 80% 20% 
0.01 80% 20% 
8.00 0% 100% 
13.00 0% 100% 
15.00 80% 20% 
Mass spectrometry was carried out using a Finnigan MAT LCQ™ (Thermofinnigan San 
Jose, CA, USA) bench top mass spectrometer fitted with an electrospray interface. Data 
was acquired and processed with Xcalibur 1.0 spl software. General instrument parameters 
were as follows; source voltage +4.5 kV; capillary voltage, (±) 0-50 kV (auto tune function 
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on ion of interest); capillary temperature, 220 °C; nitrogen sheath gas flow rate, 60 
(arbitrary units); nitrogen auxiliary gas 20 (arbitrary units). Data dependent mass 
spectrometry acquisition is a function of the Xcalibur software that allows MS/MS 
experiments selecting the MS 1 base ion to be the MS2 precursor ion for the subsequent scan 
before returning back to MS 1• This function was used to gain MS2 for individual standards 
and degradation products (where possible) in distilled and humic acid containing waters. 
Extracted ion chromatograms (EIC) were extracted from the full scan; total ion 
chromatograms (TIC) selected to mlz 0.1 and an isolation width of mlz 1. 
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6.4.1 Calibration of Standards 
6.4.1.1 External calibration of diazepam 
A calibration standard of diazepam was prepared by serial dilution of a individual stock 
solution to give concentrations in the range O.OOI to I 0 J.Lg mL-1• LC conditions were as 
given in Table 6.1. Major ions for diazepam (m/z 285.3 and 287.3) were summed using 
selected mass chromatograms. The resulting peaks were integrated and the areas plotted 
against concentration to produce a calibration graph for diazepam. 
6.4.1.2 Internal standard calibrations for authentic compounds 
Individual calibrations solutions were prepared for diazepam, nordiazepam, temazepam, 
oxazepam, 5-chloro-2-methylaminobenzophenone and 2-amino-5-chlorobenzophenone, 
were prepared in triplicate (n=3) by serial dilution of individual stock solutions and spiked 
with I mg mL"1 oxazepam-d5 (Internal standard) to give concentrations in the range 0.1 to 2 
J.Lg mL-1• The HPLC conditions were as given in Table 6.I. Major ions for each compound 
were summed using extracted ion chromatograms. The resulting peak areas for each 
authentic compound against the peak area of the internal standard were integrated and the 
peak area ratio plotted against concentration. 
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6.5 Solid Phase Extraction of benzodiazepines 
Solid phase extraction was carried out using Strata™-X SPE cartridges (500mg polymeric 
sorbent x 3 mL, Phenomenex, Macclesfield, UK). A vacuum manifold extraction system 
(Isolute, International Sorbent Technology, Hengoed, UK) at a flow rate of approximately 
5 mL min-1 was used for elution. 
Mixed stocks of 1 flg mL"1 of diazepam, nordiazepam, temazepam, oxazepam, 5-chloro-2-
methylaminobenzophenone and 2-amino-5-chlorobenzophenone were prepared in triplicate 
in aqueous solution, spiked with I flg mL"1 oxazepam-d5 (internal standard) for each solid 
phase extraction experiment. 
6.5.1 Solid-phase extraction procedure for authentic compounds from aqueous 
solutions spiked with l 1-1g mL"1 humic acids. 
Strata-X extraction cartridges were conditioned and equilibrated using methanol (3 mL) 
followed by milliQ water (3 mL). Standard mixed stock solutions (200 mL; I flg mL"1) in 
water or river Trent humic acids were loaded onto the cartridges by positive pressure, at a 
flow rate of 3-5 mL rnin·'. The columns were washed with 50:50, methanol : rnilliQ water 
(2 x 3 mL). Compounds were eluted with either 6 mL of: methanol + 0.1% formic acid; 
acetonitrile+ 0.1% formic acid or methanol:acetonitrile (50: 50 v/v) + 0.1% formic acid and 
collected in 7 ml vials. Residual solvent was removed with a stream of nitrogen at 50°C. 
Residues were re-dissolved in 1 mL water:acetonitrile (80:20 v/v) before analysis by 
LC/ESI-MS as detailed in Section 6.4. Concentrations in the extracts were determined by 
comparison to the internal standard calibrations in the concentration range 0.1 to 2 flg mL"1• 
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6.6 Photodegradation Studies 
6.6.1 Exposure Apparatus 
Laboratory photodegradation studies experiments were conducted using a Suntest CPS 
xenon lamp manufactured by Hemeus Instruments GmbH, Germany. 
specifications are shown in Table 6.2. 
Table 6.2 Xenon lamp specifications 
SUNTEST CPS - Heraeus Instruments 
Irradiance: 
(maxmium, A.< 800 nm; 
without additional filters) 
Exposure area: 
Cooling air requirement: 
Dimensions: 
Height: 
Width: 
Depth: 
Weight: 
Voltage: 
Rating of machine: 
Rating of Xenon burner: 
Current consumption: 
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765 W/m2 
approx. 500 cm2 
800 square inch 
120 m3/h 
351 mm (13.8") 
780 mm (30.7") 
350 mm (13.8") 
approx. 28 Kg (61.7lb) 
208-240 V± I 0 %, 50/60 Hz 
2.1 KVA 
1.8 KW 
14.6 A 
The unit 
The chiller thermo circulator unit model 05/CTCHG was manufactured by Conair 
Churchill Ltd., Riverside Way Uxbridge, Middlesex, UK. The specifications of the chiller 
unit are given in Table 6.3. 
Table 6.3 Chiller unit specifications 
Chiller Thermocirculator- CON AIR Churchill 
Compressor nominal HP: 
Cooling capacity: 
Temperature range: 
Low standard temp. limit: 
Pump - max flow: 
Pump - max pressure: 
Pump- type: 
Dimensions: 
Height: 
Width: 
Depth: 
Weight: 
Connections: 
Electrical supply: 
(Model 05/CTC HG) 
0.5 
700 watt o·c 
-20 to +25 •c 
(below +5 •c using antifreeze) 
+ 5 c•c 
40Um (8.8 g/m) 
0/42 bar (6 psi) 
Gland less magnetic drive 
464 mm (18.25") 
380 mm (15") 
634 mm (25") 
59 Kg 
Hose tai12 x 16 mm 
220/240 V 50 Hz: I ph 6A 
Quartz tubes (25 cm long; 2 cm o.d.; i.d. 1.8 cm; 19/26 socket ground silica joint) and 
quartz stoppers were made by H. Baumbach & Co. Ltd., Ipswich, Suffolk, UK. Whilst the 
stainless steel tank used for holding the tubes under controlled temperature during 
irradiation, was kindly originally provided by the late Dr. John Leahey, Zeneca 
Argochemicals, Jeallots Hill, Bracknell, Berkshire, UK. 
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6.6.2 Measurement of the radiation intensity 
The radiation intensity of the xenon lamp incident on the reaction tubes was measured 
periodically (approximately every 4-6 months) at seven different locations on the sample 
trays, using a Spectroradiometer Model SR9910, manufactured by Macam Photometries 
Ltd, which integrated total energy between 240-800 nm. The radiation intensity of the 
lamp was measured at all radiation intensity settings of the instrument, rating from 
maximum setting (cal) to the lowest setting (1). These measurements were made to 
determine if the radiation was uniformly received across the sample tray. 
6.6.3 Direct photolysis experiments 
Each direct photolysis experiment used essentially the same apparatus and conditions, but 
differed by compound and exposure time. Table 6.4 details the various direct photolysis 
experiments conducted using the xenon lamp. For each compound investigated a standard 
solutions were prepared in distilled water. Aliquots (50 mL) were added to quartz 
photolysis tubes, placed in a cooling bath of glycerol which was water cooled to a constant 
temperature and irradiated using the Heraeus Suntest xenon lamp. Control samples were 
wrapped in foil. The temperature of the glycerol cooling bath was constantly monitored at 
the centre of the tank at mid depth glycerol using a data logger. 2 mL aliquots were 
removed at selected time intervals, transferred to 7 mL vials, covered with foil and stored 
refrigerated until required. The aliquots of each photolysed compound were spiked with 
internal standard (oxazepam-d5, 20 mL equivalent to I Jlg mL-1) and analysed by LC/ESI-
MS" using the method described in Section 6.4. Dark controls were analysed using the 
same procedures at the beginning and end of each experiment. 
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Table 6.4 Experimental parameters for direct photolysis experiments conducted 
using a xenon arc lamp. 
Compound Concentration sampling points Solution Temperature (l'llmL) rc1 
Dlazepnm 1" 0, 24, 48, 72, 96, 216 Distilled water 25±3 
6 0, 96,216 Distilled- 25!3 
Nodlazepam 1" 0, 24, 48. 72, 98, 144. 192 Distilled waler 25! 3 
6 0, 98, 192 Distilled wa1er 25!2 
Ternazepam 1" 0, 24, 48, 72, 96 Distilled- 25±2 
6 0, 48,98 Distilled- 26±3 
Oxazepam 1" 0, 24. 48, 72, 98 Dlsblled waler 24 ±4 
6 0, 48,98 Dlsblled waler 25±3 
5-chforo.2-melhylamln00enzophenone 1" 0, 24, 48, 72, 96, 144, 218 Olslilledwaler 25!3 
2-amln<>-5-chlorobenzopllenone 1" 0, 24, 48, 72, 120. 144 Dlslilledwaler 23!4 
* denotes that the samples were prepared in triplicate 
6.6.4 Indirect photolysis experiments 
Each indirect photolysis experiment used essentially the same apparatus and conditions, 
but differed by compound and exposure time. Table 6.5 details the various indirect 
photolysis experiments conducted using the xenon lamp. For each compound investigated 
a standard solutions were prepared in distilled water spiked with I mg mL'1 river Trent 
humic acids (Thurman, 1985). Aliquots (50 mL) were added to quartz photolysis tubes, 
placed in a cooling bath of glycerol which was water cooled to a constant temperature and 
irradiated using the Heraeus Suntest xenon lamp. Control samples were wrapped in foil. 
The temperature of the glycerol cooling bath was constantly monitored at the centre of the 
tank at mid depth glycerol using a data logger. 2 mL aliquots were removed at selected 
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time intervals, extracted using the SPE procedure detailed in Section 6.5.1, transferred to 7 
mL vials, covered with foil and stored refrigemted until required. Aliquots of each 
photolysed authentic compound were spiked with internal standard (oxazepam-d5, 20 mL 
equivalent to l J.Lg mL-1) and analysed by LCIESI-MS" using the method described in 
Section 6.4. Dark controls were analysed using the same procedures at the beginning and 
end of each experiment. 
Table 6.5 Experimental parameters for indirect photolysis experiments 
conducted using a xenon arc lamp. 
Compound Concentration Sampling point& Solution Temperature (flllmll ("Cl 
Diazepam 1" 0, 24, 48, 12, 96 Dislilled water 25!. 2 
+ 1 110 ml humic acids 
Nodiazepam 1" 0, 24. 48, 72, 96 Otstitled water 25.:!:2 
+ 1 pg ml tunic adds 
Temazepam 1" 0, 24, 48, 72, 96 Dls~lled wa1er 23.t4 
+ 1 pg ml humic acids 
Oxazepam 1" 0, 24, 48. 72. 96 Olsb-wa1er 26:!:2 
+ 1 pg ml humic acids 
• denotes that the samples were prepared in triplicate 
286 
6.7 The GREAT-ER model for Aire and Exe river catchments in the UK 
The GREAT-ER (Geo-referenced Regional Exposure Assessment Tool for European 
Rivers) system was developed and validated by ECETOC (European Centre for 
Ecotoxicology of Chemicals), as an accurate aquatic chemical exposure prediction tool for 
use within environmental risk assessment schemes. Copies of the software can be 
downloaded for free from the GREAT-ER website (http://www.great-er.org). 
The GREAT-ER system has been constructed in a modular way, as described in detail in 
Feijtel et al. (1997). Unlike compartment screening level models, GREAT-ER predicts 
concentrations over a spatially referenced domain (ECETOC, 1999). The GREAT -ER 
system combines several hydrological databases with hydrological models, providing river 
flow distributions, flow velocities and river characteristics for a variety of river catchments 
(in the UK, Germany, Italy, France and Spain). In this study the GREAT-ER v2.0 
software was used for all simulations but is simply referred to as GREAT -ER in the text. 
GREAT-ER contains a range of chemical fate models of differing complexities (Boeije, 
1999; Boeije and Koormann, 2003). These models incorporate chemical loss in sewers, 
removal in STWs and the removal in the rivers. Since the interest of this study was the 
removal of PhACs in the rivers, GREAT-ER was used in the highest complexity mode 
(complexity mode 3). This mode allows phototransformation and other degradation 
process to be simulated explicitly by different sub-models, in contrast to combining all 
degradation process (e.g. biodegradation, volatilisation) in a single overall reaction rate 
constant. 
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6.7.1 Aire/Calder catchment 
The Aire/Calder catchment is a large urban/industrial Yorkshire catchment (2057 km2) 
with 63 STWs serving the population of approximately 1.9 million inhabitants. The 
m~ority of STWs are trickling filter and the remaining STWs are activated sludge or a 
combination of the two (Keller et al., 2006; Robinson et al., 2007). The Aire/Calder 
catchment has been studied in great detail as the pilot catchment for GREAT-ER 
development. 
6.7.2 Exe catchment 
The Exe catchment encompasses an area of 1530 km2 and includes the city of Exeter. It 
drains diverse rural habitats ranging from the moorland of Exmoor National Park at the 
headwaters of the river Exe, to the Exe Estuary at Exmouth. 76 STWs are associated with 
the catchment, serving a population of approximately 320,000 inhabitants (Keller et al., 
2006). 
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Conclusionsiand !Suggestions!for'F.uture Wotik 
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7.1 Conclusions 
The primary aim of this study was to investigate the susceptibility of diazepam and its 
human metabolites to phototransformation in aqueous solutions. A novel analytical method 
was established for the extraction, chromatographic separation, detection and quantification 
of these chemicals and their degradation products in aqueous solutions. At the inception of 
the research, the application of electrospray ionisation mass spectrometry (ESI-MS) to the 
detection of pharmaceuticals in natural surface waters was an emerging technique that 
appeared to have attributes compatible with the detection of diazepam and its human 
metabolites. The use of a quadrupole ion trap (QIT) mass spectrometer capable of multi-
stage mass spectrometry {MS0 ) for detection of diazepam and its metabolites in aqueous 
solutions was investigated by ESI-MS0 • Using authentic compounds, a compatible liquid 
chromatography (LC) method and chromatographic phases were developed for the 
extraction, separation and quantitation of selected I ,4-benzodiazepines from aqueous 
solutions. The developed methods were applied to the study of photolysis of aqueous 
solutions as follows: 
Authentic diazepam, nordiazepam, temazepam and oxazepam compounds were examined 
by infusion ESI-MS0 (positive ion mode) on a QIT instrument (LCQ™, ThermoFinnigan). 
Full scan (MS) and collision induced dissociation (CID) multi-stage mass spectra (MS0 ) 
were obtained for each compound. Analysis of the spectra allowed identification of 
diazepam, nordiazepam, temazepam and oxazepam with up to four daughter ion fragments 
(MS4). CID-MS0 fragmentation pathways were determined for the compounds identified 
(Figures 2.6, 2.9, 2.12 and 2.15 respectively). The results showed that ESI-MS0 was a 
powerful technique for the identification and characterisation of selected 1,4-
benzodiazepines in aqueous solutions. The particular advantages of the ion trap multi-stage 
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ESI-MS" method were: the possibility of both positive and negative ion detection, the 
ability through the so called 'ZoomScan™' facility to determine the accurate mass 
differences between chlorine isotope ions, thereby allowing unambiguous identification of 
the selected compounds. 
Diazepam and its human metabolites were shown in Chapter 2, to be amiable to ESI-MS 
detection and MS" characterisation. As such, further investigation by liquid chromatography 
(LC) coupled with ESI-MS for their determination in photodegradation samples in aqueous 
matrices was undertaken. 
In conjunction with a HPLC/ESI-MS method developed in Chapter 2, a SPE method for the 
extraction of selected I ,4-benzodiazepines from humic acids containing aqueous solutions 
was developed. A sensitive, quantitative and specific method involving SPE, followed by 
HPLC/ESI-MS, was developed for the determination of diazepam and each of its human 
metabolites at low (I ~Jg mL"1) concentrations in humic acids solutions (71-78% recovery). 
Whilst the method requires further optimisation to recover all degradation products, it 
nonetheless represents a considerable improvement on previous techniques and should 
prove valuable for environmental fate studies for pharamaceuticals. 
The ESI-MS response of authentic compounds for diazepam and its metabolites compared 
to an internal standard (oxazepam-d5) were investigated for quantitation purposes. 
Calibration graphs of peak area ratios were determined in the concentration range 0.1 to 2 
f.Lg mL-1 and showed excellent linear response across the range of standards analysed, with 
R2 values ranging from 0.9992 to 0.9998. The calibration methods developed proved 
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invaluable for quantation of the individual compounds in photodegradation studies m 
aqueous matrices (Chapter 3 and 4). 
Simulation of solar irradiation methodology was successfully established using a calibrated 
high power filtered xenon lamp (504 W m-2). The elevation of temperature caused by heat 
from the xenon lamp was controlled using a high power chiller. Quantitative determination 
of the photodegradation of diazepam in aqueous solutions in the presence and absence of 
humic acids was achieved using the previously developed HPLCIESI-MS method (Chapter 
3). Photodegradation of the parent compound diazepam was found to follow first-order 
kinetics. The rate constants (kp) were 0.0067 and 0.0251 hr-I for experiments in the absence 
and presence of humic acids. Half-lives (tin) were calculated to be 103 and 28 hours 
respectively. The presence of humic acids isolated from the river Trent, were found to 
sensitise the photolysis of diazepam under the experimental conditions used herein. The 
photodegradation results for nordiazepam also exhibited the same trend with the presence of 
humic acids found to sensitise the degradation. The rate constants (kp) were determined to 
be 0.0036 and 0.0147 hr-I, respectively. The corresponding half lives (tin) were calculated 
to be 193 and 47 hours, respectively. In each case the presence of humic acids was found to 
double the rate of degradation. 
In contrast, photodegradation results determined for both the hydroxylated metabolites, 
temazepam and oxazepam suggested that the presence of humic acids led to a reduction in 
the rate ofphotodegradation (From tin 36 and 32 hours to tw 72 and 66 hours respectively). 
It is proposed that the observed reduction in the rate of photodegradation of temazepam and 
oxazepam could be due to intramolecular quenching of generated excited states (Drug*) by 
humic acids present in solution. Phenol groups are well known constituents of humic acid 
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compounds (Watt et al., 1996 and references therein) and these hydroxyl groups could 
potentially react with the hydroxyl group present in the 3-position of both ternazepam and 
oxazepam and inhibit their photodegradation. This is shown in Figure 7 .1. The overall 
results demonstrated that with photolysis half-lives ranging from 193-32 hours, diazepam 
and its human metabolites are unlikely to be persistent in natural waters. 
Cl 
OH ····-· -·----------- HOY:R 1 I ~ 
~ 2 R 
R3 
Humic Acid 
Temazepam: R = CH 3 
Oxazepam: R = H 
Figure 7.1 Proposed Humic Acid ' Quenching' of the excited states of the hydroxylated 
1, 4-benzodiazepines: Temazepam and Oxazepam. 
Another primary aim identified at the beginning of this study was the need to identify 
photoproducts in addition to photodegradation rates. This aim was successfully 
accomplished using the developed LCIESI-MS method described in Chapter 2. A range of 
photodegradation products derived from the photodegradation of diazepam and its 
metabolites in aqueous solutions (Chapter 3 and 4) are reported here for the fust time (Some 
previous studies were conducted in methanol at 80°C). Figure 7.2 shows the 
photodegradation products common to tbel ,4-benzodiazepines. 
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Using the kinetic data generated during the course of this investigation, modelling 
predictions have been made using the GREAT-ER model (Chapter 5). In addition to being 
a useful tool for predicting the concentrations of specific pharmaceuticals in rivers, the 
results presented herein suggest that phototransformation may be an important process for 
the removal of diazepam and excreted human metabolites from natural riverine 
environments. 
riY~~ (11) 
Cl~ 
0 
Temazepam I Diazepam 
Cl Cl Cl 
j 
Cl Cl Cl 
Nordiazepam Oxazepam 
Figure 7.2 Formation of common photoproducts in aqueous solutions of diazepam and 
its human metabolites. 
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7.2 Suggestions for Future Work 
The identities of a range of photodegradation products observed in aqueous solutions of 
photodegraded 1,4-benzodiazepines (Chapters 3 and 4) were proposed based on ESI-MS" 
data analysis and comparison with authentic compounds where available. Authentic 
compounds for the remaining photoproducts were not available and would be required for 
definitive structural confirmation. Potential synthetic routes for these degradation products 
could be investigated and where successful may assist in further optimisation of the solid 
phase extraction and chromatographic separation methods developed herein, enabling 
quantitation of these minor degradation products in environmental matrices. Further 
support for structures could also be achieved by the use of additional analytical techniques 
including NMR and IR spectroscopy, following the development of sample fractionation 
and preconcentration methods. 
The photoproducts identified in this study represent final photoproducts for each 1 ,4-
beozodiazepine under the experimental conditions employed. Further photolysis studies 
should be conducted over longer time periods to test the stability of all the degradation 
products identified herein (e.g. Temazepam products: VI, IX, 11, VII, and VIII shown in 
Chapter 4, Figure 4.26). Experiments presented in this study have revealed that 
photoproduct I (5-chloro-2-methylaminobenzophenone) is photodegraded to DJ (2-amino-
5-chlorobenzophenone) in aqueous solution. Evidence to support the instability of 
benzophenone derivatives exists in the literature e.g. it is well known that 3(mt*) 
benzophenone can engage in hydrogen abstraction reactions with hydrogen donors yielding 
radicals which can undergo further degradation (Calvert and Pitts, 1966; Turro, 1991 ). 
Therefore longer irradiation studies are required to determine the long term stability of all 
the photoproducts identified in this study. 
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Degassing experiments are recommended to be undertaken in order to identify the role of 
oxygen in the photodegradation of I ,4-benzodiazepines, since molecular oxygen diffuses 
rapidly into aqueous solutions and is known to be an efficient collision quencher (Calvert 
and Pitts, 1966). Molecular oxygen is a triplet in the ground state, and thus spin matched 
with triplet-excited photosensitisers (e.g. excited drug molecules). Singlet molecular 
oxygen ('Ch) is easily fonned by electronic energy transfer from excited triplet 
photosensitisers to ground state oxygen with a subsequent regeneration of the 
photosensitiser (Turro, 1991 ). Three suitable methods for the de-oxygenation of reagent 
solutions should be investigated: (i) Bubbling of reagent with an inert gas (e.g. N2); (ii) 
Trap-to-trap distillation and (iii) the Freeze-thaw method (Calvert and Pitts, 1966). 
Comparison studies could then be made between photolysis studies conducted in the 
presence and absence of oxygen which may yield valuable data regarding the mechanisms 
of photodegradation of I ,4-benzodiazepines. 
Several transient intermediates have previously been determined for pharmaceuticals in 
aqueous solutions using laser flash photolysis experiments (Cosa and Scaiano, 2004 and 
references therein). One particular drug, ketoprofen (Martinez and Scaiano, 1997 and Cosa 
et al., 1999) contained a benzophenone chromophore, which is also present in several 
photoproducts identified during this study. Therefore laser flash photolysis studies are 
proposed to focus on the identification of photochemical intermediates for I ,4-
benzodiazepines. 
From the work reported here humic acids have been observed to effect the rate of 
photodegradation, either by absorbing energy which might otherwise energise the test 
compounds to cause degradation (in the cases of temazepam and oxazepam), or by 
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sensitising the photodegradation reaction to encourage a faster rate (observed in diazepam 
and nordiazepam experiments). However, humic acids are only one part of a wider fraction 
referred to as humic substances and including fulvic acids and hydrophilic acids. 
Investigations of the effect of these various fractions on the photodegradation of PhACs 
may provide further insight into the mechanisms of degradation. Additionally, further 
research including a broader range of origins and varying concentrations of characterised 
hwnic acids is required to better understand their role in the photolysis of I ,4-
benzodiazepines. 
A recent review by Crane et al. (2006) highlighted the scarcity of relevant ecotoxicity data 
for PhACs, leading to large knowledge gaps regarding the risks that PhACs pose to the 
environment. Therefore, the PhACs and identified photoproducts, especially those where 
authentic compounds are available, or can by easily synthesised, require toxicity studies to 
be completed. Such results could then be incorporated into environmental risk assessments 
and comparisons of toxicity with the starting compounds could be made. 
In order to test the modelling predictions given in Chapter 5, monitoring studies should be 
conducted to measure the concentrations of diazepam and its metabolites; nordiazepam, 
temazepam and oxazepam, in UK rivers. To allow a straight comparison with the GREAT-
ER model to be made, concentration measurements need to be taken from the two rivers 
used in the modelling calculations, namely the rivers Aire and Ex, respectively. Also, to 
date, no monitoring studies have focussed on the photodegradation products reported for 
any of the PhACs investigated. Therefore any such study would be unique and represent a 
significant advance in this emerging area of research. 
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Additionally, the computer modelling program package could be used to evaluate the 
relative significance of phototransfonnation as a potential removal process for 
benzodiazepine PhACs in other European countries and comparisons with the UK river 
data, established herein, be achieved. The phototransfonnation kinetics detennined in the 
present study for the photoproducts; 5-chloro-2-methylaminobenzophenone (I) and 2-
amino-5-chlorobenzophenone (Ill) could be modelled using GREAT-ER to determine 
maximum predicted environmental concentrations (PEC). 
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Appendix A1 
TABLE A.1- OCCURRENCE OF PHARMACEUTICALS IN THE ENVIRONMENT 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Acetaminophen Analgesic/anti-inflammatory Tylenol 103-90-2 6.0 1-lg l "1 Max. SlW effluents Ternes (1998) 
Acetylsalicylic acid Analgesic/anti-inflammatory Aspirin 50-78-1 
- 1 1-19 l "1 SlW effluents Richardson & Bowron 
(1985) 
1.51 1-19 l "1 Sedimentation tank Stumpf et al., (1999) 
0.16-0.34 1-lg l "1 Rivers & streams Ternes (1998) 
0.22-1 .5 1-lg l "1 SlW effluents Ternes (1998) 
w 
00 Atenolol Beta-blocker Tenormin 29122-08-7 0.049-0.242 1-lg l "1 River water Zuccato et al., (2000) 
Bezafibrate lipid regulator Befizal 41859-07-0 1.2 mg l "1 Max. Influent Stumpf et al., (1999) 
4.61-Lg l "1 Max. SlW effluent Ternes (1 998) 
3.1 1-19 l "1 Max. Surface water Ternes (1 998) 
0-0.38 1-lg l "1 Surface water Stumpf et al., (1996) 
0.19 1-19 l "1 Surface water Stumpf et al., (1 999) 
0.027 ~-Lg l "1 Potable water Stumpf et al., ( 1996) 
0.015-0.202 1-19 l "1 River water Zuccato et al., (2000) 
Betaxolol Beta-blocker Betoptic 63659-18-7 0.191-lg l "1 Max. SlW effluent Ternes (1 998) 
0 .028 ~-Lg l "1 Max. Surface water Hlrsch et al., (1996) 
Bleomycin Anti-neoplastic B lenoxane 11056-06-7 0.01 1-0.019 1-lg l "1 SlW effluent Aheme et al., (1 990) 
0.005-0.017 1-19 l "1 River water Aherne et al., ( 1990) 
0.005-0.013 1-lg l "1 Potable water Aherne et a/., (1990) 
CONT ... 
Phannaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Bisoprolol Beta-blocker Zebeta 66722-44-9 0-0.37 1-19 l "1 S1W effluent Hirsch et al., (1996) 
0. 37~-LQ l "1 Max. S1W effluent Ternes (1 998) 
0-0.24 1-19 l "1 Surface water Hirsch eta/., (1 996) 
2.9 1-19 l ., Max. Surface water Ternes (1 998) 
Carazolol Beta-blocker 57775-29-8 0.12 i-!9 L"' Max. S1W effluent Ternes (1 998) 
0-0.24 i-!9 L·' Surface water Hirsch et 81., (1996) 
0.11 i-!9 L"' Max. Surface water Ternes (1998) 
Carbamazepine Anti-epileptic Tegretol 298-46-4 0.87-12 1-19 l "1 S1Weffluent Andreozzi et al., (2003) 
w 2.1-6.3 i-!9 l "1 S1W effluent Ternes (1998) 
\0 0.25-1.1 1-19 l "1 Rivers & streams Ternes (1998) 
1. 78 1-!9 l "1 S1W influent Herberer et al., (2002) 
1.631J.9 L"' S1W effluent Herberer et 81., (2002) 
0.25 1J.Q l "1 Surface water Herberer et 81., (2002) 
Chloramphenicol Antibiotic Chloromycetin 57-75-7 0. 56~-LQ l "1 Max. S1W effluent Hirsch et 81., (1999) 
0.06 i-!9 L"' Surface water Hirsch et al., ( 1999) 
Cimetidine Histamine Hrreceptor Tagamet 51481-61-9 0.54 1-!9 l ' 1 Max. Stream water Kolpin et al., (2002) 
antagonist 
0.074 1-19 l '1 Med. Stream water Kolpin et al., (2002) 
Clarithromycin Antibiotic Biaxin 81103-11 -9 0.24 i-!9 l ' 1 Max. S1W effluent Hirsch et al., (1999) 
0.26 i-!9 L"' Surface water Hirsch et al. , (1999) 
Clenbuterol B2-Sympathomimetic Spiropent 37148-27-9 0-0.180 i-!9 l "1 Max. S1W effluent Hirsch et 81. , (1999) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Clofibrate Lipid regulator Bioscleran 637-07-0 
-0.040 J.l9 L'1 River water Richardson & Bowron 
(1985) 
Clofibric acid Lipid regulator metabolite 882-09-7 0.36-1.6 J.l9 L'1 STW effluent Ternes (1998) 
0.066-0.55 J.l9 L'1 Rivers & streams Ternes (1998) 
0.0078 J.lg L'1 North Sea Buser et al., ( 1998) 
0.68 J.l9 L'1 STW effluents Andreozzi et al., (2003) 
0-0.220 J.lQ L'1 River water Europe Herberer et al., (1 995) 
0-0.27 J.lg L'1 Tap water Herberer et al., (1 998) 
0.07-7.3 J.l9 L'1 Ground water Herberer et al., (1997) 
w 0-0.90 J.lg L'1 Surface water Stumpf et al., ( 1996) 
N 
0 0-0.07 J.lg L'1 Potable water Stumpf et al., ( 1996) 
0.01-0.165 J.l9 L'1 Potable water Stan et al., (1994) 
0.27 J.lg L'1 Potable water Herberer et al., (1997) 
0-0.0053 J.l9 L'1 Potable water Zuccato et al., (2000) 
0-0.0013 J.l9 L'1 North Sea Weigel et al., (2002) 
0.8 - 2.0 J.lg L'1 STW effluent Garrison et al., (1 975) 
Cyclophosphamide Anti-neoplastic Cytoxan 50-18-0 0.018-0.020 J.l9 L' 1 STW effluent Temes (1 998) 
0.146 J.lg L' 1 Hospital sewage Steger-Hartmann et al., 
(1 996) 
0.019-4.5 J.l9 L'1 Hospital sewage Steger-Hartmann et al. , 
(1 997) 
0.008-0.143 J.l9 L'1 STW effluent Kummerer et al., (1997) 
0-0.010 J.l9 L' 1 River water Zuccato et al., (2000) 
CONT ... 
Phannaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Diazepam Psychiatric drug Valium 439-14-5 0.03·0.04 J.!g L'' STW effluent Ternes (1998) 
- 1 J.!g L·' STW effluent Waggott (1981) 
- 0.010 J.!g L·' River water Waggott (1981) 
-0.010 J.!g L'' Potable water Waggott (1981) 
0-0.002 J.!g L'' River water Calamari et 81. , (2003) 
0-0.0012 J.!g L'1 River water Zuccato et 8/., (2000) 
0.019-0.023 J.!g L'1 Potable water Zuccato et 81., (2000) 
Diclofenac Analgesic Voltaren 15307-86-5 3.02 J.!9 L'' STW influent Herberer et 81., (2002) 
w 2.51 J.!g L·' STW effluent Herberer et 8/., (2002) 
N 0.015-0.489 J.!g L'1 River water Stumpf et 81., (1999) 
0.15-1.2 J.!g l'1 Rivers & streams Tames (1998) 
0.81-2.1 J.!g L'' STW effluent Ternes (1998) 
0.68-5.45 J.!g L'1 STW effluent Andreozzi et 8/., (2003) 
0-0.37 J.!g L'' Surface water Buser et 81., (1998a) 
0-0.38 J.!g L'' Groundwater Herberer et 81., (1997) 
0.006 J.lg L'1 Max. Potable water Stumpf et 8/., (1996) 
0.006.2 J.!g l ' 1 Max. Estuary Weigel et 81., (2002) 
Dlmethylaminophenazone Analgesic Piridol 58-15-1 1.0 J.!9 L'1 Max. STW effluent Ternes (1998) 
0.34 J.!g L'' Max. Surface waters Temes (1998) 
Erythromycin Antibiotic llosone 114-07-8 0-0.0174 )lg L'1 River water Zuccato et 8/., (2000) 
Estradiol Hormone 50-28-2 0.01 J.!g L'1 STWinfluent Buchet et 8/., (2002) 
0.003 J.!g L-1 STW effluent Buchet et 8/., (2002) 
0.16 J.!g L' ' Median. River water Kolpin et 8/., (2002) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
17a Ethinylestradiol Hormone Oradiol 57-85-2 0.2 J.i9 L.1 Surface water Kalbfus (1995) 
0.002-0.015 J.i9 L"1 River water Aherne & Briggs (1989) 
0.001-0.003 J.i9 L.1 Reservoir Aheme & Briggs (1 989) 
-0.004 J.i9 L.1 Potable water Aherne & Briggs (1 989) 
0.0064 J.i9 L"1 Potable water Rurainski et al., (1977) 
Fenofibrate Lipid regulator Lipo-Merz 49562-28-9 0-0.1 J.i9 L"1 Max. STW effluent Ternes (1998) 
0.03 J.ig L"1 Surface water Stan et al., ( 1997) 
0-0.045 J.ig L"1 Groundwater Herberer et al., (1997) 
w 
N Fenofibric acid Lipid regulator metabolite 42017-89-0 1.2 J.i9 L.1 Max. STW effluent Ternes (1998) N 
0.68 J.i9 L.1 Max. STW effluent Stan et al., (1997) 
0.4 J.ig L.1 Max. Influent Stumpf et al., (1999) 
0-0.17 J.ig L.1 Surface water Stumpf et al., (1996) 
0.28 J.i9 L.1 Max. Surface waters Ternes (1 998) 
0.03-0.35 J.i9 L.1 Surface water Stumpf et al., (1 999) 
Fenoterol 82-Sympathomimetic Airum 13392-18-2 0.07 J.ig L.1 STW effluent Hirsch et al., 1999 
0.06 J.i9 L.1 Max. STW effluent Ternes (1 998) 
Fluoxetine Antidepressant (SS RI) Prozac 54910-89-3 0.012 J.ig L.1 River water Kolpin et al., (2002) 
Furosemide Diuretic 0-0.088 J.i9 L.1 River water Zuccato et al., (2000) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Gemfibrozil Lipid regulator Lop id 25812-30-0 1.32 1-19 L' 1 Max. STW effluent Stan et al., (1997) 
0-1 .46 ).lg L'1 STW effluent Stumpf et al., (1 996) 
1.5 J.lg L'1 Max. STW effluent Ternes (1998) 
0.95 J.lg L'1 Max. STW effluent Stumpf et al., (1 999) 
0.51 1-19 L'1 Max. Surface waters Ternes (1 998) 
0.25 Jlg L'1 Max. Surface waters Stumpf et al., (1998) 
Gentisic acid Aspirin metabolite 490-79-9 0.59 J.lg L'1 Max. STW effluent Ternes (1998) 
0.111-19 L'1 Median Surface Ternes (1 998) 
w 
waters 
N 
w lbuprofen Analgesic/anti-inflammatory Advil 15687-27-1 3.35 J.lg L'1 Stumpf et al., (1 996) Sedimentation tank 
0.006-0.041 ).lg L'1 River water Stumpf et al., (1996) 
0.07-0.53 J.lg L' 1 Rivers & streams Ternes (1998) 
0.37-3.4 1-19 L'1 STW effluent Ternes (1998) 
0.19J.lgL'1 Surface water Stumpf et al., (1 999) 
0-0.20 J.lg L'1 Groundwater Herberer et al., (1997) 
0.003 J.lg L'1 Max. Potable water Stumpf et al., (1996) 
0.001-0.092 J.lg L'1 River water Zuccato et al., (2000) 
0.0006 J.lg L'1 Max. Estuary Weigel et al., (2002) 
Ifosfamide Anti-neoplastic Mitoxana 3778-73-2 2.9 ).lg L'1 Max. STW effluent Ternes (1998) 
1.91 Jlg L'1 Hospital effluent Kummerer et al., (1 997) 
0.043 J.lg L-1 STW effluent Kummerer et al., (1997) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
lndomethacine Anti-inflammatory Am uno 53-86-1 0.029 1-19 L.1 STW effluent Stan et al., ( 1997) 
0-0.52 1!9 L.1 STW effluent Stumpf et al., (1 996) 
0.60 J.L9 L-1 Max. STW effluent Ternes (1 998) 
1.0 1-19 L"1 Max. STW effluent Stumpf et al., ( 1999) 
0-0.12 J.19 L"1 Surface water Stumpfeta/., (1996) 
0.2 1J.9 L.1 Max. Surface waters Ternes (1998) 
Ketoprofen Anti-inflammatory Oruvail 22071-15-4 0.20-0.38 1-19 L-1 STW effluents Ternes (1998) 
0.1 2 1-19 L-1 Max. Rivers & streams Ternes (1998) 
\....) 0-0.065 J.L9 L"1 Surface waters Herberer et al., (2002) N 
~ 0.5 J.L9 L"1 STW influent Stumpf et al., (1999) 
0.21 1-19 L"1 Max. Surface waters Stumpf et al., (1999) 
Lincomycin Antibiotic Lincocin 7179-49-9 0-0.0138 J.L9 L-1 River water Zuccato et al., (2000) 
Menstranol Hormone Hormone 72-33-3 0.004 1-19 L.1 STW influent Ternes et al., (1999a) 
Metoprolol Beta-blocker Lopressor 37350-58-6 0.73-2.21-19 L-1 STW effluents Hirsch et al., (1999) 
0.45-2.2 1-19 L-1 Surface waters Ternes (1998) 
0.003-1 .54 1-19 L"1 Surface waters Stan et al., (1997) 
Metformin Anti-hyperglycemic Glucophage 1115-70-3 0.151-lQ L_, Max. Stream waters Kolpin et al., (2002) 
0.11 1-19 L"1 Median. Stream Kolpin et al., (2002) 
waters 
Nadolol Beta-blocker Corgard 42200-33-9 0-0.29 1-19 L-1 STW effluents Hirsch eta/., (1996) 
0.0091J.Q L-1 Surface waters Hlrsch et al., ( 1996) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Naproxen Analgesic Naprosyn 22204-53-1 0-0.095 !!g L'1 Surface waters Herberer et si., (2002) 
0.063-0.1 06 1-1g L'1 STW effluents Boyd et si., (2003) 
0.037-0.039 l!g L' 1 River waters Boyd et si., (2003) 
0.022-0.107 1-1g L'1 Lake waters Boyd et si., (2003) 
0.010-0.020 1-1g L'1 Groundwater Drewes et al., (2002) 
0.61!Q L'1 STW effluents Daughton & Ternes (1999) 
0.020 1-1g L' 1 Median. Surface water Stumpf et al., (1 999) 
Phenazone Analgesic Parodyne 60-80-0 0.41 1-1g L'1 Max. STW efflunet Ternes (1 998) 
w 0.151-lg L'1 Surface waters Ternes (1 998) 
N 0-1.25 1-1g L.1 Groundwater Herberer et al., ( 1997) V1 
Propanolol Beta-blocker Avlocardyl 525-66-6 0.17-0.291-lg L'1 STW effluent Ternes (1998) 
0.012-0.59 1-1g L'1 Rivers & Streams Ternes (1998) 
0.01-0.09 1-19 L'1 STW effluent Andreozzl et al., (2003) 
0-0.098 1-1g L'1 Surface water Hirsch et al., (1996) 
Propylphenazone Analgesic lsoprochin 479-92-5 1.9 1-19 L'1 Max. STW efflunet Herberer et al., ( 1998) 
0-0.35 1-1g L'1 Surface water Herberer et al., (1 998) 
0-1 .46 1-1g L.1 Groundwater Herberer et al., (1997) 
Roxithromycin Antibiotic Rulid 80214-83-1 1.0 1-19 L'1 Max. STW efflunet Hirsch et al., (1999) 
0.561-lg L' 1 Surface water Hirsch et al. , (1999) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Ranitidine Histamine Hrreceptor Zantac 66357-35-5 0.01 IJ-9 L., Max. Stream water Kolpin et al., (2002) 
antagonist 
0.0094 IJ-9 L., River Water Zuccato et al., (2000) 
0.00039 IJ-9 L., Rivers Calamari et al., (2003) 
0-0.0017 !J-9 L.1 Potable water Zuccato et al., (2000) 
Salbutamol 82-Sympathomimetic Ventolin 18559-94-9 0.171J.Q L.1 Max. Influent Ternes (1998) 
0.035 ~J-9 L.1 Max. Surface waters Ternes (1998) 
0-0.0046 IJ-9 L., River water Zuccato et al., (2000) 
w Salicylic acid Aspirin metabolite 69-72-7 0.1 4 1J.Q L., Max. STW effluent Temes (1 998) N 
0\ 0.60 ~J-9 L., Max. STW effluent Hi9nite & Azarnoff (1 977) 
0.13-4.1 ~J-9 L.1 Surface water Ternes (1 998) 
0-0.068 ~J-9 L.1 River water Zuccato et al., (2000) 
Sulphamethazine Antibiotic 57-68-1 0.161J.Q L.1 Groundwater Hirsch et al., (1999) 
Sulphamethoxazole Antibiotic Gantanol 723-46-6 2.0 !J-9 L.1 Max. STW effluent Hirsch et al., (1 999) 
- 1.0 IJ-9 L.1 Surface water Watts et al., (1 983) 
0.481J.Q L.1 Max. Surface water Hirsch et al., (1 999) 
0.47 ~J-9 L.1 Groundwater Hirsch et al., (1 999) 
Terbutaline 82-Sympathomimetic Bricanyl 0-0.121J.9 L.1 STW effluent Hirsch et al., (1996) 
0.009 1J.Q L.1 Surface water Hirsch et al., (1996) 
Tetracycline Antibiotic Achromycin 60-54-8 -1 .0 1J.9 L., Surface water Watts eta/., (1 983) 
CONT ... 
Pharmaceutical Therapeutic Use Brand name CAS Number Environmental occurrence References 
Concentration Matrix 
Timolol Beta-blocker Betimol 26839-75-8 0-0.07 ll9 L-1 STW effluent Hirsch et al., (1996) 
0.07 ll9 L-1 Max. STW effluent Ternes (1 998) 
0-0.01 ll9 L'1 Surface water Hirsch et al., (1 996) 
0-0.01 ll9 L'1 Surface water Ternes (1 998) 
Triclosan Antiseptic lrgasan DP 300 3380-34-5 2.3 J.!Q L'1 Max. Stream Kolpin et al., (2002) 
Trimethoprim Antibiotic Proloprim 738-70-5 0.20 ll9 L'1 Surface water Hirsch et al., (1999) 
w 
N 
--...l 
Appendix A2 
TABLE A.2 - SELECTION DATA FOR PHARMACEUTICALS 
Compound Usage Toxicity data Occurance Biodegradation Photodegradatlon Metabolltes Removal In STW 
Acetaminophen 403.11 tons (in 2000) a yes yes ' yes m no data acetaminophen 99% Activated sludge STWb 
glucuronide 
acetaminophen sulphate 
Acetylsalicylic 78.57 tons (In 2000) a yes 0 yes ' yes m no data salicyluronic acid 81 % Activated sludge STW • 
acid salicyl-o-glucuronide 
salicyl ester glucuronide 
w Bleomycin no data no data no data no data no data not known no data N 
00 
Captopril 2.69 tons (in 2000) • yes h no data not readily biodegradable no data captopril dimer no data 
conjugates 
Carbamazepine 40.35 tons (in 2000) • yes h yes' no data yes ' 32 known metabolites e.g. 7% Activated sludge STW • 
Carbamazepine-1 0-11-
oxide 
Chrysin no data no data no data no data no data not known no data 
Cimetidlne 35.64 tons (in 2000) • no data yes 1 no data yes 1 hydroxymethyl cimetidine no data 
Clofibric acid no data yes 1 yes 1 not readily biodegradable rr yes 1 this is a metabolite 51% Activated s ludge STW • 
15% Biological filter STW 0 
Clotrimazole no data no data no data no data no data not known no data 
CONT ... 
Compound Usage Toxicity data Occurance Biodegradation Photodegradation Metabolites Removal In SlW 
Cyclophosphamide no data no data yes 1 not readily biodegradable no data 4-ketocyctophosphamide Negligable 
carboxyphosphamide 
acrolein 
phosphamide mustard 
Diazepam 1146.24 kg yr"1 yes l yes 1 not readily biodegradable Expected Nordiazepam 5% maximum " 
Temazepam 
Oxazepam 
Diclofenac 26.11 tons (in 2000) • no data yes 1 no data yes 1 diclofenac glucuronide 75% Activated sludge STW d 
w 
9% Biological filter STW d 
N 
\0 
Enatapril no data no data no data no data no data Enalaprilat no data 
(17~-) Estradiol no data no data yes 1 no data no data not known no data 
Ethinyl estradiol no data yes 1 yes 1 no data no data not known 78% Activated sludge STW • 
64% Biological filter STW • 
Fadrozole no data no data no data no data no data not known no data 
Flutamide no data no data no data no data no data not known no data 
Fluoxetine 2.83 tons (in 2000) • yes k yes 1 no data no data • Norfluoxetine no data 
tbuprofen 162.91 tons (in 2000) • yes L yes 1 yes m yes 1 2-hydroxy-ibuprofen 90% Activated sludge STW c 
ibuprofen glucuronide 22% Biological fitter STW d 
CONT ... 
Compound Usage Toxicity data Occurance Biodegradation Photodegradatlon Metabolltes Removal In STW 
Ketoconazole no data no data no data not readily biodegradable no data not known no data 
Lovastatln no data yes h no data no data no data betahydroxy acid no data 
6-hydroxy metabolite 
Metoprolol 2.63 tons (in 2000) • yes h yes ' no data no data alpha-hydroxymetoprolol 83% Activated sludge STW c 
Metformin 205.79 tons (in 2000) • yes h yes ' no data no data none no data 
Mevastatin no data no data no data no data no data none no data 
w 
w 
0 
Mevinolin no data no data no data no data no data mevinolinic acid no data 
6-hydroxy metabolite 
Mitomycin C no data yes h no data not readily biodegradable no data not known no data 
Nalidixic acid no data no data no data no data no data hydroxynalidixic acid no data 
glucuronic acid conjugates 
dicarboxylic acid derivative 
Naproxen 35.14 tons (in 2000) • no data yes ' not readily biodegradable .,. yes ' 6-desmethylnaproxen 78% Activated sludge STW d 
glucuronide conjugate 15% Biological filter STW d 
Propanolol 8. 16 tons (In 2000) • yes 1 yes ' no data yes' 4-hydroxypropranolol 96% Activated sludge STW • 
naphthoxylacetic acid 
w 
w 
CONT ... 
Compound Usage 
Quinidine no data 
Ranitidine 36.32 tons (in 2000) • 
a = (Sebastine & Wakeman, 2003). 
b= (Ternes, 2000) 
c= (Ternes, 1998) 
d= (Stumpf et al. 1999) 
e= (Ternes et al. 1999) 
f= (Boreen et al. 2003) 
g= (Stuer-Lauridsen et al. (2000) 
h= (Toxnet data) 
i= (Kopf 1995) 
j= Calleja et al. 1993) 
k= (Brooks et al. 2003) 
L= Halling-Sorensen et al. 1998) 
m= (Richardson and Bowron, 1985) 
n = (Loffier et al. 2005) 
Toxicity data Occurance 
yes " no data 
no data yes' 
•= photochemical data published by Lam et al., (2005) after selection 
Biodegradation Photodegradation Metabolltes Removal In STW 
not readily biodegradable no data 3-hydroxy-quinidine (3HQ) no data 
no data yes ' desmethylranitidine no data 
ranitidine-N-oxide 
ranitidine-S-oxide 
Appendix A3 Figure A.l - Diazepam Calibration Data 
Replicate Series 1 Replicate Series 2 Replicate Series 3 
100 100 l 100 
1 Oiaupom 2 110 mL·• Dloupom 2 ppm Oiaupom 2 110 ml"' 
l RT 7.21 RT: 7.18 RT: 7.13 Aru: 383001221 Ma: .CS1810718 MO: $002562~ 1 d1-oxanpam 1 J.lQ mL'"' d1.ouzeP>'m 1 ~ ml'' d.-oxazepem 1 110 mL • 
RT. 5.93 RT: 5.89 RT: 5.8e 
Ma: 112281599 MO: 123885738 Area: 117597883 
0 0 0 
100 . 100 ' 100 
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Replicate Series 1 
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Figure A.2- Nordiazepam Calibration Data 
Replicate Series 2 
d1-<)x.lzepam 1 J1G ml ·1 
RT: 5.93 
Area: 1•0713540 
d1-oxaupam 1 1'Q mL'1 f\ 
RT: 5.88 /1 I 
Area: 138763521 \ 
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Areo: 222627 466 
100 
Replicate Series 3 
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RT. 5.89 I\ Area· 156092659 
1 
\ 
Nordlazapam 0.5 ~g ml'' 
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Appendix A3 Figure A.3 - Temazepam Calibration Data 
Replicate Series 1 Replicate Series 2 Replicate Series 3 
100 j Temazepam 2 ~ mL·' 100 Tema.npam 2 J.iG mL·' 100 Temazepam 2 ..a mL., 
RT· &.69 RT: 6.69 RT: 6.63 
' 
Area: 524676292 Area. 546337972 Area: &31103755 
l d6~xazepam 1 JJQ ml '' d1<>u.zepam 1 I'll mL 4 d1-ouzep.m 1 ~ mt..·t 
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d1-ouHpam 1 I'll mL·' )1 Temazepam 1 J.I.U mL·1 ·· -·~~u Temaupam 1 f.L8 mL·' Tamuopam 1 I'll mL'' RT. 5.67 ~ RT· 6.67 RT: 5.66 RT: 6.63 d1-oxazepam 1 lo'Q ml:' RT: 6.70 1 Area: 156762797 Area: 256665642 
- "m""' l Area: 2&2310298 RT: 5.87 Area: 250622635 i l Area: 153673333 
oj _ __ju ol 0 
<U 
u 100 100 100 c: ~ d1-oxazepam 1 JAQ mL·' (1) ~ d,-<>xuepom 1 I'll mL· Temazepam 0.6 ~ mL:' Temaupam O.S...; mL'' d1-oxazepam 1 J1G mL., Tomuopam 0.8 I'll mL'' w "0 RT: 5.66 r RT: 6.66 RT: 5 .89 RT: 6.&7 RT: 5.91 RT: e.ee w c: ~ ~ Area: 1&5611«46 Area: 175392625 Area: 160540566 Area: 171876070 Area: 169n3112 ~ Area: 171191167 .c ~ oL <U ..JLJ > :00 0 0 (1) 
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Appendix A3 Figure A.4- Oxazepam Calibration Data* 
Replicate 1 
Oxazepam Concentration Oxazepam Peak 
(J.L9 ml-1) Area 
2.0 302506753 
1.0 156983777 
0.6 90378021 
0.3 30517942 
0.1 16319122 
Internal Std. 
(Oxazepam-d5) 
Peak Area 
154015225 
159530523 
153785784 
156343517 
166732012 
Replicate 2 
Oxazepam Peak 
Area 
313572343 
142532882 
93443139 
33262369 
15325919 
Internal Std. 
(Oxazepam-d5) 
Peak Area 
155918285 
155738105 
145938824 
166600377 
161730688 
Replicate 3 
Oxazepam Peak 
Area 
329665932 
150500872 
93456154 
28506044 
14553373 
Internal Std. 
(Oxazepam-d5) 
Peak Area 
153637849 
138223928 
155820568 
137364317 
155488562 
LC/ESI-MS Chromatograms for oxazepam and the internal standard (oxazepam-ds) yield one peak due to eo-elution ofthe compounds. 
Therefore extracted mass chromatograms (El C) for each compound (oxazepam, mlz 287.2 and oxazepam-d5, mlz 292.2) were used to 
calculate respective peak areas. 
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Figure A.S 151 Order kinetic plot of the change in concentration of diazepam 
degradation product I , 5-chloro-2-methylaminobenzophenone with 
increasing irradiation time in pure water. (Data points indicate mean 
(n=3); error bars represent± cr, n=3). 
*A greater correlation (R2 value) was found to occur using a Zero 
order kinetic plot (Chapter 3, Figure 3.27). 
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Figure A.6 151 Order kinetic plot of the change in concentration of diazepam 
degradation product Ill, 2-amino-5-cWorobenzophenone with 
increasing irradiation time in pure water. (Data points indicate mean 
(n=3); error bars represent± cr, n=3). 
*A greater correlation (R2 value) was found to occur using a Zero 
order kinetic plot (Chapter 3, Figure 3.33). 
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